id	sid	tid	token	lemma	pos
bam-8383	1	1	inos	ino	NOUN
bam-8383	1	2	inhibition	inhibition	VERB
bam-8383	1	3	for	for	ADP
bam-8383	1	4	vitiligo	vitiligo	PROPN
bam-8383	1	5	eur	eur	PROPN
bam-8383	1	6	j	j	PROPN
bam-8383	1	7	transl	transl	PROPN
bam-8383	1	8	myol	myol	ADV
bam-8383	1	9	29	29	NUM
bam-8383	1	10	(	(	PUNCT
bam-8383	1	11	3	3	NUM
bam-8383	1	12	):	):	PUNCT
bam-8383	1	13	251	251	NUM
bam-8383	1	14	-	-	SYM
bam-8383	1	15	260	260	NUM
bam-8383	1	16	,	,	PUNCT
bam-8383	1	17	2019	2019	NUM
bam-8383	1	18	251	251	NUM
bam-8383	1	19	therapeutic	therapeutic	ADJ
bam-8383	1	20	effects	effect	NOUN
bam-8383	1	21	of	of	ADP
bam-8383	1	22	inos	ino	NOUN
bam-8383	1	23	inhibition	inhibition	VERB
bam-8383	1	24	against	against	ADP
bam-8383	1	25	vitiligo	vitiligo	NOUN
bam-8383	1	26	in	in	ADP
bam-8383	1	27	an	an	DET
bam-8383	1	28	animal	animal	NOUN
bam-8383	1	29	model	model	NOUN
bam-8383	1	30	hamid	hamid	PROPN
bam-8383	1	31	mansourpour	mansourpour	PROPN
bam-8383	1	32	(	(	PUNCT
bam-8383	1	33	1	1	NUM
bam-8383	1	34	)	)	PUNCT
bam-8383	1	35	,	,	PUNCT
bam-8383	1	36	katayoun	katayoun	NOUN
bam-8383	1	37	ziari	ziari	X
bam-8383	1	38	(	(	PUNCT
bam-8383	1	39	2	2	NUM
bam-8383	1	40	)	)	PUNCT
bam-8383	1	41	,	,	PUNCT
bam-8383	1	42	sahar	sahar	PROPN
bam-8383	1	43	kalantar	kalantar	PROPN
bam-8383	1	44	motamedi	motamedi	PROPN
bam-8383	1	45	(	(	PUNCT
bam-8383	1	46	3	3	NUM
bam-8383	1	47	)	)	PUNCT
bam-8383	1	48	,	,	PUNCT
bam-8383	1	49	amin	amin	NOUN
bam-8383	1	50	hassan	hassan	PROPN
bam-8383	1	51	poor	poor	ADJ
bam-8383	1	52	(	(	PUNCT
bam-8383	1	53	4	4	NUM
bam-8383	1	54	)	)	PUNCT
bam-8383	1	55	(	(	PUNCT
bam-8383	1	56	1	1	X
bam-8383	1	57	)	)	PUNCT
bam-8383	1	58	shahid	shahid	NOUN
bam-8383	1	59	beheshti	beheshti	VERB
bam-8383	1	60	university	university	NOUN
bam-8383	1	61	of	of	ADP
bam-8383	1	62	medical	medical	ADJ
bam-8383	1	63	science	science	NOUN
bam-8383	1	64	,	,	PUNCT
bam-8383	1	65	tehran	tehran	PROPN
bam-8383	1	66	,	,	PUNCT
bam-8383	1	67	iran	iran	PROPN
bam-8383	1	68	and	and	CCONJ
bam-8383	1	69	aja	aja	PROPN
bam-8383	1	70	university	university	PROPN
bam-8383	1	71	of	of	ADP
bam-8383	1	72	medical	medical	ADJ
bam-8383	1	73	science	science	NOUN
bam-8383	1	74	,	,	PUNCT
bam-8383	1	75	tehran	tehran	PROPN
bam-8383	1	76	,	,	PUNCT
bam-8383	1	77	iran	iran	PROPN
bam-8383	1	78	;	;	PUNCT
bam-8383	1	79	(	(	PUNCT
bam-8383	1	80	2	2	X
bam-8383	1	81	)	)	PUNCT
bam-8383	1	82	department	department	NOUN
bam-8383	1	83	of	of	ADP
bam-8383	1	84	pathology	pathology	PROPN
bam-8383	1	85	,	,	PUNCT
bam-8383	1	86	aja	aja	PROPN
bam-8383	1	87	university	university	PROPN
bam-8383	1	88	of	of	ADP
bam-8383	1	89	medical	medical	ADJ
bam-8383	1	90	science	science	NOUN
bam-8383	1	91	,	,	PUNCT
bam-8383	1	92	tehran	tehran	PROPN
bam-8383	1	93	,	,	PUNCT
bam-8383	1	94	iran	iran	PROPN
bam-8383	1	95	;	;	PUNCT
bam-8383	1	96	(	(	PUNCT
bam-8383	1	97	3	3	X
bam-8383	1	98	)	)	PUNCT
bam-8383	1	99	shahid	shahid	NOUN
bam-8383	1	100	beheshti	beheshti	VERB
bam-8383	1	101	university	university	NOUN
bam-8383	1	102	of	of	ADP
bam-8383	1	103	medical	medical	ADJ
bam-8383	1	104	science	science	NOUN
bam-8383	1	105	,	,	PUNCT
bam-8383	1	106	tehran	tehran	PROPN
bam-8383	1	107	,	,	PUNCT
bam-8383	1	108	iran	iran	PROPN
bam-8383	1	109	;	;	PUNCT
bam-8383	1	110	(	(	PUNCT
bam-8383	1	111	4	4	X
bam-8383	1	112	)	)	PUNCT
bam-8383	1	113	tehran	tehran	PROPN
bam-8383	1	114	university	university	PROPN
bam-8383	1	115	of	of	ADP
bam-8383	1	116	medical	medical	ADJ
bam-8383	1	117	science	science	NOUN
bam-8383	1	118	,	,	PUNCT
bam-8383	1	119	tehran	tehran	PROPN
bam-8383	1	120	,	,	PUNCT
bam-8383	1	121	iran	iran	PROPN
bam-8383	1	122	this	this	DET
bam-8383	1	123	article	article	NOUN
bam-8383	1	124	is	be	AUX
bam-8383	1	125	distributed	distribute	VERB
bam-8383	1	126	under	under	ADP
bam-8383	1	127	the	the	DET
bam-8383	1	128	terms	term	NOUN
bam-8383	1	129	of	of	ADP
bam-8383	1	130	the	the	DET
bam-8383	1	131	creative	creative	ADJ
bam-8383	1	132	commons	common	NOUN
bam-8383	1	133	attribution	attribution	NOUN
bam-8383	1	134	noncommercial	noncommercial	ADJ
bam-8383	1	135	license	license	NOUN
bam-8383	1	136	(	(	PUNCT
bam-8383	1	137	cc	cc	NOUN
bam-8383	1	138	by	by	ADP
bam-8383	1	139	-	-	PUNCT
bam-8383	1	140	nc	nc	PROPN
bam-8383	1	141	4.0	4.0	NUM
bam-8383	1	142	)	)	PUNCT
bam-8383	1	143	which	which	PRON
bam-8383	1	144	permits	permit	VERB
bam-8383	1	145	any	any	DET
bam-8383	1	146	noncommercial	noncommercial	ADJ
bam-8383	1	147	use	use	NOUN
bam-8383	1	148	,	,	PUNCT
bam-8383	1	149	distribution	distribution	NOUN
bam-8383	1	150	,	,	PUNCT
bam-8383	1	151	and	and	CCONJ
bam-8383	1	152	reproduction	reproduction	NOUN
bam-8383	1	153	in	in	ADP
bam-8383	1	154	any	any	DET
bam-8383	1	155	medium	medium	NOUN
bam-8383	1	156	,	,	PUNCT
bam-8383	1	157	provided	provide	VERB
bam-8383	1	158	the	the	DET
bam-8383	1	159	original	original	ADJ
bam-8383	1	160	author(s	author(s	NOUN
bam-8383	1	161	)	)	PUNCT
bam-8383	1	162	and	and	CCONJ
bam-8383	1	163	source	source	NOUN
bam-8383	1	164	are	be	AUX
bam-8383	1	165	credited	credit	VERB
bam-8383	1	166	.	.	PUNCT
bam-8383	2	1	abstract	abstract	ADJ
bam-8383	2	2	nitric	nitric	ADJ
bam-8383	2	3	oxide	oxide	NOUN
bam-8383	2	4	(	(	PUNCT
bam-8383	2	5	no	no	NOUN
bam-8383	2	6	)	)	PUNCT
bam-8383	2	7	is	be	AUX
bam-8383	2	8	involved	involve	VERB
bam-8383	2	9	in	in	ADP
bam-8383	2	10	several	several	ADJ
bam-8383	2	11	biological	biological	ADJ
bam-8383	2	12	processes	process	NOUN
bam-8383	2	13	,	,	PUNCT
bam-8383	2	14	but	but	CCONJ
bam-8383	2	15	its	its	PRON
bam-8383	2	16	role	role	NOUN
bam-8383	2	17	in	in	ADP
bam-8383	2	18	human	human	ADJ
bam-8383	2	19	melanogenesis	melanogenesis	NOUN
bam-8383	2	20	and	and	CCONJ
bam-8383	2	21	vitiligo	vitiligo	VERB
bam-8383	2	22	need	need	VERB
bam-8383	2	23	further	further	ADJ
bam-8383	2	24	studies	study	NOUN
bam-8383	2	25	.	.	PUNCT
bam-8383	3	1	previous	previous	ADJ
bam-8383	3	2	studies	study	NOUN
bam-8383	3	3	revealed	reveal	VERB
bam-8383	3	4	that	that	SCONJ
bam-8383	3	5	exposure	exposure	NOUN
bam-8383	3	6	to	to	ADP
bam-8383	3	7	uva	uva	PROPN
bam-8383	3	8	and	and	CCONJ
bam-8383	3	9	uvb	uvb	NOUN
bam-8383	3	10	were	be	AUX
bam-8383	3	11	capable	capable	ADJ
bam-8383	3	12	of	of	ADP
bam-8383	3	13	the	the	DET
bam-8383	3	14	inducing	induce	VERB
bam-8383	3	15	nitric	nitric	ADJ
bam-8383	3	16	oxide	oxide	NOUN
bam-8383	3	17	production	production	NOUN
bam-8383	3	18	in	in	ADP
bam-8383	3	19	keratinocytes	keratinocyte	NOUN
bam-8383	3	20	and	and	CCONJ
bam-8383	3	21	melanocytes	melanocyte	NOUN
bam-8383	3	22	through	through	ADP
bam-8383	3	23	the	the	DET
bam-8383	3	24	activation	activation	NOUN
bam-8383	3	25	of	of	ADP
bam-8383	3	26	constitutive	constitutive	ADJ
bam-8383	3	27	nitric	nitric	ADJ
bam-8383	3	28	oxide	oxide	NOUN
bam-8383	3	29	synthase	synthase	NOUN
bam-8383	3	30	,	,	PUNCT
bam-8383	3	31	whereas	whereas	SCONJ
bam-8383	3	32	inducible	inducible	ADJ
bam-8383	3	33	nitric	nitric	ADJ
bam-8383	3	34	oxide	oxide	NOUN
bam-8383	3	35	synthase	synthase	NOUN
bam-8383	3	36	overexpression	overexpression	NOUN
bam-8383	3	37	has	have	AUX
bam-8383	3	38	been	be	AUX
bam-8383	3	39	reported	report	VERB
bam-8383	3	40	to	to	PART
bam-8383	3	41	play	play	VERB
bam-8383	3	42	an	an	DET
bam-8383	3	43	important	important	ADJ
bam-8383	3	44	role	role	NOUN
bam-8383	3	45	in	in	ADP
bam-8383	3	46	hyperpigmentary	hyperpigmentary	ADJ
bam-8383	3	47	disorders	disorder	NOUN
bam-8383	3	48	.	.	PUNCT
bam-8383	4	1	the	the	DET
bam-8383	4	2	aim	aim	NOUN
bam-8383	4	3	of	of	ADP
bam-8383	4	4	this	this	DET
bam-8383	4	5	study	study	NOUN
bam-8383	4	6	was	be	AUX
bam-8383	4	7	to	to	PART
bam-8383	4	8	evaluate	evaluate	VERB
bam-8383	4	9	inos	ino	NOUN
bam-8383	4	10	inhibitor	inhibitor	NOUN
bam-8383	4	11	aminoguanidine	aminoguanidine	NOUN
bam-8383	4	12	(	(	PUNCT
bam-8383	4	13	ag	ag	PROPN
bam-8383	4	14	)	)	PUNCT
bam-8383	4	15	as	as	ADP
bam-8383	4	16	a	a	DET
bam-8383	4	17	therapeutic	therapeutic	ADJ
bam-8383	4	18	agent	agent	NOUN
bam-8383	4	19	in	in	ADP
bam-8383	4	20	our	our	PRON
bam-8383	4	21	mouse	mouse	NOUN
bam-8383	4	22	model	model	NOUN
bam-8383	4	23	of	of	ADP
bam-8383	4	24	vitiligo	vitiligo	NOUN
bam-8383	4	25	.	.	PUNCT
bam-8383	5	1	in	in	ADP
bam-8383	5	2	this	this	DET
bam-8383	5	3	study	study	NOUN
bam-8383	5	4	,	,	PUNCT
bam-8383	5	5	male	male	ADJ
bam-8383	5	6	c57bl/6j	c57bl/6j	NOUN
bam-8383	5	7	ler	ler	PROPN
bam-8383	5	8	-	-	PUNCT
bam-8383	5	9	vit	vit	NOUN
bam-8383	5	10	/	/	SYM
bam-8383	5	11	vit	vit	ADJ
bam-8383	5	12	mice	mouse	NOUN
bam-8383	5	13	were	be	AUX
bam-8383	5	14	purchased	purchase	VERB
bam-8383	5	15	to	to	PART
bam-8383	5	16	evaluate	evaluate	VERB
bam-8383	5	17	the	the	DET
bam-8383	5	18	effect	effect	NOUN
bam-8383	5	19	of	of	ADP
bam-8383	5	20	inos	ino	NOUN
bam-8383	5	21	inhibitor	inhibitor	NOUN
bam-8383	5	22	(	(	PUNCT
bam-8383	5	23	aminoguanidine	aminoguanidine	NOUN
bam-8383	5	24	)	)	PUNCT
bam-8383	5	25	(	(	PUNCT
bam-8383	5	26	50	50	NUM
bam-8383	5	27	and	and	CCONJ
bam-8383	5	28	100	100	NUM
bam-8383	5	29	mg	mg	NUM
bam-8383	5	30	/	/	SYM
bam-8383	5	31	kg	kg	NOUN
bam-8383	5	32	)	)	PUNCT
bam-8383	5	33	and	and	CCONJ
bam-8383	5	34	l	l	NOUN
bam-8383	5	35	-	-	NOUN
bam-8383	5	36	arginine	arginine	NOUN
bam-8383	5	37	(	(	PUNCT
bam-8383	5	38	100	100	NUM
bam-8383	5	39	mg	mg	NUM
bam-8383	5	40	/	/	SYM
bam-8383	5	41	kg	kg	NOUN
bam-8383	5	42	)	)	PUNCT
bam-8383	5	43	in	in	ADP
bam-8383	5	44	a	a	DET
bam-8383	5	45	mouse	mouse	NOUN
bam-8383	5	46	model	model	NOUN
bam-8383	5	47	of	of	ADP
bam-8383	5	48	vitiligo	vitiligo	NOUN
bam-8383	5	49	induced	induce	VERB
bam-8383	5	50	by	by	ADP
bam-8383	5	51	monobenzone	monobenzone	NOUN
bam-8383	5	52	40	40	NUM
bam-8383	5	53	%	%	NOUN
bam-8383	5	54	.	.	PUNCT
bam-8383	6	1	moreover	moreover	ADV
bam-8383	6	2	,	,	PUNCT
bam-8383	6	3	we	we	PRON
bam-8383	6	4	used	use	VERB
bam-8383	6	5	phototherapy	phototherapy	NOUN
bam-8383	6	6	device	device	NOUN
bam-8383	6	7	to	to	PART
bam-8383	6	8	treat	treat	VERB
bam-8383	6	9	the	the	DET
bam-8383	6	10	mice	mouse	NOUN
bam-8383	6	11	with	with	ADP
bam-8383	6	12	nbuvb	nbuvb	NOUN
bam-8383	6	13	as	as	ADP
bam-8383	6	14	a	a	DET
bam-8383	6	15	gold	gold	NOUN
bam-8383	6	16	standard.the	standard.the	DET
bam-8383	6	17	findings	finding	NOUN
bam-8383	6	18	revealed	reveal	VERB
bam-8383	6	19	that	that	SCONJ
bam-8383	6	20	monobenzone	monobenzone	NOUN
bam-8383	6	21	was	be	AUX
bam-8383	6	22	capable	capable	ADJ
bam-8383	6	23	of	of	ADP
bam-8383	6	24	inducing	induce	VERB
bam-8383	6	25	depigmentation	depigmentation	NOUN
bam-8383	6	26	after	after	ADP
bam-8383	6	27	6	6	NUM
bam-8383	6	28	weeks	week	NOUN
bam-8383	6	29	.	.	PUNCT
bam-8383	7	1	however	however	ADV
bam-8383	7	2	,	,	PUNCT
bam-8383	7	3	aminoguanidine	aminoguanidine	NOUN
bam-8383	7	4	in	in	ADP
bam-8383	7	5	combination	combination	NOUN
bam-8383	7	6	with	with	ADP
bam-8383	7	7	monobenzone	monobenzone	NOUN
bam-8383	7	8	was	be	AUX
bam-8383	7	9	decrease	decrease	VERB
bam-8383	7	10	the	the	DET
bam-8383	7	11	effect	effect	NOUN
bam-8383	7	12	of	of	ADP
bam-8383	7	13	monobenzone	monobenzone	NOUN
bam-8383	7	14	,	,	PUNCT
bam-8383	7	15	while	while	SCONJ
bam-8383	7	16	l	l	NOUN
bam-8383	7	17	-	-	NOUN
bam-8383	7	18	arginine	arginine	NOUN
bam-8383	7	19	play	play	VERB
bam-8383	7	20	a	a	DET
bam-8383	7	21	key	key	ADJ
bam-8383	7	22	role	role	NOUN
bam-8383	7	23	in	in	ADP
bam-8383	7	24	promoting	promote	VERB
bam-8383	7	25	the	the	DET
bam-8383	7	26	effect	effect	NOUN
bam-8383	7	27	of	of	ADP
bam-8383	7	28	monobenzone	monobenzone	NOUN
bam-8383	7	29	(	(	PUNCT
bam-8383	7	30	p<0.001	p<0.001	PROPN
bam-8383	7	31	)	)	PUNCT
bam-8383	7	32	.	.	PUNCT
bam-8383	8	1	based	base	VERB
bam-8383	8	2	on	on	ADP
bam-8383	8	3	the	the	DET
bam-8383	8	4	phototherapy	phototherapy	NOUN
bam-8383	8	5	,	,	PUNCT
bam-8383	8	6	the	the	DET
bam-8383	8	7	efficacy	efficacy	NOUN
bam-8383	8	8	of	of	ADP
bam-8383	8	9	phototherapy	phototherapy	NOUN
bam-8383	8	10	significantly	significantly	ADV
bam-8383	8	11	increased	increase	VERB
bam-8383	8	12	by	by	ADP
bam-8383	8	13	adding	add	VERB
bam-8383	8	14	l	l	NOUN
bam-8383	8	15	-	-	NOUN
bam-8383	8	16	arginine	arginine	NOUN
bam-8383	8	17	(	(	PUNCT
bam-8383	8	18	p<0.05	p<0.05	NOUN
bam-8383	8	19	)	)	PUNCT
bam-8383	8	20	.	.	PUNCT
bam-8383	9	1	taken	take	VERB
bam-8383	9	2	together	together	ADV
bam-8383	9	3	,	,	PUNCT
bam-8383	9	4	we	we	PRON
bam-8383	9	5	suggest	suggest	VERB
bam-8383	9	6	that	that	SCONJ
bam-8383	9	7	inos	ino	NOUN
bam-8383	9	8	inhibitor	inhibitor	NOUN
bam-8383	9	9	can	can	AUX
bam-8383	9	10	be	be	AUX
bam-8383	9	11	a	a	DET
bam-8383	9	12	novel	novel	ADJ
bam-8383	9	13	treatment	treatment	NOUN
bam-8383	9	14	for	for	ADP
bam-8383	9	15	the	the	DET
bam-8383	9	16	prevention	prevention	NOUN
bam-8383	9	17	and	and	CCONJ
bam-8383	9	18	treatment	treatment	NOUN
bam-8383	9	19	of	of	ADP
bam-8383	9	20	vitiligo	vitiligo	NOUN
bam-8383	9	21	by	by	ADP
bam-8383	9	22	combination	combination	NOUN
bam-8383	9	23	of	of	ADP
bam-8383	9	24	nbuvb	nbuvb	ADJ
bam-8383	9	25	therapy	therapy	NOUN
bam-8383	9	26	,	,	PUNCT
bam-8383	9	27	furthermore	furthermore	ADV
bam-8383	9	28	;	;	PUNCT
bam-8383	9	29	no	no	DET
bam-8383	9	30	agents	agent	NOUN
bam-8383	9	31	like	like	ADP
bam-8383	9	32	l	l	NOUN
bam-8383	9	33	-	-	NOUN
bam-8383	9	34	arginine	arginine	NOUN
bam-8383	9	35	could	could	AUX
bam-8383	9	36	also	also	ADV
bam-8383	9	37	increase	increase	VERB
bam-8383	9	38	the	the	DET
bam-8383	9	39	effectiveness	effectiveness	NOUN
bam-8383	9	40	of	of	ADP
bam-8383	9	41	phototherapy	phototherapy	NOUN
bam-8383	9	42	.	.	PUNCT
bam-8383	10	1	taken	take	VERB
bam-8383	10	2	together	together	ADV
bam-8383	10	3	,	,	PUNCT
bam-8383	10	4	this	this	DET
bam-8383	10	5	pilot	pilot	NOUN
bam-8383	10	6	study	study	NOUN
bam-8383	10	7	showed	show	VERB
bam-8383	10	8	significant	significant	ADJ
bam-8383	10	9	repigmentation	repigmentation	NOUN
bam-8383	10	10	of	of	ADP
bam-8383	10	11	vitiligous	vitiligous	ADJ
bam-8383	10	12	lesions	lesion	NOUN
bam-8383	10	13	treated	treat	VERB
bam-8383	10	14	with	with	ADP
bam-8383	10	15	inos	ino	NOUN
bam-8383	10	16	inhibitor	inhibitor	NOUN
bam-8383	10	17	plus	plus	CCONJ
bam-8383	10	18	nbuvb	nbuvb	ADJ
bam-8383	10	19	therapy	therapy	NOUN
bam-8383	10	20	,	,	PUNCT
bam-8383	10	21	where	where	SCONJ
bam-8383	10	22	other	other	ADJ
bam-8383	10	23	aspect	aspect	NOUN
bam-8383	10	24	including	include	VERB
bam-8383	10	25	expression	expression	NOUN
bam-8383	10	26	of	of	ADP
bam-8383	10	27	an	an	DET
bam-8383	10	28	inducible	inducible	ADJ
bam-8383	10	29	inos	ino	NOUN
bam-8383	10	30	,	,	PUNCT
bam-8383	10	31	no	no	PRON
bam-8383	10	32	and	and	CCONJ
bam-8383	10	33	tnf	tnf	PROPN
bam-8383	10	34	levels	level	NOUN
bam-8383	10	35	remained	remain	VERB
bam-8383	10	36	to	to	PART
bam-8383	10	37	be	be	AUX
bam-8383	10	38	evaluated	evaluate	VERB
bam-8383	10	39	in	in	ADP
bam-8383	10	40	mice	mouse	NOUN
bam-8383	10	41	model	model	NOUN
bam-8383	10	42	.	.	PUNCT
bam-8383	11	1	key	key	ADJ
bam-8383	11	2	words	word	NOUN
bam-8383	11	3	:	:	PUNCT
bam-8383	11	4	vitiligo	vitiligo	NOUN
bam-8383	11	5	,	,	PUNCT
bam-8383	11	6	nitric	nitric	ADJ
bam-8383	11	7	oxide	oxide	NOUN
bam-8383	11	8	,	,	PUNCT
bam-8383	11	9	inos	ino	NOUN
bam-8383	11	10	,	,	PUNCT
bam-8383	11	11	monobenzone	monobenzone	NOUN
bam-8383	11	12	,	,	PUNCT
bam-8383	11	13	treatment	treatment	NOUN
bam-8383	11	14	.	.	PUNCT
bam-8383	12	1	eur	eur	PROPN
bam-8383	12	2	j	j	PROPN
bam-8383	12	3	transl	transl	PROPN
bam-8383	12	4	myol	myol	ADV
bam-8383	12	5	29	29	NUM
bam-8383	12	6	(	(	PUNCT
bam-8383	12	7	3	3	NUM
bam-8383	12	8	):	):	PUNCT
bam-8383	12	9	251	251	NUM
bam-8383	12	10	-	-	SYM
bam-8383	12	11	260	260	NUM
bam-8383	12	12	,	,	PUNCT
bam-8383	12	13	2019	2019	NUM
bam-8383	12	14	vitiligo	vitiligo	VERB
bam-8383	12	15	,	,	PUNCT
bam-8383	12	16	a	a	DET
bam-8383	12	17	skin	skin	NOUN
bam-8383	12	18	disease	disease	NOUN
bam-8383	12	19	,	,	PUNCT
bam-8383	12	20	is	be	AUX
bam-8383	12	21	a	a	DET
bam-8383	12	22	common	common	ADJ
bam-8383	12	23	progressive	progressive	ADJ
bam-8383	12	24	depigmentation	depigmentation	NOUN
bam-8383	12	25	of	of	ADP
bam-8383	12	26	epidermis	epidermis	NOUN
bam-8383	12	27	that	that	PRON
bam-8383	12	28	results	result	VERB
bam-8383	12	29	in	in	ADP
bam-8383	12	30	the	the	DET
bam-8383	12	31	destruction	destruction	NOUN
bam-8383	12	32	of	of	ADP
bam-8383	12	33	melanocytes	melanocyte	NOUN
bam-8383	12	34	in	in	ADP
bam-8383	12	35	the	the	DET
bam-8383	12	36	depigmented	depigmented	ADJ
bam-8383	12	37	parts	part	NOUN
bam-8383	12	38	of	of	ADP
bam-8383	12	39	the	the	DET
bam-8383	12	40	skin	skin	NOUN
bam-8383	12	41	,	,	PUNCT
bam-8383	12	42	mucous	mucous	ADJ
bam-8383	12	43	membrane	membrane	NOUN
bam-8383	12	44	and	and	CCONJ
bam-8383	12	45	retinal	retinal	ADJ
bam-8383	12	46	wall	wall	NOUN
bam-8383	12	47	.	.	PUNCT
bam-8383	13	1	as	as	ADP
bam-8383	13	2	a	a	DET
bam-8383	13	3	result	result	NOUN
bam-8383	13	4	,	,	PUNCT
bam-8383	13	5	irregular	irregular	ADJ
bam-8383	13	6	white	white	ADJ
bam-8383	13	7	patches	patch	NOUN
bam-8383	13	8	appear	appear	VERB
bam-8383	13	9	in	in	ADP
bam-8383	13	10	different	different	ADJ
bam-8383	13	11	areas	area	NOUN
bam-8383	13	12	of	of	ADP
bam-8383	13	13	the	the	DET
bam-8383	13	14	body	body	NOUN
bam-8383	13	15	.	.	PUNCT
bam-8383	14	1	vitiligo	vitiligo	PROPN
bam-8383	14	2	has	have	AUX
bam-8383	14	3	been	be	AUX
bam-8383	14	4	estimated	estimate	VERB
bam-8383	14	5	to	to	PART
bam-8383	14	6	be	be	AUX
bam-8383	14	7	one	one	NUM
bam-8383	14	8	of	of	ADP
bam-8383	14	9	the	the	DET
bam-8383	14	10	most	most	ADV
bam-8383	14	11	frequent	frequent	ADJ
bam-8383	14	12	pigmentary	pigmentary	NOUN
bam-8383	14	13	diseases	disease	NOUN
bam-8383	14	14	,	,	PUNCT
bam-8383	14	15	accounting	account	VERB
bam-8383	14	16	for	for	ADP
bam-8383	14	17	about	about	ADV
bam-8383	14	18	0.1	0.1	NUM
bam-8383	14	19	–	–	PUNCT
bam-8383	14	20	2	2	NUM
bam-8383	14	21	%	%	NOUN
bam-8383	14	22	of	of	ADP
bam-8383	14	23	the	the	DET
bam-8383	14	24	worldwide	worldwide	ADJ
bam-8383	14	25	population.1	population.1	NOUN
bam-8383	14	26	-	-	PUNCT
bam-8383	14	27	3	3	NUM
bam-8383	14	28	the	the	DET
bam-8383	14	29	pathophysiology	pathophysiology	NOUN
bam-8383	14	30	of	of	ADP
bam-8383	14	31	this	this	DET
bam-8383	14	32	disease	disease	NOUN
bam-8383	14	33	is	be	AUX
bam-8383	14	34	not	not	PART
bam-8383	14	35	well	well	ADV
bam-8383	14	36	understood	understand	VERB
bam-8383	14	37	;	;	PUNCT
bam-8383	14	38	however	however	ADV
bam-8383	14	39	,	,	PUNCT
bam-8383	14	40	several	several	ADJ
bam-8383	14	41	theories	theory	NOUN
bam-8383	14	42	about	about	ADP
bam-8383	14	43	the	the	DET
bam-8383	14	44	pathomechanism	pathomechanism	NOUN
bam-8383	14	45	of	of	ADP
bam-8383	14	46	vitiligo	vitiligo	NOUN
bam-8383	14	47	have	have	AUX
bam-8383	14	48	been	be	AUX
bam-8383	14	49	previously	previously	ADV
bam-8383	14	50	defined	define	VERB
bam-8383	14	51	,	,	PUNCT
bam-8383	14	52	such	such	ADJ
bam-8383	14	53	as	as	ADP
bam-8383	14	54	genetic	genetic	ADJ
bam-8383	14	55	,	,	PUNCT
bam-8383	14	56	biochemical	biochemical	ADJ
bam-8383	14	57	,	,	PUNCT
bam-8383	14	58	immunological	immunological	ADJ
bam-8383	14	59	,	,	PUNCT
bam-8383	14	60	and	and	CCONJ
bam-8383	14	61	environmental	environmental	ADJ
bam-8383	14	62	theories.4,5	theories.4,5	NOUN
bam-8383	14	63	on	on	ADP
bam-8383	14	64	the	the	DET
bam-8383	14	65	other	other	ADJ
bam-8383	14	66	hand	hand	NOUN
bam-8383	14	67	,	,	PUNCT
bam-8383	14	68	increasing	increase	VERB
bam-8383	14	69	evidence	evidence	NOUN
bam-8383	14	70	indicated	indicate	VERB
bam-8383	14	71	that	that	SCONJ
bam-8383	14	72	there	there	PRON
bam-8383	14	73	has	have	VERB
bam-8383	14	74	a	a	DET
bam-8383	14	75	correlation	correlation	NOUN
bam-8383	14	76	between	between	ADP
bam-8383	14	77	vitiligo	vitiligo	NOUN
bam-8383	14	78	and	and	CCONJ
bam-8383	14	79	other	other	ADJ
bam-8383	14	80	autoimmune	autoimmune	ADJ
bam-8383	14	81	disease	disease	NOUN
bam-8383	14	82	of	of	ADP
bam-8383	14	83	the	the	DET
bam-8383	14	84	endocrine	endocrine	ADJ
bam-8383	14	85	glands,6,7	glands,6,7	PROPN
bam-8383	14	86	as	as	ADV
bam-8383	14	87	well	well	ADV
bam-8383	14	88	as	as	ADP
bam-8383	14	89	a	a	DET
bam-8383	14	90	lymphocytic	lymphocytic	ADJ
bam-8383	14	91	infiltrate	infiltrate	NOUN
bam-8383	14	92	was	be	AUX
bam-8383	14	93	found	find	VERB
bam-8383	14	94	to	to	PART
bam-8383	14	95	play	play	VERB
bam-8383	14	96	an	an	DET
bam-8383	14	97	important	important	ADJ
bam-8383	14	98	role	role	NOUN
bam-8383	14	99	in	in	ADP
bam-8383	14	100	development	development	NOUN
bam-8383	14	101	of	of	ADP
bam-8383	14	102	disease	disease	NOUN
bam-8383	14	103	when	when	SCONJ
bam-8383	14	104	detected	detect	VERB
bam-8383	14	105	in	in	ADP
bam-8383	14	106	perilesional	perilesional	ADJ
bam-8383	14	107	skin	skin	NOUN
bam-8383	14	108	of	of	ADP
bam-8383	14	109	actively	actively	ADV
bam-8383	14	110	spreading	spread	VERB
bam-8383	14	111	vitiligo.8	vitiligo.8	NOUN
bam-8383	14	112	several	several	ADJ
bam-8383	14	113	cell	cell	NOUN
bam-8383	14	114	lines	line	NOUN
bam-8383	14	115	has	have	AUX
bam-8383	14	116	been	be	AUX
bam-8383	14	117	described	describe	VERB
bam-8383	14	118	to	to	PART
bam-8383	14	119	play	play	VERB
bam-8383	14	120	their	their	PRON
bam-8383	14	121	role	role	NOUN
bam-8383	14	122	in	in	ADP
bam-8383	14	123	vitiligo	vitiligo	ADJ
bam-8383	14	124	development	development	NOUN
bam-8383	14	125	including	include	VERB
bam-8383	14	126	lymphocytes	lymphocyte	NOUN
bam-8383	14	127	,	,	PUNCT
bam-8383	14	128	keratinocytes	keratinocyte	NOUN
bam-8383	14	129	,	,	PUNCT
bam-8383	14	130	and	and	CCONJ
bam-8383	14	131	endothelial	endothelial	ADJ
bam-8383	14	132	cells	cell	NOUN
bam-8383	14	133	,	,	PUNCT
bam-8383	14	134	involving	involve	VERB
bam-8383	14	135	in	in	ADP
bam-8383	14	136	melanocyte	melanocyte	NOUN
bam-8383	14	137	migration	migration	NOUN
bam-8383	14	138	,	,	PUNCT
bam-8383	14	139	proliferation	proliferation	NOUN
bam-8383	14	140	,	,	PUNCT
bam-8383	14	141	and	and	CCONJ
bam-8383	14	142	differentiation.2	differentiation.2	ADJ
bam-8383	14	143	,	,	PUNCT
bam-8383	14	144	9	9	NUM
bam-8383	14	145	-	-	SYM
bam-8383	14	146	11	11	NUM
bam-8383	14	147	increasing	increase	VERB
bam-8383	14	148	evidence	evidence	NOUN
bam-8383	14	149	supports	support	VERB
bam-8383	14	150	that	that	SCONJ
bam-8383	14	151	vitiligo	vitiligo	NOUN
bam-8383	14	152	could	could	AUX
bam-8383	14	153	be	be	AUX
bam-8383	14	154	a	a	DET
bam-8383	14	155	disorder	disorder	NOUN
bam-8383	14	156	of	of	ADP
bam-8383	14	157	the	the	DET
bam-8383	14	158	entire	entire	ADJ
bam-8383	14	159	epidermal	epidermal	ADJ
bam-8383	14	160	melanin	melanin	NOUN
bam-8383	14	161	unit.12	unit.12	NOUN
bam-8383	14	162	especially	especially	ADV
bam-8383	14	163	,	,	PUNCT
bam-8383	14	164	keratinocytes	keratinocyte	NOUN
bam-8383	14	165	has	have	AUX
bam-8383	14	166	been	be	AUX
bam-8383	14	167	revealed	reveal	VERB
bam-8383	14	168	to	to	PART
bam-8383	14	169	contribute	contribute	VERB
bam-8383	14	170	to	to	ADP
bam-8383	14	171	the	the	DET
bam-8383	14	172	melanocyte	melanocyte	NOUN
bam-8383	14	173	homeostasis	homeostasis	NOUN
bam-8383	14	174	and	and	CCONJ
bam-8383	14	175	its	its	PRON
bam-8383	14	176	changes	change	NOUN
bam-8383	14	177	affecting	affect	VERB
bam-8383	14	178	melanocyte	melanocyte	NOUN
bam-8383	14	179	dysfunction	dysfunction	NOUN
bam-8383	14	180	in	in	ADP
bam-8383	14	181	vitiligo	vitiligo	NOUN
bam-8383	14	182	epidermis.1,13,14	epidermis.1,13,14	ADV
bam-8383	14	183	vitiligo	vitiligo	PROPN
bam-8383	14	184	has	have	AUX
bam-8383	14	185	been	be	AUX
bam-8383	14	186	defined	define	VERB
bam-8383	14	187	as	as	ADP
bam-8383	14	188	a	a	DET
bam-8383	14	189	multifactorial	multifactorial	ADJ
bam-8383	14	190	disease	disease	NOUN
bam-8383	14	191	with	with	ADP
bam-8383	14	192	autocytotoxic	autocytotoxic	ADJ
bam-8383	14	193	,	,	PUNCT
bam-8383	14	194	neural	neural	ADJ
bam-8383	14	195	,	,	PUNCT
bam-8383	14	196	and	and	CCONJ
bam-8383	14	197	autoimmune	autoimmune	ADJ
bam-8383	14	198	susceptibilities	susceptibility	NOUN
bam-8383	14	199	as	as	ADV
bam-8383	14	200	well	well	ADV
bam-8383	14	201	as	as	ADP
bam-8383	14	202	environmental	environmental	ADJ
bam-8383	14	203	factors.15,16	factors.15,16	ADJ
bam-8383	14	204	nitric	nitric	ADJ
bam-8383	14	205	oxide	oxide	NOUN
bam-8383	14	206	as	as	SCONJ
bam-8383	14	207	an	an	DET
bam-8383	14	208	intracellular	intracellular	ADJ
bam-8383	14	209	messenger	messenger	NOUN
bam-8383	14	210	plays	play	VERB
bam-8383	14	211	an	an	DET
bam-8383	14	212	important	important	ADJ
bam-8383	14	213	role	role	NOUN
bam-8383	14	214	in	in	ADP
bam-8383	14	215	the	the	DET
bam-8383	14	216	synthesis	synthesis	NOUN
bam-8383	14	217	of	of	ADP
bam-8383	14	218	an	an	DET
bam-8383	14	219	enzyme	enzyme	NOUN
bam-8383	14	220	called	call	VERB
bam-8383	14	221	no	no	DET
bam-8383	14	222	synthase	synthase	NOUN
bam-8383	14	223	,	,	PUNCT
bam-8383	14	224	which	which	PRON
bam-8383	14	225	consists	consist	VERB
bam-8383	14	226	of	of	ADP
bam-8383	14	227	three	three	NUM
bam-8383	14	228	non	non	X
bam-8383	14	229	co	co	X
bam-8383	14	230	mmerc	mmerc	PROPN
bam-8383	14	231	ial	ial	PROPN
bam-8383	14	232	us	us	PROPN
bam-8383	14	233	e	e	NOUN
bam-8383	14	234	o	o	NOUN
bam-8383	14	235	nly	nly	ADV
bam-8383	14	236	inos	ino	NOUN
bam-8383	14	237	inhibition	inhibition	NOUN
bam-8383	14	238	for	for	ADP
bam-8383	14	239	vitiligo	vitiligo	PROPN
bam-8383	14	240	eur	eur	PROPN
bam-8383	14	241	j	j	PROPN
bam-8383	14	242	transl	transl	PROPN
bam-8383	14	243	myol	myol	ADV
bam-8383	14	244	29	29	NUM
bam-8383	14	245	(	(	PUNCT
bam-8383	14	246	3	3	NUM
bam-8383	14	247	):	):	PUNCT
bam-8383	14	248	251	251	NUM
bam-8383	14	249	-	-	SYM
bam-8383	14	250	260	260	NUM
bam-8383	14	251	,	,	PUNCT
bam-8383	14	252	2019	2019	NUM
bam-8383	14	253	252	252	NUM
bam-8383	14	254	isoforms	isoform	NOUN
bam-8383	14	255	:	:	PUNCT
bam-8383	14	256	inducible	inducible	ADJ
bam-8383	14	257	nos	no	NOUN
bam-8383	14	258	(	(	PUNCT
bam-8383	14	259	inos	ino	NOUN
bam-8383	14	260	)	)	PUNCT
bam-8383	14	261	,	,	PUNCT
bam-8383	14	262	neuronal	neuronal	ADJ
bam-8383	14	263	nos	no	NOUN
bam-8383	14	264	(	(	PUNCT
bam-8383	14	265	nnos	nno	NOUN
bam-8383	14	266	)	)	PUNCT
bam-8383	14	267	,	,	PUNCT
bam-8383	14	268	and	and	CCONJ
bam-8383	14	269	endothelial	endothelial	ADJ
bam-8383	14	270	nos	nos	X
bam-8383	14	271	(	(	PUNCT
bam-8383	14	272	enos).17	enos).17	PROPN
bam-8383	14	273	-	-	PUNCT
bam-8383	14	274	30	30	NUM
bam-8383	14	275	nitric	nitric	ADJ
bam-8383	14	276	oxide	oxide	NOUN
bam-8383	14	277	has	have	AUX
bam-8383	14	278	been	be	AUX
bam-8383	14	279	suggested	suggest	VERB
bam-8383	14	280	as	as	ADP
bam-8383	14	281	a	a	DET
bam-8383	14	282	potential	potential	ADJ
bam-8383	14	283	factor	factor	NOUN
bam-8383	14	284	in	in	ADP
bam-8383	14	285	inhibiting	inhibit	VERB
bam-8383	14	286	cell	cell	NOUN
bam-8383	14	287	proliferation	proliferation	NOUN
bam-8383	14	288	,	,	PUNCT
bam-8383	14	289	differentiation	differentiation	NOUN
bam-8383	14	290	,	,	PUNCT
bam-8383	14	291	and	and	CCONJ
bam-8383	14	292	apoptosis	apoptosis	NOUN
bam-8383	14	293	.	.	PUNCT
bam-8383	15	1	this	this	DET
bam-8383	15	2	free	free	ADJ
bam-8383	15	3	radical	radical	ADJ
bam-8383	15	4	gas	gas	NOUN
bam-8383	15	5	can	can	AUX
bam-8383	15	6	be	be	AUX
bam-8383	15	7	considered	consider	VERB
bam-8383	15	8	as	as	ADP
bam-8383	15	9	a	a	DET
bam-8383	15	10	great	great	ADJ
bam-8383	15	11	challenge	challenge	NOUN
bam-8383	15	12	,	,	PUNCT
bam-8383	15	13	when	when	SCONJ
bam-8383	15	14	a	a	DET
bam-8383	15	15	key	key	ADJ
bam-8383	15	16	role	role	NOUN
bam-8383	15	17	plays	play	VERB
bam-8383	15	18	in	in	ADP
bam-8383	15	19	pathogenesis	pathogenesis	NOUN
bam-8383	15	20	of	of	ADP
bam-8383	15	21	a	a	DET
bam-8383	15	22	lot	lot	NOUN
bam-8383	15	23	of	of	ADP
bam-8383	15	24	kind	kind	NOUN
bam-8383	15	25	of	of	ADP
bam-8383	15	26	autoimmune	autoimmune	ADJ
bam-8383	15	27	diseases	disease	NOUN
bam-8383	15	28	such	such	ADJ
bam-8383	15	29	as	as	ADP
bam-8383	15	30	vitiligo	vitiligo	NOUN
bam-8383	15	31	.	.	PUNCT
bam-8383	16	1	additionally	additionally	ADV
bam-8383	16	2	,	,	PUNCT
bam-8383	16	3	it	it	PRON
bam-8383	16	4	is	be	AUX
bam-8383	16	5	likely	likely	ADJ
bam-8383	16	6	to	to	PART
bam-8383	16	7	be	be	AUX
bam-8383	16	8	involved	involve	VERB
bam-8383	16	9	,	,	PUNCT
bam-8383	16	10	not	not	PART
bam-8383	16	11	only	only	ADV
bam-8383	16	12	in	in	ADP
bam-8383	16	13	melanocyte	melanocyte	ADJ
bam-8383	16	14	dysfunction	dysfunction	NOUN
bam-8383	16	15	and/or	and/or	CCONJ
bam-8383	16	16	destruction	destruction	NOUN
bam-8383	16	17	,	,	PUNCT
bam-8383	16	18	but	but	CCONJ
bam-8383	16	19	also	also	ADV
bam-8383	16	20	in	in	ADP
bam-8383	16	21	the	the	DET
bam-8383	16	22	accumulating	accumulate	VERB
bam-8383	16	23	toxic	toxic	ADJ
bam-8383	16	24	intermediates	intermediate	NOUN
bam-8383	16	25	of	of	ADP
bam-8383	16	26	melanin	melanin	NOUN
bam-8383	16	27	synthesis	synthesis	NOUN
bam-8383	16	28	and	and	CCONJ
bam-8383	16	29	in	in	ADP
bam-8383	16	30	elevating	elevate	VERB
bam-8383	16	31	reactive	reactive	ADJ
bam-8383	16	32	oxygen	oxygen	NOUN
bam-8383	16	33	species.17	species.17	PROPN
bam-8383	16	34	-	-	PUNCT
bam-8383	16	35	20,22	20,22	NUM
bam-8383	16	36	-	-	PUNCT
bam-8383	16	37	27	27	NUM
bam-8383	16	38	a	a	DET
bam-8383	16	39	growing	grow	VERB
bam-8383	16	40	body	body	NOUN
bam-8383	16	41	of	of	ADP
bam-8383	16	42	evidence	evidence	NOUN
bam-8383	16	43	highlights	highlight	NOUN
bam-8383	16	44	that	that	DET
bam-8383	16	45	exposure	exposure	NOUN
bam-8383	16	46	to	to	ADP
bam-8383	16	47	uva	uva	PROPN
bam-8383	16	48	and	and	CCONJ
bam-8383	16	49	uvb	uvb	NOUN
bam-8383	16	50	may	may	AUX
bam-8383	16	51	be	be	AUX
bam-8383	16	52	capable	capable	ADJ
bam-8383	16	53	of	of	ADP
bam-8383	16	54	producing	produce	VERB
bam-8383	16	55	nitric	nitric	ADJ
bam-8383	16	56	oxide	oxide	NOUN
bam-8383	16	57	,	,	PUNCT
bam-8383	16	58	especially	especially	ADV
bam-8383	16	59	in	in	ADP
bam-8383	16	60	keratinocytes	keratinocyte	NOUN
bam-8383	16	61	and	and	CCONJ
bam-8383	16	62	melanocytes	melanocyte	NOUN
bam-8383	16	63	,	,	PUNCT
bam-8383	16	64	where	where	SCONJ
bam-8383	16	65	it	it	PRON
bam-8383	16	66	is	be	AUX
bam-8383	16	67	involved	involve	VERB
bam-8383	16	68	,	,	PUNCT
bam-8383	16	69	not	not	PART
bam-8383	16	70	only	only	ADV
bam-8383	16	71	in	in	ADP
bam-8383	16	72	increasing	increase	VERB
bam-8383	16	73	tyrosinase	tyrosinase	ADJ
bam-8383	16	74	activity	activity	NOUN
bam-8383	16	75	via	via	ADP
bam-8383	16	76	activating	activate	VERB
bam-8383	16	77	constitutive	constitutive	ADJ
bam-8383	16	78	nos	no	NOUN
bam-8383	16	79	,	,	PUNCT
bam-8383	16	80	but	but	CCONJ
bam-8383	16	81	also	also	ADV
bam-8383	16	82	in	in	ADP
bam-8383	16	83	the	the	DET
bam-8383	16	84	synthesis	synthesis	NOUN
bam-8383	16	85	melanin.21	melanin.21	NOUN
bam-8383	16	86	,	,	PUNCT
bam-8383	16	87	31	31	NUM
bam-8383	16	88	the	the	DET
bam-8383	16	89	use	use	NOUN
bam-8383	16	90	of	of	ADP
bam-8383	16	91	nbuvb	nbuvb	NOUN
bam-8383	16	92	can	can	AUX
bam-8383	16	93	improve	improve	VERB
bam-8383	16	94	treatment	treatment	NOUN
bam-8383	16	95	of	of	ADP
bam-8383	16	96	vitiligo	vitiligo	NOUN
bam-8383	16	97	by	by	ADP
bam-8383	16	98	stimulating	stimulate	VERB
bam-8383	16	99	the	the	DET
bam-8383	16	100	proliferation	proliferation	NOUN
bam-8383	16	101	and	and	CCONJ
bam-8383	16	102	migration	migration	NOUN
bam-8383	16	103	of	of	ADP
bam-8383	16	104	melanocytes	melanocyte	NOUN
bam-8383	16	105	,	,	PUNCT
bam-8383	16	106	as	as	ADV
bam-8383	16	107	well	well	ADV
bam-8383	16	108	as	as	ADP
bam-8383	16	109	stimulating	stimulate	VERB
bam-8383	16	110	the	the	DET
bam-8383	16	111	differentiation	differentiation	NOUN
bam-8383	16	112	of	of	ADP
bam-8383	16	113	melanocyte	melanocyte	ADJ
bam-8383	16	114	stem	stem	NOUN
bam-8383	16	115	cells	cell	NOUN
bam-8383	16	116	.	.	PUNCT
bam-8383	17	1	uva	uva	PROPN
bam-8383	17	2	and	and	CCONJ
bam-8383	17	3	nbuvb	nbuvb	NOUN
bam-8383	17	4	have	have	AUX
bam-8383	17	5	been	be	AUX
bam-8383	17	6	introduced	introduce	VERB
bam-8383	17	7	as	as	ADP
bam-8383	17	8	common	common	ADJ
bam-8383	17	9	types	type	NOUN
bam-8383	17	10	of	of	ADP
bam-8383	17	11	phototherapy	phototherapy	NOUN
bam-8383	17	12	in	in	ADP
bam-8383	17	13	vitiligo	vitiligo	NOUN
bam-8383	17	14	.	.	PUNCT
bam-8383	18	1	despite	despite	SCONJ
bam-8383	18	2	the	the	DET
bam-8383	18	3	similar	similar	ADJ
bam-8383	18	4	effect	effect	NOUN
bam-8383	18	5	of	of	ADP
bam-8383	18	6	both	both	DET
bam-8383	18	7	interventions	intervention	NOUN
bam-8383	18	8	,	,	PUNCT
bam-8383	18	9	narrowband	narrowband	NOUN
bam-8383	18	10	ultraviolet	ultraviolet	PROPN
bam-8383	18	11	b	b	PROPN
bam-8383	18	12	(	(	PUNCT
bam-8383	18	13	nbuvb	nbuvb	ADJ
bam-8383	18	14	)	)	PUNCT
bam-8383	18	15	phototherapy	phototherapy	NOUN
bam-8383	18	16	can	can	AUX
bam-8383	18	17	be	be	AUX
bam-8383	18	18	more	more	ADV
bam-8383	18	19	effective	effective	ADJ
bam-8383	18	20	for	for	ADP
bam-8383	18	21	patients	patient	NOUN
bam-8383	18	22	suffering	suffer	VERB
bam-8383	18	23	from	from	ADP
bam-8383	18	24	vitiligo	vitiligo	NOUN
bam-8383	18	25	due	due	ADP
bam-8383	18	26	to	to	ADP
bam-8383	18	27	the	the	DET
bam-8383	18	28	lack	lack	NOUN
bam-8383	18	29	of	of	ADP
bam-8383	18	30	side	side	NOUN
bam-8383	18	31	effects	effect	NOUN
bam-8383	18	32	of	of	ADP
bam-8383	18	33	psoralen.32,33	psoralen.32,33	NOUN
bam-8383	18	34	the	the	DET
bam-8383	18	35	topical	topical	ADJ
bam-8383	18	36	use	use	NOUN
bam-8383	18	37	of	of	ADP
bam-8383	18	38	immunosuppressive	immunosuppressive	ADJ
bam-8383	18	39	agents	agent	NOUN
bam-8383	18	40	,	,	PUNCT
bam-8383	18	41	including	include	VERB
bam-8383	18	42	glucocorticoids	glucocorticoid	NOUN
bam-8383	18	43	and	and	CCONJ
bam-8383	18	44	calcineurin	calcineurin	ADJ
bam-8383	18	45	inhibitors	inhibitor	NOUN
bam-8383	18	46	,	,	PUNCT
bam-8383	18	47	have	have	AUX
bam-8383	18	48	been	be	AUX
bam-8383	18	49	introduced	introduce	VERB
bam-8383	18	50	as	as	ADP
bam-8383	18	51	the	the	DET
bam-8383	18	52	first	first	ADJ
bam-8383	18	53	line	line	NOUN
bam-8383	18	54	treatment	treatment	NOUN
bam-8383	18	55	,	,	PUNCT
bam-8383	18	56	while	while	SCONJ
bam-8383	18	57	the	the	DET
bam-8383	18	58	use	use	NOUN
bam-8383	18	59	of	of	ADP
bam-8383	18	60	phototherapy	phototherapy	NOUN
bam-8383	18	61	has	have	AUX
bam-8383	18	62	been	be	AUX
bam-8383	18	63	considered	consider	VERB
bam-8383	18	64	as	as	SCONJ
bam-8383	18	65	the	the	DET
bam-8383	18	66	second	second	ADJ
bam-8383	18	67	line	line	NOUN
bam-8383	18	68	for	for	ADP
bam-8383	18	69	treating	treat	VERB
bam-8383	18	70	these	these	DET
bam-8383	18	71	patients.32	patients.32	ADJ
bam-8383	18	72	inos	ino	NOUN
bam-8383	18	73	is	be	AUX
bam-8383	18	74	involved	involve	VERB
bam-8383	18	75	in	in	ADP
bam-8383	18	76	the	the	DET
bam-8383	18	77	production	production	NOUN
bam-8383	18	78	of	of	ADP
bam-8383	18	79	no	no	PRON
bam-8383	18	80	,	,	PUNCT
bam-8383	18	81	where	where	SCONJ
bam-8383	18	82	promotor	promotor	NOUN
bam-8383	18	83	polymorphisms	polymorphism	NOUN
bam-8383	18	84	of	of	ADP
bam-8383	18	85	inos	ino	NOUN
bam-8383	18	86	gene	gene	NOUN
bam-8383	18	87	and	and	CCONJ
bam-8383	18	88	no	no	DET
bam-8383	18	89	overproduction	overproduction	NOUN
bam-8383	18	90	has	have	AUX
bam-8383	18	91	been	be	AUX
bam-8383	18	92	found	find	VERB
bam-8383	18	93	to	to	PART
bam-8383	18	94	be	be	AUX
bam-8383	18	95	associated	associate	VERB
bam-8383	18	96	with	with	ADP
bam-8383	18	97	the	the	DET
bam-8383	18	98	pathogenesis	pathogenesis	NOUN
bam-8383	18	99	of	of	ADP
bam-8383	18	100	vitiligo	vitiligo	NOUN
bam-8383	18	101	,	,	PUNCT
bam-8383	18	102	leading	lead	VERB
bam-8383	18	103	to	to	ADP
bam-8383	18	104	melanocyte	melanocyte	NOUN
bam-8383	18	105	destruction.34	destruction.34	NOUN
bam-8383	18	106	-	-	PUNCT
bam-8383	18	107	38	38	NUM
bam-8383	18	108	based	base	VERB
bam-8383	18	109	on	on	ADP
bam-8383	18	110	above	above	ADV
bam-8383	18	111	-	-	PUNCT
bam-8383	18	112	mentioned	mention	VERB
bam-8383	18	113	data	datum	NOUN
bam-8383	18	114	,	,	PUNCT
bam-8383	18	115	the	the	DET
bam-8383	18	116	current	current	ADJ
bam-8383	18	117	study	study	NOUN
bam-8383	18	118	was	be	AUX
bam-8383	18	119	aimed	aim	VERB
bam-8383	18	120	to	to	PART
bam-8383	18	121	demonstrate	demonstrate	VERB
bam-8383	18	122	the	the	DET
bam-8383	18	123	association	association	NOUN
bam-8383	18	124	of	of	ADP
bam-8383	18	125	vitiligo	vitiligo	PROPN
bam-8383	18	126	with	with	ADP
bam-8383	18	127	inos	ino	NOUN
bam-8383	18	128	in	in	ADP
bam-8383	18	129	phototherapy	phototherapy	NOUN
bam-8383	18	130	and	and	CCONJ
bam-8383	18	131	to	to	PART
bam-8383	18	132	investigate	investigate	VERB
bam-8383	18	133	the	the	DET
bam-8383	18	134	pathophysiology	pathophysiology	NOUN
bam-8383	18	135	of	of	ADP
bam-8383	18	136	this	this	DET
bam-8383	18	137	disease	disease	NOUN
bam-8383	18	138	using	use	VERB
bam-8383	18	139	a	a	DET
bam-8383	18	140	pharmacological	pharmacological	ADJ
bam-8383	18	141	inhibition	inhibition	NOUN
bam-8383	18	142	of	of	ADP
bam-8383	18	143	the	the	DET
bam-8383	18	144	inos	ino	NOUN
bam-8383	18	145	,	,	PUNCT
bam-8383	18	146	where	where	SCONJ
bam-8383	18	147	a	a	DET
bam-8383	18	148	mouse	mouse	NOUN
bam-8383	18	149	model	model	NOUN
bam-8383	18	150	of	of	ADP
bam-8383	18	151	vitiligo	vitiligo	PROPN
bam-8383	18	152	was	be	AUX
bam-8383	18	153	induced	induce	VERB
bam-8383	18	154	by	by	ADP
bam-8383	18	155	monobenzone	monobenzone	NOUN
bam-8383	18	156	.	.	PUNCT
bam-8383	19	1	materials	material	NOUN
bam-8383	19	2	and	and	CCONJ
bam-8383	19	3	method	method	NOUN
bam-8383	19	4	ethics	ethic	NOUN
bam-8383	19	5	approvals	approval	NOUN
bam-8383	19	6	all	all	DET
bam-8383	19	7	procedures	procedure	NOUN
bam-8383	19	8	were	be	AUX
bam-8383	19	9	performed	perform	VERB
bam-8383	19	10	in	in	ADP
bam-8383	19	11	accordance	accordance	NOUN
bam-8383	19	12	with	with	ADP
bam-8383	19	13	the	the	DET
bam-8383	19	14	national	national	PROPN
bam-8383	19	15	institutes	institutes	PROPN
bam-8383	19	16	of	of	ADP
bam-8383	19	17	health	health	PROPN
bam-8383	19	18	(	(	PUNCT
bam-8383	19	19	nih	nih	NOUN
bam-8383	19	20	)	)	PUNCT
bam-8383	19	21	guide	guide	NOUN
bam-8383	19	22	for	for	ADP
bam-8383	19	23	the	the	DET
bam-8383	19	24	care	care	NOUN
bam-8383	19	25	and	and	CCONJ
bam-8383	19	26	use	use	NOUN
bam-8383	19	27	of	of	ADP
bam-8383	19	28	laboratory	laboratory	NOUN
bam-8383	19	29	animals	animal	NOUN
bam-8383	19	30	(	(	PUNCT
bam-8383	19	31	nih	nih	PROPN
bam-8383	19	32	publication	publication	NOUN
bam-8383	19	33	#	#	NOUN
bam-8383	19	34	8023	8023	NUM
bam-8383	19	35	)	)	PUNCT
bam-8383	19	36	and	and	CCONJ
bam-8383	19	37	institutional	institutional	ADJ
bam-8383	19	38	guidelines	guideline	NOUN
bam-8383	19	39	for	for	ADP
bam-8383	19	40	animal	animal	NOUN
bam-8383	19	41	care	care	NOUN
bam-8383	19	42	and	and	CCONJ
bam-8383	19	43	use	use	NOUN
bam-8383	19	44	(	(	PUNCT
bam-8383	19	45	department	department	NOUN
bam-8383	19	46	of	of	ADP
bam-8383	19	47	pharmacology	pharmacology	NOUN
bam-8383	19	48	,	,	PUNCT
bam-8383	19	49	school	school	NOUN
bam-8383	19	50	of	of	ADP
bam-8383	19	51	medicine	medicine	NOUN
bam-8383	19	52	,	,	PUNCT
bam-8383	19	53	tums	tums	PROPN
bam-8383	19	54	)	)	PUNCT
bam-8383	19	55	.	.	PUNCT
bam-8383	20	1	each	each	DET
bam-8383	20	2	experimental	experimental	ADJ
bam-8383	20	3	group	group	NOUN
bam-8383	20	4	consisted	consist	VERB
bam-8383	20	5	of	of	ADP
bam-8383	20	6	6	6	NUM
bam-8383	20	7	to	to	PART
bam-8383	20	8	8	8	NUM
bam-8383	20	9	animals	animal	NOUN
bam-8383	20	10	.	.	PUNCT
bam-8383	21	1	animals	animal	NOUN
bam-8383	21	2	in	in	ADP
bam-8383	21	3	this	this	DET
bam-8383	21	4	study	study	NOUN
bam-8383	21	5	,	,	PUNCT
bam-8383	21	6	male	male	ADJ
bam-8383	21	7	c57bl/6j	c57bl/6j	NOUN
bam-8383	21	8	ler	ler	PROPN
bam-8383	21	9	-	-	PUNCT
bam-8383	21	10	vit	vit	NOUN
bam-8383	21	11	/	/	SYM
bam-8383	21	12	vit	vit	ADJ
bam-8383	21	13	mice	mouse	NOUN
bam-8383	21	14	were	be	AUX
bam-8383	21	15	obtained	obtain	VERB
bam-8383	21	16	from	from	ADP
bam-8383	21	17	pasteur	pasteur	PROPN
bam-8383	21	18	institute	institute	PROPN
bam-8383	21	19	,	,	PUNCT
bam-8383	21	20	tehran	tehran	PROPN
bam-8383	21	21	,	,	PUNCT
bam-8383	21	22	iran	iran	PROPN
bam-8383	21	23	(	(	PUNCT
bam-8383	21	24	weighing	weigh	VERB
bam-8383	21	25	25	25	NUM
bam-8383	21	26	-	-	SYM
bam-8383	21	27	30	30	NUM
bam-8383	21	28	g	g	NOUN
bam-8383	21	29	)	)	PUNCT
bam-8383	21	30	.	.	PUNCT
bam-8383	22	1	animals	animal	NOUN
bam-8383	22	2	were	be	AUX
bam-8383	22	3	then	then	ADV
bam-8383	22	4	housed	house	VERB
bam-8383	22	5	in	in	ADP
bam-8383	22	6	plexiglas	plexiglas	NOUN
bam-8383	22	7	boxes	box	NOUN
bam-8383	22	8	(	(	PUNCT
bam-8383	22	9	25	25	NUM
bam-8383	22	10	×	×	NOUN
bam-8383	22	11	25	25	NUM
bam-8383	22	12	×	×	NOUN
bam-8383	22	13	15	15	NUM
bam-8383	22	14	cm	cm	NOUN
bam-8383	22	15	)	)	PUNCT
bam-8383	22	16	,	,	PUNCT
bam-8383	22	17	under	under	ADP
bam-8383	22	18	standard	standard	ADJ
bam-8383	22	19	conditions	condition	NOUN
bam-8383	22	20	(	(	PUNCT
bam-8383	22	21	temperature	temperature	NOUN
bam-8383	22	22	:	:	PUNCT
bam-8383	22	23	22	22	NUM
bam-8383	22	24	±	±	NUM
bam-8383	22	25	2	2	NUM
bam-8383	23	1	°	°	ADP
bam-8383	23	2	c	c	NOUN
bam-8383	23	3	,	,	PUNCT
bam-8383	23	4	humidity	humidity	NOUN
bam-8383	23	5	:	:	PUNCT
bam-8383	23	6	50	50	NUM
bam-8383	23	7	±	±	NUM
bam-8383	23	8	10	10	NUM
bam-8383	23	9	%	%	NOUN
bam-8383	23	10	,	,	PUNCT
bam-8383	23	11	12	12	NUM
bam-8383	23	12	-	-	PUNCT
bam-8383	23	13	h	h	NOUN
bam-8383	23	14	light	light	ADJ
bam-8383	23	15	–	–	PUNCT
bam-8383	23	16	dark	dark	ADJ
bam-8383	23	17	cycle	cycle	NOUN
bam-8383	23	18	,	,	PUNCT
bam-8383	23	19	and	and	CCONJ
bam-8383	23	20	free	free	ADJ
bam-8383	23	21	access	access	NOUN
bam-8383	23	22	to	to	ADP
bam-8383	23	23	food	food	NOUN
bam-8383	23	24	and	and	CCONJ
bam-8383	23	25	water	water	NOUN
bam-8383	23	26	)	)	PUNCT
bam-8383	23	27	.	.	PUNCT
bam-8383	24	1	phototherapy	phototherapy	NOUN
bam-8383	24	2	device	device	PROPN
bam-8383	24	3	bioskin	bioskin	PROPN
bam-8383	24	4	®	®	PROPN
bam-8383	24	5	,	,	PUNCT
bam-8383	24	6	a	a	DET
bam-8383	24	7	phototherapy	phototherapy	NOUN
bam-8383	24	8	device	device	NOUN
bam-8383	24	9	is	be	AUX
bam-8383	24	10	equipped	equip	VERB
bam-8383	24	11	with	with	ADP
bam-8383	24	12	a	a	DET
bam-8383	24	13	short	short	ADJ
bam-8383	24	14	arc	arc	NOUN
bam-8383	24	15	generator	generator	NOUN
bam-8383	24	16	that	that	PRON
bam-8383	24	17	provides	provide	VERB
bam-8383	24	18	a	a	DET
bam-8383	24	19	beam	beam	NOUN
bam-8383	24	20	of	of	ADP
bam-8383	24	21	visible	visible	ADJ
bam-8383	24	22	and	and	CCONJ
bam-8383	24	23	ultraviolet	ultraviolet	ADJ
bam-8383	24	24	radiations	radiation	NOUN
bam-8383	24	25	,	,	PUNCT
bam-8383	24	26	and	and	CCONJ
bam-8383	24	27	is	be	AUX
bam-8383	24	28	also	also	ADV
bam-8383	24	29	filtered	filter	VERB
bam-8383	24	30	by	by	ADP
bam-8383	24	31	an	an	DET
bam-8383	24	32	interference	interference	NOUN
bam-8383	24	33	filter	filter	NOUN
bam-8383	24	34	for	for	ADP
bam-8383	24	35	obtaining	obtain	VERB
bam-8383	24	36	uv	uv	NOUN
bam-8383	24	37	-	-	PUNCT
bam-8383	24	38	b	b	NOUN
bam-8383	24	39	narrow	narrow	ADJ
bam-8383	24	40	band	band	NOUN
bam-8383	24	41	.	.	PUNCT
bam-8383	25	1	the	the	DET
bam-8383	25	2	operator	operator	NOUN
bam-8383	25	3	is	be	AUX
bam-8383	25	4	capable	capable	ADJ
bam-8383	25	5	of	of	ADP
bam-8383	25	6	regulating	regulate	VERB
bam-8383	25	7	emission	emission	NOUN
bam-8383	25	8	time	time	NOUN
bam-8383	25	9	,	,	PUNCT
bam-8383	25	10	and	and	CCONJ
bam-8383	25	11	plays	play	VERB
bam-8383	25	12	its	its	PRON
bam-8383	25	13	role	role	NOUN
bam-8383	25	14	in	in	ADP
bam-8383	25	15	regulating	regulate	VERB
bam-8383	25	16	emission	emission	NOUN
bam-8383	25	17	time	time	NOUN
bam-8383	25	18	by	by	ADP
bam-8383	25	19	accompanying	accompany	VERB
bam-8383	25	20	a	a	DET
bam-8383	25	21	time	time	NOUN
bam-8383	25	22	-	-	PUNCT
bam-8383	25	23	controlled	control	VERB
bam-8383	25	24	shutter	shutter	NOUN
bam-8383	25	25	.	.	PUNCT
bam-8383	26	1	furthermore	furthermore	ADV
bam-8383	26	2	,	,	PUNCT
bam-8383	26	3	bioskin	bioskin	NOUN
bam-8383	26	4	®	®	NOUN
bam-8383	26	5	is	be	AUX
bam-8383	26	6	equipped	equip	VERB
bam-8383	26	7	to	to	PART
bam-8383	26	8	prepare	prepare	VERB
bam-8383	26	9	a	a	DET
bam-8383	26	10	spectrum	spectrum	NOUN
bam-8383	26	11	of	of	ADP
bam-8383	26	12	intensity	intensity	NOUN
bam-8383	26	13	up	up	ADP
bam-8383	26	14	to	to	PART
bam-8383	26	15	400	400	NUM
bam-8383	26	16	mw	mw	NOUN
bam-8383	26	17	/	/	SYM
bam-8383	26	18	cm2	cm2	NOUN
bam-8383	26	19	,	,	PUNCT
bam-8383	26	20	where	where	SCONJ
bam-8383	26	21	provide	provide	VERB
bam-8383	26	22	coverage	coverage	NOUN
bam-8383	26	23	from	from	ADP
bam-8383	26	24	300	300	NUM
bam-8383	26	25	to	to	PART
bam-8383	26	26	320	320	NUM
bam-8383	26	27	nm	nm	NOUN
bam-8383	26	28	for	for	ADP
bam-8383	26	29	emission	emission	NOUN
bam-8383	26	30	spectrum	spectrum	NOUN
bam-8383	26	31	,	,	PUNCT
bam-8383	26	32	with	with	ADP
bam-8383	26	33	an	an	DET
bam-8383	26	34	emission	emission	NOUN
bam-8383	26	35	peak	peak	NOUN
bam-8383	26	36	of	of	ADP
bam-8383	26	37	311	311	NUM
bam-8383	26	38	nm	nm	NOUN
bam-8383	26	39	.	.	PUNCT
bam-8383	27	1	mice	mouse	NOUN
bam-8383	27	2	were	be	AUX
bam-8383	27	3	then	then	ADV
bam-8383	27	4	irradiated	irradiate	VERB
bam-8383	27	5	three	three	NUM
bam-8383	27	6	times	time	NOUN
bam-8383	27	7	a	a	DET
bam-8383	27	8	week	week	NOUN
bam-8383	27	9	for	for	ADP
bam-8383	27	10	4	4	NUM
bam-8383	27	11	weeks	week	NOUN
bam-8383	27	12	.	.	PUNCT
bam-8383	28	1	the	the	DET
bam-8383	28	2	narrow	narrow	ADJ
bam-8383	28	3	band	band	NOUN
bam-8383	28	4	uv	uv	NOUN
bam-8383	28	5	-	-	PUNCT
bam-8383	28	6	b	b	NOUN
bam-8383	28	7	(	(	PUNCT
bam-8383	28	8	nbuvb	nbuvb	ADJ
bam-8383	28	9	)	)	PUNCT
bam-8383	28	10	irradiation	irradiation	NOUN
bam-8383	28	11	was	be	AUX
bam-8383	28	12	performed	perform	VERB
bam-8383	28	13	using	use	VERB
bam-8383	28	14	a	a	DET
bam-8383	28	15	bioskin	bioskin	NOUN
bam-8383	28	16	®	®	NOUN
bam-8383	28	17	device	device	NOUN
bam-8383	28	18	.	.	PUNCT
bam-8383	29	1	it	it	PRON
bam-8383	29	2	is	be	AUX
bam-8383	29	3	worth	worth	ADJ
bam-8383	29	4	noting	note	VERB
bam-8383	29	5	fig	fig	NOUN
bam-8383	29	6	1	1	NUM
bam-8383	29	7	.	.	PUNCT
bam-8383	30	1	monobenzone	monobenzone	NOUN
bam-8383	30	2	40	40	NUM
bam-8383	30	3	%	%	NOUN
bam-8383	30	4	induced	induce	VERB
bam-8383	30	5	depigmentation	depigmentation	NOUN
bam-8383	30	6	in	in	ADP
bam-8383	30	7	exposed	expose	VERB
bam-8383	30	8	regions	region	NOUN
bam-8383	30	9	.	.	PUNCT
bam-8383	31	1	fig	fig	NOUN
bam-8383	31	2	1	1	NUM
bam-8383	31	3	.	.	PUNCT
bam-8383	32	1	monobenzone	monobenzone	NOUN
bam-8383	32	2	40	40	NUM
bam-8383	32	3	%	%	NOUN
bam-8383	32	4	induced	induce	VERB
bam-8383	32	5	depigmentation	depigmentation	NOUN
bam-8383	32	6	in	in	ADP
bam-8383	32	7	exposed	expose	VERB
bam-8383	32	8	regions	region	NOUN
bam-8383	32	9	.	.	PUNCT
bam-8383	33	1	non	non	PROPN
bam-8383	33	2	co	co	PROPN
bam-8383	33	3	mmerc	mmerc	PROPN
bam-8383	33	4	ial	ial	PROPN
bam-8383	33	5	us	us	PROPN
bam-8383	34	1	e	e	NOUN
bam-8383	34	2	o	o	PROPN
bam-8383	34	3	nly	nly	ADV
bam-8383	34	4	https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=5&cad=rja&uact=8&ved=2ahukewjzuoay8z_dahvfalakhcgtdqaqfjaeegqibrab&url=https%3a%2f%2fwww.researchgate.net%2fpublication%2f242016069_a_mouse_model_of_vitiligo_induced_by_monobenzone&usg=aovvaw1k8bshffzsadh29qwhq22f	https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=5&cad=rja&uact=8&ved=2ahukewjzuoay8z_dahvfalakhcgtdqaqfjaeegqibrab&url=https%3a%2f%2fwww.researchgate.net%2fpublication%2f242016069_a_mouse_model_of_vitiligo_induced_by_monobenzone&usg=aovvaw1k8bshffzsadh29qwhq22f	PROPN
bam-8383	34	5	https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=5&cad=rja&uact=8&ved=2ahukewjzuoay8z_dahvfalakhcgtdqaqfjaeegqibrab&url=https%3a%2f%2fwww.researchgate.net%2fpublication%2f242016069_a_mouse_model_of_vitiligo_induced_by_monobenzone&usg=aovvaw1k8bshffzsadh29qwhq22f	https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=5&cad=rja&uact=8&ved=2ahukewjzuoay8z_dahvfalakhcgtdqaqfjaeegqibrab&url=https%3a%2f%2fwww.researchgate.net%2fpublication%2f242016069_a_mouse_model_of_vitiligo_induced_by_monobenzone&usg=aovvaw1k8bshffzsadh29qwhq22f	PROPN
bam-8383	34	6	inos	ino	NOUN
bam-8383	34	7	inhibition	inhibition	VERB
bam-8383	34	8	for	for	ADP
bam-8383	34	9	vitiligo	vitiligo	PROPN
bam-8383	34	10	eur	eur	PROPN
bam-8383	34	11	j	j	PROPN
bam-8383	34	12	transl	transl	PROPN
bam-8383	34	13	myol	myol	ADV
bam-8383	34	14	29	29	NUM
bam-8383	34	15	(	(	PUNCT
bam-8383	34	16	3	3	NUM
bam-8383	34	17	):	):	PUNCT
bam-8383	34	18	251	251	NUM
bam-8383	34	19	-	-	SYM
bam-8383	34	20	260	260	NUM
bam-8383	34	21	,	,	PUNCT
bam-8383	34	22	2019	2019	NUM
bam-8383	34	23	253	253	NUM
bam-8383	34	24	that	that	PRON
bam-8383	34	25	vitiligo	vitiligo	NOUN
bam-8383	34	26	patches	patch	NOUN
bam-8383	34	27	were	be	AUX
bam-8383	34	28	next	next	ADV
bam-8383	34	29	irradiated	irradiate	VERB
bam-8383	34	30	by	by	ADP
bam-8383	34	31	excluding	exclude	VERB
bam-8383	34	32	mucous	mucous	ADJ
bam-8383	34	33	membrane	membrane	NOUN
bam-8383	34	34	and	and	CCONJ
bam-8383	34	35	genital	genital	ADJ
bam-8383	34	36	part	part	NOUN
bam-8383	34	37	for	for	ADP
bam-8383	34	38	each	each	DET
bam-8383	34	39	microphototherapy	microphototherapy	PROPN
bam-8383	34	40	session	session	NOUN
bam-8383	34	41	.	.	PUNCT
bam-8383	35	1	although	although	SCONJ
bam-8383	35	2	bioskin	bioskin	NOUN
bam-8383	35	3	®	®	NOUN
bam-8383	35	4	equipment	equipment	NOUN
bam-8383	35	5	is	be	AUX
bam-8383	35	6	able	able	ADJ
bam-8383	35	7	to	to	PART
bam-8383	35	8	provide	provide	VERB
bam-8383	35	9	a	a	DET
bam-8383	35	10	large	large	ADJ
bam-8383	35	11	spectrum	spectrum	NOUN
bam-8383	35	12	of	of	ADP
bam-8383	35	13	intensity	intensity	NOUN
bam-8383	35	14	(	(	PUNCT
bam-8383	35	15	0–400	0–400	NOUN
bam-8383	35	16	mw	mw	PROPN
bam-8383	35	17	/	/	SYM
bam-8383	35	18	cm2	cm2	NOUN
bam-8383	35	19	)	)	PUNCT
bam-8383	35	20	,	,	PUNCT
bam-8383	35	21	the	the	DET
bam-8383	35	22	intensity	intensity	NOUN
bam-8383	35	23	of	of	ADP
bam-8383	35	24	50	50	NUM
bam-8383	35	25	mw	mw	NOUN
bam-8383	35	26	/	/	SYM
bam-8383	35	27	cm2	cm2	PROPN
bam-8383	35	28	was	be	AUX
bam-8383	35	29	employed	employ	VERB
bam-8383	35	30	in	in	ADP
bam-8383	35	31	the	the	DET
bam-8383	35	32	present	present	ADJ
bam-8383	35	33	study	study	NOUN
bam-8383	35	34	for	for	ADP
bam-8383	35	35	all	all	DET
bam-8383	35	36	animals	animal	NOUN
bam-8383	35	37	during	during	ADP
bam-8383	35	38	all	all	DET
bam-8383	35	39	sessions	session	NOUN
bam-8383	35	40	.	.	PUNCT
bam-8383	36	1	the	the	DET
bam-8383	36	2	initial	initial	ADJ
bam-8383	36	3	dose	dose	NOUN
bam-8383	36	4	of	of	ADP
bam-8383	36	5	irradiation	irradiation	NOUN
bam-8383	36	6	was	be	AUX
bam-8383	36	7	20	20	NUM
bam-8383	36	8	%	%	NOUN
bam-8383	36	9	less	less	ADJ
bam-8383	36	10	than	than	ADP
bam-8383	36	11	minimum	minimum	ADJ
bam-8383	36	12	erythema	erythema	NOUN
bam-8383	36	13	dose	dose	NOUN
bam-8383	36	14	(	(	PUNCT
bam-8383	36	15	med	med	PROPN
bam-8383	36	16	)	)	PUNCT
bam-8383	36	17	that	that	PRON
bam-8383	36	18	was	be	AUX
bam-8383	36	19	applied	apply	VERB
bam-8383	36	20	to	to	ADP
bam-8383	36	21	vitiligo	vitiligo	NOUN
bam-8383	36	22	area	area	NOUN
bam-8383	36	23	at	at	ADV
bam-8383	36	24	least	least	ADV
bam-8383	36	25	3	3	NUM
bam-8383	36	26	days	day	NOUN
bam-8383	36	27	before	before	ADP
bam-8383	36	28	the	the	DET
bam-8383	36	29	beginning	beginning	NOUN
bam-8383	36	30	of	of	ADP
bam-8383	36	31	the	the	DET
bam-8383	36	32	treatment	treatment	NOUN
bam-8383	36	33	.	.	PUNCT
bam-8383	37	1	during	during	ADP
bam-8383	37	2	the	the	DET
bam-8383	37	3	subsequent	subsequent	ADJ
bam-8383	37	4	sessions	session	NOUN
bam-8383	37	5	,	,	PUNCT
bam-8383	37	6	the	the	DET
bam-8383	37	7	dose	dose	NOUN
bam-8383	37	8	in	in	ADP
bam-8383	37	9	each	each	DET
bam-8383	37	10	session	session	NOUN
bam-8383	37	11	increased	increase	VERB
bam-8383	37	12	to	to	ADP
bam-8383	37	13	20	20	NUM
bam-8383	37	14	%	%	NOUN
bam-8383	37	15	until	until	ADP
bam-8383	37	16	the	the	DET
bam-8383	37	17	development	development	NOUN
bam-8383	37	18	of	of	ADP
bam-8383	37	19	erythema	erythema	ADJ
bam-8383	37	20	.	.	PUNCT
bam-8383	38	1	additional	additional	ADJ
bam-8383	38	2	dose	dose	NOUN
bam-8383	38	3	of	of	ADP
bam-8383	38	4	the	the	DET
bam-8383	38	5	next	next	ADJ
bam-8383	38	6	session	session	NOUN
bam-8383	38	7	was	be	AUX
bam-8383	38	8	diminished	diminish	VERB
bam-8383	38	9	by	by	ADP
bam-8383	38	10	20	20	NUM
bam-8383	38	11	%	%	NOUN
bam-8383	38	12	only	only	ADV
bam-8383	38	13	in	in	ADP
bam-8383	38	14	the	the	DET
bam-8383	38	15	erythematous	erythematous	ADJ
bam-8383	38	16	area	area	NOUN
bam-8383	38	17	when	when	SCONJ
bam-8383	38	18	erythema	erythema	ADV
bam-8383	38	19	was	be	AUX
bam-8383	38	20	developed	develop	VERB
bam-8383	38	21	.	.	PUNCT
bam-8383	39	1	experimental	experimental	ADJ
bam-8383	39	2	design	design	NOUN
bam-8383	39	3	in	in	ADP
bam-8383	39	4	the	the	DET
bam-8383	39	5	present	present	ADJ
bam-8383	39	6	study	study	NOUN
bam-8383	39	7	,	,	PUNCT
bam-8383	39	8	sex	sex	NOUN
bam-8383	39	9	-	-	PUNCT
bam-8383	39	10	matched	match	VERB
bam-8383	39	11	mice	mouse	NOUN
bam-8383	39	12	were	be	AUX
bam-8383	39	13	divided	divide	VERB
bam-8383	39	14	in	in	ADP
bam-8383	39	15	6	6	NUM
bam-8383	39	16	groups	group	NOUN
bam-8383	39	17	of	of	ADP
bam-8383	39	18	10	10	NUM
bam-8383	39	19	mice	mouse	NOUN
bam-8383	39	20	.	.	PUNCT
bam-8383	40	1	in	in	ADP
bam-8383	40	2	the	the	DET
bam-8383	40	3	first	first	ADJ
bam-8383	40	4	part	part	NOUN
bam-8383	40	5	of	of	ADP
bam-8383	40	6	this	this	DET
bam-8383	40	7	study	study	NOUN
bam-8383	40	8	we	we	PRON
bam-8383	40	9	emploied	emploie	VERB
bam-8383	40	10	the	the	DET
bam-8383	40	11	vitiligo	vitiligo	NOUN
bam-8383	40	12	-	-	PUNCT
bam-8383	40	13	inducing	induce	VERB
bam-8383	40	14	agent	agent	NOUN
bam-8383	40	15	monobenzone	monobenzone	NOUN
bam-8383	40	16	in	in	ADP
bam-8383	40	17	the	the	DET
bam-8383	40	18	mice	mice	NOUN
bam-8383	40	19	model	model	NOUN
bam-8383	40	20	,	,	PUNCT
bam-8383	40	21	as	as	SCONJ
bam-8383	40	22	previously	previously	ADV
bam-8383	40	23	described	describe	VERB
bam-8383	40	24	by	by	ADP
bam-8383	40	25	zhu	zhu	PROPN
bam-8383	40	26	et	et	PROPN
bam-8383	40	27	al	al	PROPN
bam-8383	40	28	.	.	PROPN
bam-8383	40	29	,39	,39	PUNCT
bam-8383	40	30	highlightening	highlightene	VERB
bam-8383	40	31	that	that	SCONJ
bam-8383	40	32	monobenzone	monobenzone	NOUN
bam-8383	40	33	-	-	PUNCT
bam-8383	40	34	induced	induce	VERB
bam-8383	40	35	vitiligo	vitiligo	NOUN
bam-8383	40	36	is	be	AUX
bam-8383	40	37	a	a	DET
bam-8383	40	38	valid	valid	ADJ
bam-8383	40	39	mouse	mouse	NOUN
bam-8383	40	40	model	model	NOUN
bam-8383	40	41	of	of	ADP
bam-8383	40	42	vitiligo	vitiligo	NOUN
bam-8383	40	43	.	.	PUNCT
bam-8383	41	1	in	in	ADP
bam-8383	41	2	the	the	DET
bam-8383	41	3	first	first	ADJ
bam-8383	41	4	group	group	NOUN
bam-8383	41	5	(	(	PUNCT
bam-8383	41	6	control	control	NOUN
bam-8383	41	7	group	group	NOUN
bam-8383	41	8	)	)	PUNCT
bam-8383	41	9	,	,	PUNCT
bam-8383	41	10	mice	mouse	NOUN
bam-8383	41	11	received	receive	VERB
bam-8383	41	12	only	only	ADV
bam-8383	41	13	monobenzone	monobenzone	NOUN
bam-8383	41	14	cream	cream	NOUN
bam-8383	41	15	40	40	NUM
bam-8383	41	16	%	%	NOUN
bam-8383	41	17	on	on	ADP
bam-8383	41	18	the	the	DET
bam-8383	41	19	mouse	mouse	NOUN
bam-8383	41	20	tail	tail	NOUN
bam-8383	41	21	and	and	CCONJ
bam-8383	41	22	skin	skin	NOUN
bam-8383	41	23	on	on	ADP
bam-8383	41	24	the	the	DET
bam-8383	41	25	back	back	NOUN
bam-8383	41	26	of	of	ADP
bam-8383	41	27	the	the	DET
bam-8383	41	28	mouse	mouse	NOUN
bam-8383	41	29	and	and	CCONJ
bam-8383	41	30	thereafter	thereafter	ADV
bam-8383	41	31	skin	skin	NOUN
bam-8383	41	32	hypo	hypo	ADJ
bam-8383	41	33	-	-	PUNCT
bam-8383	41	34	pigmentations	pigmentation	NOUN
bam-8383	41	35	were	be	AUX
bam-8383	41	36	investigated	investigate	VERB
bam-8383	41	37	every	every	DET
bam-8383	41	38	week	week	NOUN
bam-8383	41	39	as	as	SCONJ
bam-8383	41	40	compared	compare	VERB
bam-8383	41	41	to	to	ADP
bam-8383	41	42	intact	intact	ADJ
bam-8383	41	43	part	part	NOUN
bam-8383	41	44	.	.	PUNCT
bam-8383	42	1	in	in	ADP
bam-8383	42	2	the	the	DET
bam-8383	42	3	second	second	ADJ
bam-8383	42	4	group	group	NOUN
bam-8383	42	5	,	,	PUNCT
bam-8383	42	6	the	the	DET
bam-8383	42	7	mice	mouse	NOUN
bam-8383	42	8	receive	receive	VERB
bam-8383	42	9	phototherapy	phototherapy	NOUN
bam-8383	42	10	(	(	PUNCT
bam-8383	42	11	bioskin	bioskin	NOUN
bam-8383	42	12	®	®	NOUN
bam-8383	42	13	device	device	NOUN
bam-8383	42	14	;	;	PUNCT
bam-8383	42	15	50mw	50mw	X
bam-8383	42	16	/	/	SYM
bam-8383	42	17	cm2	cm2	NOUN
bam-8383	42	18	)	)	PUNCT
bam-8383	42	19	in	in	ADP
bam-8383	42	20	combination	combination	NOUN
bam-8383	42	21	with	with	ADP
bam-8383	42	22	the	the	DET
bam-8383	42	23	monobenzone	monobenzone	NOUN
bam-8383	42	24	,	,	PUNCT
bam-8383	42	25	which	which	PRON
bam-8383	42	26	was	be	AUX
bam-8383	42	27	considered	consider	VERB
bam-8383	42	28	a	a	DET
bam-8383	42	29	positive	positive	ADJ
bam-8383	42	30	control	control	NOUN
bam-8383	42	31	.	.	PUNCT
bam-8383	43	1	in	in	ADP
bam-8383	43	2	the	the	DET
bam-8383	43	3	third	third	ADJ
bam-8383	43	4	group	group	NOUN
bam-8383	43	5	of	of	ADP
bam-8383	43	6	mice	mouse	NOUN
bam-8383	43	7	,	,	PUNCT
bam-8383	43	8	the	the	DET
bam-8383	43	9	role	role	NOUN
bam-8383	43	10	of	of	ADP
bam-8383	43	11	inos	ino	NOUN
bam-8383	43	12	in	in	ADP
bam-8383	43	13	development	development	NOUN
bam-8383	43	14	of	of	ADP
bam-8383	43	15	vitiligo	vitiligo	NOUN
bam-8383	43	16	was	be	AUX
bam-8383	43	17	then	then	ADV
bam-8383	43	18	evaluated	evaluate	VERB
bam-8383	43	19	.	.	PUNCT
bam-8383	44	1	therefore	therefore	ADV
bam-8383	44	2	,	,	PUNCT
bam-8383	44	3	beginning	begin	VERB
bam-8383	44	4	the	the	DET
bam-8383	44	5	first	first	ADJ
bam-8383	44	6	day	day	NOUN
bam-8383	44	7	after	after	SCONJ
bam-8383	44	8	vitiligo	vitiligo	NOUN
bam-8383	44	9	induction	induction	NOUN
bam-8383	44	10	animals	animal	NOUN
bam-8383	44	11	were	be	AUX
bam-8383	44	12	treated	treat	VERB
bam-8383	44	13	with	with	ADP
bam-8383	44	14	aminoguanidine	aminoguanidine	NOUN
bam-8383	44	15	(	(	PUNCT
bam-8383	44	16	ag	ag	PROPN
bam-8383	44	17	)	)	PUNCT
bam-8383	44	18	,	,	PUNCT
bam-8383	44	19	an	an	DET
bam-8383	44	20	injectable	injectable	ADJ
bam-8383	44	21	inos	ino	NOUN
bam-8383	44	22	inhibitor	inhibitor	NOUN
bam-8383	44	23	,	,	PUNCT
bam-8383	44	24	at	at	ADP
bam-8383	44	25	daily	daily	ADJ
bam-8383	44	26	dose	dose	PROPN
bam-8383	44	27	of	of	ADP
bam-8383	44	28	50	50	NUM
bam-8383	44	29	and	and	CCONJ
bam-8383	44	30	100	100	NUM
bam-8383	44	31	mg	mg	NUM
bam-8383	44	32	/	/	SYM
bam-8383	44	33	kg	kg	PROPN
bam-8383	44	34	(	(	PUNCT
bam-8383	45	1	i.p	i.p	PROPN
bam-8383	45	2	.	.	PROPN
bam-8383	45	3	6x	6x	PROPN
bam-8383	45	4	weekly	weekly	ADJ
bam-8383	45	5	)	)	PUNCT
bam-8383	46	1	to	to	PART
bam-8383	46	2	clarify	clarify	VERB
bam-8383	46	3	the	the	DET
bam-8383	46	4	no	no	DET
bam-8383	46	5	pathway	pathway	NOUN
bam-8383	46	6	.	.	PUNCT
bam-8383	47	1	in	in	ADP
bam-8383	47	2	group	group	NOUN
bam-8383	47	3	5	5	NUM
bam-8383	47	4	,	,	PUNCT
bam-8383	47	5	the	the	DET
bam-8383	47	6	combined	combined	ADJ
bam-8383	47	7	effect	effect	NOUN
bam-8383	47	8	of	of	ADP
bam-8383	47	9	this	this	DET
bam-8383	47	10	inhibitor	inhibitor	NOUN
bam-8383	47	11	with	with	ADP
bam-8383	47	12	phototherapy	phototherapy	NOUN
bam-8383	47	13	was	be	AUX
bam-8383	47	14	investigated	investigate	VERB
bam-8383	47	15	.	.	PUNCT
bam-8383	48	1	in	in	ADP
bam-8383	48	2	the	the	DET
bam-8383	48	3	sixth	sixth	ADJ
bam-8383	48	4	group	group	NOUN
bam-8383	48	5	,	,	PUNCT
bam-8383	48	6	injectable	injectable	ADJ
bam-8383	48	7	no	no	DET
bam-8383	48	8	inducer	inducer	NOUN
bam-8383	48	9	was	be	AUX
bam-8383	48	10	daily	daily	ADV
bam-8383	48	11	used	use	VERB
bam-8383	48	12	at	at	ADP
bam-8383	48	13	dose	dose	NOUN
bam-8383	48	14	of	of	ADP
bam-8383	48	15	100	100	NUM
bam-8383	48	16	mg	mg	PROPN
bam-8383	48	17	/	/	SYM
bam-8383	48	18	kg	kg	PROPN
bam-8383	48	19	(	(	PUNCT
bam-8383	48	20	l	l	NOUN
bam-8383	48	21	-	-	NOUN
bam-8383	48	22	arginine	arginine	NOUN
bam-8383	48	23	)	)	PUNCT
bam-8383	48	24	and	and	CCONJ
bam-8383	48	25	the	the	DET
bam-8383	48	26	combined	combined	ADJ
bam-8383	48	27	effect	effect	NOUN
bam-8383	48	28	of	of	ADP
bam-8383	48	29	this	this	DET
bam-8383	48	30	drug	drug	NOUN
bam-8383	48	31	was	be	AUX
bam-8383	48	32	investigated	investigate	VERB
bam-8383	48	33	by	by	ADP
bam-8383	48	34	phototherapy	phototherapy	NOUN
bam-8383	48	35	.	.	PUNCT
bam-8383	49	1	as	as	ADP
bam-8383	49	2	a	a	DET
bam-8383	49	3	matter	matter	NOUN
bam-8383	49	4	of	of	ADP
bam-8383	49	5	fact	fact	NOUN
bam-8383	49	6	,	,	PUNCT
bam-8383	49	7	the	the	DET
bam-8383	49	8	effects	effect	NOUN
bam-8383	49	9	of	of	ADP
bam-8383	49	10	larginine	larginine	NOUN
bam-8383	49	11	and	and	CCONJ
bam-8383	49	12	ag	ag	PROPN
bam-8383	49	13	on	on	ADP
bam-8383	49	14	development	development	NOUN
bam-8383	49	15	of	of	ADP
bam-8383	49	16	vitiligo	vitiligo	NOUN
bam-8383	49	17	were	be	AUX
bam-8383	49	18	assessed	assess	VERB
bam-8383	49	19	by	by	ADP
bam-8383	49	20	the	the	DET
bam-8383	49	21	vitiligo	vitiligo	NOUN
bam-8383	49	22	-	-	PUNCT
bam-8383	49	23	inducing	induce	VERB
bam-8383	49	24	compound	compound	NOUN
bam-8383	49	25	monobenzone	monobenzone	NOUN
bam-8383	49	26	.	.	PUNCT
bam-8383	50	1	optimal	optimal	ADJ
bam-8383	50	2	treatment	treatment	NOUN
bam-8383	50	3	dose	dose	NOUN
bam-8383	50	4	of	of	ADP
bam-8383	50	5	aminoguanidine	aminoguanidine	NOUN
bam-8383	50	6	was	be	AUX
bam-8383	50	7	determined	determine	VERB
bam-8383	50	8	by	by	ADP
bam-8383	50	9	implementing	implement	VERB
bam-8383	50	10	a	a	DET
bam-8383	50	11	dose	dose	NOUN
bam-8383	50	12	-	-	PUNCT
bam-8383	50	13	response	response	NOUN
bam-8383	50	14	model	model	NOUN
bam-8383	50	15	,	,	PUNCT
bam-8383	50	16	assessing	assess	VERB
bam-8383	50	17	increasing	increase	VERB
bam-8383	50	18	doses	dose	NOUN
bam-8383	50	19	(	(	PUNCT
bam-8383	50	20	50	50	NUM
bam-8383	50	21	mg	mg	NOUN
bam-8383	50	22	and	and	CCONJ
bam-8383	50	23	100	100	NUM
bam-8383	50	24	mg	mg	NUM
bam-8383	50	25	)	)	PUNCT
bam-8383	50	26	.	.	PUNCT
bam-8383	51	1	all	all	DET
bam-8383	51	2	drugs	drug	NOUN
bam-8383	51	3	were	be	AUX
bam-8383	51	4	purchased	purchase	VERB
bam-8383	51	5	from	from	ADP
bam-8383	51	6	sigma	sigma	PROPN
bam-8383	51	7	,	,	PUNCT
bam-8383	51	8	st	st	PROPN
bam-8383	51	9	louis	louis	PROPN
bam-8383	51	10	,	,	PUNCT
bam-8383	51	11	mo	mo	PROPN
bam-8383	51	12	,	,	PUNCT
bam-8383	51	13	usa	usa	PROPN
bam-8383	51	14	and	and	CCONJ
bam-8383	51	15	afterward	afterward	ADV
bam-8383	51	16	dissolved	dissolve	VERB
bam-8383	51	17	in	in	ADP
bam-8383	51	18	saline	saline	NOUN
bam-8383	51	19	.	.	PUNCT
bam-8383	52	1	animals	animal	NOUN
bam-8383	52	2	received	receive	VERB
bam-8383	52	3	drugs	drug	NOUN
bam-8383	52	4	intraperitoneally	intraperitoneally	ADV
bam-8383	52	5	(	(	PUNCT
bam-8383	52	6	i.p	i.p	PROPN
bam-8383	52	7	.	.	PROPN
bam-8383	52	8	)	)	PUNCT
bam-8383	52	9	,	,	PUNCT
bam-8383	52	10	except	except	SCONJ
bam-8383	52	11	for	for	ADP
bam-8383	52	12	monobenzone	monobenzone	NOUN
bam-8383	52	13	.	.	PUNCT
bam-8383	53	1	results	result	NOUN
bam-8383	53	2	monobenzone	monobenzone	NOUN
bam-8383	53	3	induced	induce	VERB
bam-8383	53	4	vitiligo	vitiligo	NOUN
bam-8383	53	5	in	in	ADP
bam-8383	53	6	the	the	DET
bam-8383	53	7	first	first	ADJ
bam-8383	53	8	step	step	NOUN
bam-8383	53	9	of	of	ADP
bam-8383	53	10	this	this	DET
bam-8383	53	11	study	study	NOUN
bam-8383	53	12	,	,	PUNCT
bam-8383	53	13	we	we	PRON
bam-8383	53	14	tried	try	VERB
bam-8383	53	15	to	to	PART
bam-8383	53	16	evaluate	evaluate	VERB
bam-8383	53	17	monobenzone	monobenzone	NOUN
bam-8383	53	18	40%-induced	40%-induced	NUM
bam-8383	53	19	depigmentation	depigmentation	NOUN
bam-8383	53	20	from	from	ADP
bam-8383	53	21	1	1	NUM
bam-8383	53	22	to	to	PART
bam-8383	53	23	6	6	NUM
bam-8383	53	24	weeks	week	NOUN
bam-8383	53	25	after	after	ADP
bam-8383	53	26	exposure	exposure	NOUN
bam-8383	53	27	.	.	PUNCT
bam-8383	54	1	analysis	analysis	NOUN
bam-8383	54	2	revealed	reveal	VERB
bam-8383	54	3	that	that	SCONJ
bam-8383	54	4	monobenzone	monobenzone	NOUN
bam-8383	54	5	40	40	NUM
bam-8383	54	6	%	%	NOUN
bam-8383	54	7	can	can	AUX
bam-8383	54	8	induce	induce	VERB
bam-8383	54	9	vitiligo	vitiligo	NOUN
bam-8383	54	10	with	with	ADP
bam-8383	54	11	a	a	DET
bam-8383	54	12	mean	mean	NOUN
bam-8383	54	13	of	of	ADP
bam-8383	54	14	95	95	NUM
bam-8383	54	15	%	%	NOUN
bam-8383	54	16	depigmentation	depigmentation	NOUN
bam-8383	54	17	after	after	ADP
bam-8383	54	18	6	6	NUM
bam-8383	54	19	weeks	week	NOUN
bam-8383	54	20	,	,	PUNCT
bam-8383	54	21	which	which	PRON
bam-8383	54	22	was	be	AUX
bam-8383	54	23	associated	associate	VERB
bam-8383	54	24	with	with	ADP
bam-8383	54	25	the	the	DET
bam-8383	54	26	increasing	increase	VERB
bam-8383	54	27	trend	trend	NOUN
bam-8383	54	28	of	of	ADP
bam-8383	54	29	vitiligo	vitiligo	NOUN
bam-8383	54	30	.	.	PUNCT
bam-8383	55	1	one	one	NUM
bam-8383	55	2	-	-	PUNCT
bam-8383	55	3	way	way	NOUN
bam-8383	55	4	anova	anova	PROPN
bam-8383	55	5	analysis	analysis	NOUN
bam-8383	55	6	revealed	reveal	VERB
bam-8383	55	7	that	that	SCONJ
bam-8383	55	8	monobezone	monobezone	NOUN
bam-8383	55	9	could	could	AUX
bam-8383	55	10	significantly	significantly	ADV
bam-8383	55	11	induce	induce	VERB
bam-8383	55	12	depigmentation	depigmentation	NOUN
bam-8383	55	13	after	after	ADP
bam-8383	55	14	6	6	NUM
bam-8383	55	15	weeks	week	NOUN
bam-8383	55	16	(	(	PUNCT
bam-8383	55	17	f	f	X
bam-8383	56	1	[	[	X
bam-8383	56	2	6	6	NUM
bam-8383	56	3	,	,	PUNCT
bam-8383	56	4	35	35	NUM
bam-8383	56	5	]	]	PUNCT
bam-8383	56	6	=	=	SYM
bam-8383	56	7	218.2	218.2	NUM
bam-8383	56	8	,	,	PUNCT
bam-8383	56	9	p<0.001	p<0.001	PROPN
bam-8383	56	10	,	,	PUNCT
bam-8383	56	11	fig1	fig1	PROPN
bam-8383	56	12	)	)	PUNCT
bam-8383	56	13	.	.	PUNCT
bam-8383	57	1	post	post	PROPN
bam-8383	57	2	tukey	tukey	PROPN
bam-8383	57	3	’s	’s	PART
bam-8383	57	4	analysis	analysis	NOUN
bam-8383	57	5	showed	show	VERB
bam-8383	57	6	depigmentation	depigmentation	NOUN
bam-8383	57	7	of	of	ADP
bam-8383	57	8	exposed	expose	VERB
bam-8383	57	9	regions	region	NOUN
bam-8383	57	10	using	use	VERB
bam-8383	57	11	color	color	NOUN
bam-8383	57	12	cell	cell	NOUN
bam-8383	57	13	compression	compression	NOUN
bam-8383	57	14	,	,	PUNCT
bam-8383	57	15	as	as	SCONJ
bam-8383	57	16	given	give	VERB
bam-8383	57	17	by	by	ADP
bam-8383	57	18	a	a	DET
bam-8383	57	19	computer	computer	NOUN
bam-8383	57	20	software	software	NOUN
bam-8383	57	21	after	after	ADP
bam-8383	57	22	6	6	NUM
bam-8383	57	23	weeks	week	NOUN
bam-8383	57	24	(	(	PUNCT
bam-8383	57	25	p<0.001	p<0.001	PROPN
bam-8383	57	26	)	)	PUNCT
bam-8383	57	27	.	.	PUNCT
bam-8383	58	1	as	as	SCONJ
bam-8383	58	2	shown	show	VERB
bam-8383	58	3	in	in	ADP
bam-8383	58	4	figure	figure	NOUN
bam-8383	58	5	1	1	NUM
bam-8383	58	6	,	,	PUNCT
bam-8383	58	7	we	we	PRON
bam-8383	58	8	suggested	suggest	VERB
bam-8383	58	9	an	an	DET
bam-8383	58	10	increased	increase	VERB
bam-8383	58	11	trend	trend	NOUN
bam-8383	58	12	of	of	ADP
bam-8383	58	13	depigmentation	depigmentation	NOUN
bam-8383	58	14	in	in	ADP
bam-8383	58	15	initiation	initiation	NOUN
bam-8383	58	16	phase	phase	NOUN
bam-8383	58	17	on	on	ADP
bam-8383	58	18	exposed	expose	VERB
bam-8383	58	19	area	area	NOUN
bam-8383	58	20	.	.	PUNCT
bam-8383	59	1	co	co	NOUN
bam-8383	59	2	-	-	NOUN
bam-8383	59	3	treatment	treatment	NOUN
bam-8383	59	4	of	of	ADP
bam-8383	59	5	monobenzone	monobenzone	NOUN
bam-8383	59	6	with	with	ADP
bam-8383	59	7	inos	ino	NOUN
bam-8383	59	8	inhibitor	inhibitor	NOUN
bam-8383	59	9	following	follow	VERB
bam-8383	59	10	mentioned	mention	VERB
bam-8383	59	11	experiment	experiment	NOUN
bam-8383	59	12	,	,	PUNCT
bam-8383	59	13	we	we	PRON
bam-8383	59	14	provide	provide	VERB
bam-8383	59	15	a	a	DET
bam-8383	59	16	cotreatment	cotreatment	NOUN
bam-8383	59	17	of	of	ADP
bam-8383	59	18	inos	ino	NOUN
bam-8383	59	19	inhibitor	inhibitor	NOUN
bam-8383	59	20	(	(	PUNCT
bam-8383	59	21	aminoguanidine	aminoguanidine	NOUN
bam-8383	59	22	at	at	ADP
bam-8383	59	23	100	100	NUM
bam-8383	59	24	mg	mg	PROPN
bam-8383	59	25	/	/	SYM
bam-8383	59	26	kg	kg	NOUN
bam-8383	59	27	)	)	PUNCT
bam-8383	59	28	with	with	ADP
bam-8383	59	29	monobenzone	monobenzone	NOUN
bam-8383	59	30	40	40	NUM
bam-8383	59	31	%	%	NOUN
bam-8383	59	32	to	to	PART
bam-8383	59	33	clarify	clarify	VERB
bam-8383	59	34	the	the	DET
bam-8383	59	35	interaction	interaction	NOUN
bam-8383	59	36	between	between	ADP
bam-8383	59	37	nitrergic	nitrergic	ADJ
bam-8383	59	38	system	system	NOUN
bam-8383	59	39	and	and	CCONJ
bam-8383	59	40	vitiligo	vitiligo	VERB
bam-8383	59	41	.	.	PUNCT
bam-8383	60	1	statistical	statistical	ADJ
bam-8383	60	2	analysis	analysis	NOUN
bam-8383	60	3	fig	fig	NOUN
bam-8383	60	4	2	2	NUM
bam-8383	60	5	.	.	PUNCT
bam-8383	60	6	effect	effect	NOUN
bam-8383	60	7	of	of	ADP
bam-8383	60	8	aminiguanidine	aminiguanidine	ADJ
bam-8383	60	9	(	(	PUNCT
bam-8383	60	10	100	100	NUM
bam-8383	60	11	mg	mg	PROPN
bam-8383	60	12	/	/	SYM
bam-8383	60	13	kg	kg	NOUN
bam-8383	60	14	)	)	PUNCT
bam-8383	60	15	plus	plus	CCONJ
bam-8383	60	16	monobenzone	monobenzone	NOUN
bam-8383	60	17	40	40	NUM
bam-8383	60	18	%	%	NOUN
bam-8383	60	19	on	on	ADP
bam-8383	60	20	depigmentation	depigmentation	NOUN
bam-8383	60	21	non	non	PROPN
bam-8383	60	22	co	co	PROPN
bam-8383	60	23	mmerc	mmerc	PROPN
bam-8383	60	24	ial	ial	PROPN
bam-8383	60	25	us	us	PROPN
bam-8383	61	1	e	e	NOUN
bam-8383	61	2	o	o	NOUN
bam-8383	61	3	nly	nly	ADV
bam-8383	61	4	inos	ino	NOUN
bam-8383	61	5	inhibition	inhibition	NOUN
bam-8383	61	6	for	for	ADP
bam-8383	61	7	vitiligo	vitiligo	PROPN
bam-8383	61	8	eur	eur	PROPN
bam-8383	61	9	j	j	PROPN
bam-8383	61	10	transl	transl	PROPN
bam-8383	61	11	myol	myol	ADV
bam-8383	61	12	29	29	NUM
bam-8383	61	13	(	(	PUNCT
bam-8383	61	14	3	3	NUM
bam-8383	61	15	):	):	PUNCT
bam-8383	61	16	251	251	NUM
bam-8383	61	17	-	-	SYM
bam-8383	61	18	260	260	NUM
bam-8383	61	19	,	,	PUNCT
bam-8383	61	20	2019	2019	NUM
bam-8383	61	21	254	254	NUM
bam-8383	61	22	revealed	reveal	VERB
bam-8383	61	23	that	that	SCONJ
bam-8383	61	24	co	co	NOUN
bam-8383	61	25	-	-	NOUN
bam-8383	61	26	treatment	treatment	NOUN
bam-8383	61	27	of	of	ADP
bam-8383	61	28	aminoguanidine	aminoguanidine	NOUN
bam-8383	61	29	(	(	PUNCT
bam-8383	61	30	100	100	NUM
bam-8383	61	31	mg	mg	NUM
bam-8383	61	32	/	/	SYM
bam-8383	61	33	kg	kg	PROPN
bam-8383	61	34	i.p	i.p	PROPN
bam-8383	61	35	)	)	PUNCT
bam-8383	61	36	with	with	ADP
bam-8383	61	37	monobenzone	monobenzone	NOUN
bam-8383	61	38	40	40	NUM
bam-8383	61	39	%	%	NOUN
bam-8383	61	40	could	could	AUX
bam-8383	61	41	significantly	significantly	ADV
bam-8383	61	42	decrease	decrease	VERB
bam-8383	61	43	vitiligo	vitiligo	VERB
bam-8383	61	44	-	-	PUNCT
bam-8383	61	45	inducing	induce	VERB
bam-8383	61	46	effect	effect	NOUN
bam-8383	61	47	of	of	ADP
bam-8383	61	48	monobenzone	monobenzone	NOUN
bam-8383	61	49	(	(	PUNCT
bam-8383	61	50	f	f	PROPN
bam-8383	62	1	[	[	X
bam-8383	62	2	12	12	NUM
bam-8383	62	3	,	,	PUNCT
bam-8383	62	4	65	65	NUM
bam-8383	62	5	]	]	PUNCT
bam-8383	62	6	=	=	SYM
bam-8383	62	7	127.1	127.1	NUM
bam-8383	62	8	;	;	PUNCT
bam-8383	62	9	p<0.001	p<0.001	PROPN
bam-8383	62	10	;	;	PUNCT
bam-8383	62	11	fig	fig	NOUN
bam-8383	62	12	2	2	NUM
bam-8383	62	13	)	)	PUNCT
bam-8383	62	14	.	.	PUNCT
bam-8383	63	1	post	post	VERB
bam-8383	63	2	hoc	hoc	X
bam-8383	63	3	analysis	analysis	NOUN
bam-8383	63	4	demonstrated	demonstrate	VERB
bam-8383	63	5	a	a	DET
bam-8383	63	6	significant	significant	ADJ
bam-8383	63	7	difference	difference	NOUN
bam-8383	63	8	4	4	NUM
bam-8383	63	9	weeks	week	NOUN
bam-8383	63	10	after	after	ADP
bam-8383	63	11	treatment	treatment	NOUN
bam-8383	63	12	(	(	PUNCT
bam-8383	63	13	p<0.001	p<0.001	PROPN
bam-8383	63	14	)	)	PUNCT
bam-8383	63	15	.	.	PUNCT
bam-8383	64	1	in	in	ADP
bam-8383	64	2	addition	addition	NOUN
bam-8383	64	3	,	,	PUNCT
bam-8383	64	4	the	the	DET
bam-8383	64	5	difference	difference	NOUN
bam-8383	64	6	between	between	ADP
bam-8383	64	7	groups	group	NOUN
bam-8383	64	8	was	be	AUX
bam-8383	64	9	determined	determine	VERB
bam-8383	64	10	as	as	ADP
bam-8383	64	11	about	about	ADP
bam-8383	64	12	50	50	NUM
bam-8383	64	13	%	%	NOUN
bam-8383	64	14	of	of	ADP
bam-8383	64	15	depigmentation	depigmentation	NOUN
bam-8383	64	16	after	after	ADP
bam-8383	64	17	6	6	NUM
bam-8383	64	18	weeks	week	NOUN
bam-8383	64	19	.	.	PUNCT
bam-8383	65	1	overall	overall	ADJ
bam-8383	65	2	,	,	PUNCT
bam-8383	65	3	aminoguanidine	aminoguanidine	NOUN
bam-8383	65	4	(	(	PUNCT
bam-8383	65	5	100	100	NUM
bam-8383	65	6	mg	mg	NUM
bam-8383	65	7	/	/	SYM
bam-8383	65	8	kg	kg	NOUN
bam-8383	65	9	)	)	PUNCT
bam-8383	65	10	decreased	decrease	VERB
bam-8383	65	11	50	50	NUM
bam-8383	65	12	%	%	NOUN
bam-8383	65	13	of	of	ADP
bam-8383	65	14	depigmentation	depigmentation	NOUN
bam-8383	65	15	after	after	ADP
bam-8383	65	16	about	about	ADV
bam-8383	65	17	6	6	NUM
bam-8383	65	18	weeks	week	NOUN
bam-8383	65	19	.	.	PUNCT
bam-8383	66	1	co	co	NOUN
bam-8383	66	2	-	-	NOUN
bam-8383	66	3	treatment	treatment	NOUN
bam-8383	66	4	of	of	ADP
bam-8383	66	5	monobenzone	monobenzone	NOUN
bam-8383	66	6	with	with	ADP
bam-8383	66	7	no	no	DET
bam-8383	66	8	agent	agent	NOUN
bam-8383	66	9	in	in	ADP
bam-8383	66	10	the	the	DET
bam-8383	66	11	next	next	ADJ
bam-8383	66	12	step	step	NOUN
bam-8383	66	13	,	,	PUNCT
bam-8383	66	14	we	we	PRON
bam-8383	66	15	use	use	VERB
bam-8383	66	16	nos	nos	PROPN
bam-8383	66	17	agent	agent	NOUN
bam-8383	66	18	(	(	PUNCT
bam-8383	66	19	l	l	NOUN
bam-8383	66	20	-	-	NOUN
bam-8383	66	21	arginine	arginine	NOUN
bam-8383	66	22	at	at	ADP
bam-8383	66	23	100	100	NUM
bam-8383	66	24	mg	mg	PROPN
bam-8383	66	25	/	/	SYM
bam-8383	66	26	kg	kg	NOUN
bam-8383	66	27	)	)	PUNCT
bam-8383	66	28	in	in	ADP
bam-8383	66	29	combination	combination	NOUN
bam-8383	66	30	with	with	ADP
bam-8383	66	31	monobenzone	monobenzone	NOUN
bam-8383	66	32	40	40	NUM
bam-8383	66	33	%	%	NOUN
bam-8383	66	34	to	to	PART
bam-8383	66	35	evaluate	evaluate	VERB
bam-8383	66	36	the	the	DET
bam-8383	66	37	interaction	interaction	NOUN
bam-8383	66	38	between	between	ADP
bam-8383	66	39	increasing	increase	VERB
bam-8383	66	40	no	no	DET
bam-8383	66	41	level	level	NOUN
bam-8383	66	42	and	and	CCONJ
bam-8383	66	43	vitiligo	vitiligo	NOUN
bam-8383	66	44	(	(	PUNCT
bam-8383	66	45	f	f	PROPN
bam-8383	67	1	[	[	X
bam-8383	67	2	12	12	NUM
bam-8383	67	3	,	,	PUNCT
bam-8383	67	4	65	65	NUM
bam-8383	67	5	]	]	PUNCT
bam-8383	67	6	=	=	SYM
bam-8383	67	7	181.2	181.2	NUM
bam-8383	67	8	;	;	PUNCT
bam-8383	67	9	p<0.001	p<0.001	X
bam-8383	67	10	;	;	PUNCT
bam-8383	67	11	fig3	fig3	PROPN
bam-8383	67	12	)	)	PUNCT
bam-8383	67	13	.	.	PUNCT
bam-8383	68	1	one	one	NUM
bam-8383	68	2	-	-	PUNCT
bam-8383	68	3	way	way	NOUN
bam-8383	68	4	anova	anova	PROPN
bam-8383	68	5	analysis	analysis	NOUN
bam-8383	68	6	demonstrated	demonstrate	VERB
bam-8383	68	7	that	that	SCONJ
bam-8383	68	8	a	a	DET
bam-8383	68	9	co	co	NOUN
bam-8383	68	10	-	-	NOUN
bam-8383	68	11	treatment	treatment	NOUN
bam-8383	68	12	of	of	ADP
bam-8383	68	13	larginine	larginine	NOUN
bam-8383	68	14	(	(	PUNCT
bam-8383	68	15	100	100	NUM
bam-8383	68	16	mg	mg	NUM
bam-8383	68	17	/	/	SYM
bam-8383	68	18	kg	kg	PROPN
bam-8383	68	19	i.p	i.p	PROPN
bam-8383	68	20	.	.	PUNCT
bam-8383	68	21	)	)	PUNCT
bam-8383	68	22	with	with	ADP
bam-8383	68	23	monobenzone	monobenzone	NOUN
bam-8383	68	24	40	40	NUM
bam-8383	68	25	%	%	NOUN
bam-8383	68	26	was	be	AUX
bam-8383	68	27	significantly	significantly	ADV
bam-8383	68	28	associated	associate	VERB
bam-8383	68	29	with	with	ADP
bam-8383	68	30	an	an	DET
bam-8383	68	31	increased	increase	VERB
bam-8383	68	32	level	level	NOUN
bam-8383	68	33	of	of	ADP
bam-8383	68	34	vitiligo	vitiligo	NOUN
bam-8383	68	35	-	-	PUNCT
bam-8383	68	36	inducing	induce	VERB
bam-8383	68	37	effect	effect	NOUN
bam-8383	68	38	of	of	ADP
bam-8383	68	39	monobenzone	monobenzone	NOUN
bam-8383	68	40	.	.	PUNCT
bam-8383	69	1	additionally	additionally	ADV
bam-8383	69	2	,	,	PUNCT
bam-8383	69	3	post	post	VERB
bam-8383	69	4	hoc	hoc	X
bam-8383	69	5	analysis	analysis	NOUN
bam-8383	69	6	revealed	reveal	VERB
bam-8383	69	7	a	a	DET
bam-8383	69	8	significant	significant	ADJ
bam-8383	69	9	difference	difference	NOUN
bam-8383	69	10	between	between	ADP
bam-8383	69	11	groups	group	NOUN
bam-8383	69	12	after	after	ADP
bam-8383	69	13	3	3	NUM
bam-8383	69	14	weeks	week	NOUN
bam-8383	69	15	of	of	ADP
bam-8383	69	16	treatment	treatment	NOUN
bam-8383	69	17	(	(	PUNCT
bam-8383	69	18	p<0.05	p<0.05	NOUN
bam-8383	69	19	)	)	PUNCT
bam-8383	69	20	.	.	PUNCT
bam-8383	70	1	in	in	ADP
bam-8383	70	2	addition	addition	NOUN
bam-8383	70	3	,	,	PUNCT
bam-8383	70	4	the	the	DET
bam-8383	70	5	difference	difference	NOUN
bam-8383	70	6	between	between	ADP
bam-8383	70	7	groups	group	NOUN
bam-8383	70	8	comprised	comprise	VERB
bam-8383	70	9	of	of	ADP
bam-8383	70	10	35	35	NUM
bam-8383	70	11	%	%	NOUN
bam-8383	70	12	of	of	ADP
bam-8383	70	13	depigmentation	depigmentation	NOUN
bam-8383	70	14	.	.	PUNCT
bam-8383	71	1	furthermore	furthermore	ADV
bam-8383	71	2	,	,	PUNCT
bam-8383	71	3	a	a	DET
bam-8383	71	4	significant	significant	ADJ
bam-8383	71	5	difference	difference	NOUN
bam-8383	71	6	was	be	AUX
bam-8383	71	7	only	only	ADV
bam-8383	71	8	observed	observe	VERB
bam-8383	71	9	after	after	ADP
bam-8383	71	10	4	4	NUM
bam-8383	71	11	weeks	week	NOUN
bam-8383	71	12	of	of	ADP
bam-8383	71	13	treatment	treatment	NOUN
bam-8383	71	14	(	(	PUNCT
bam-8383	71	15	p<0.001	p<0.001	PROPN
bam-8383	71	16	)	)	PUNCT
bam-8383	71	17	.	.	PUNCT
bam-8383	72	1	overall	overall	ADJ
bam-8383	72	2	,	,	PUNCT
bam-8383	72	3	l	l	NOUN
bam-8383	72	4	-	-	NOUN
bam-8383	72	5	arginine	arginine	NOUN
bam-8383	72	6	(	(	PUNCT
bam-8383	72	7	100	100	NUM
bam-8383	72	8	mg	mg	NUM
bam-8383	72	9	/	/	SYM
bam-8383	72	10	kg	kg	NOUN
bam-8383	72	11	)	)	PUNCT
bam-8383	72	12	significantly	significantly	ADV
bam-8383	72	13	accelerated	accelerate	VERB
bam-8383	72	14	the	the	DET
bam-8383	72	15	depigmentation	depigmentation	NOUN
bam-8383	72	16	after	after	ADP
bam-8383	72	17	about	about	ADV
bam-8383	72	18	3	3	NUM
bam-8383	72	19	weeks	week	NOUN
bam-8383	72	20	(	(	PUNCT
bam-8383	72	21	figure	figure	NOUN
bam-8383	72	22	3	3	NUM
bam-8383	72	23	)	)	PUNCT
bam-8383	72	24	.	.	PUNCT
bam-8383	73	1	dose	dose	VERB
bam-8383	73	2	dependency	dependency	NOUN
bam-8383	73	3	of	of	ADP
bam-8383	73	4	aminiguanidine	aminiguanidine	NOUN
bam-8383	73	5	on	on	ADP
bam-8383	73	6	inducing	induce	VERB
bam-8383	73	7	vitiligo	vitiligo	NOUN
bam-8383	73	8	in	in	ADP
bam-8383	73	9	the	the	DET
bam-8383	73	10	next	next	ADJ
bam-8383	73	11	step	step	NOUN
bam-8383	73	12	,	,	PUNCT
bam-8383	73	13	we	we	PRON
bam-8383	73	14	tried	try	VERB
bam-8383	73	15	to	to	PART
bam-8383	73	16	show	show	VERB
bam-8383	73	17	the	the	DET
bam-8383	73	18	dose	dose	NOUN
bam-8383	73	19	dependency	dependency	NOUN
bam-8383	73	20	of	of	ADP
bam-8383	73	21	aminiguanidine	aminiguanidine	ADJ
bam-8383	73	22	50	50	NUM
bam-8383	73	23	and	and	CCONJ
bam-8383	73	24	100	100	NUM
bam-8383	73	25	mg	mg	NUM
bam-8383	73	26	/	/	SYM
bam-8383	73	27	kg	kg	PROPN
bam-8383	73	28	as	as	SCONJ
bam-8383	73	29	previously	previously	ADV
bam-8383	73	30	indicated	indicate	VERB
bam-8383	73	31	by	by	ADP
bam-8383	73	32	our	our	PRON
bam-8383	73	33	experiments	experiment	NOUN
bam-8383	73	34	.	.	PUNCT
bam-8383	74	1	in	in	ADP
bam-8383	74	2	order	order	NOUN
bam-8383	74	3	to	to	PART
bam-8383	74	4	evaluate	evaluate	VERB
bam-8383	74	5	the	the	DET
bam-8383	74	6	dose	dose	NOUN
bam-8383	74	7	dependency	dependency	NOUN
bam-8383	74	8	of	of	ADP
bam-8383	74	9	inos	ino	NOUN
bam-8383	74	10	inhibitor	inhibitor	NOUN
bam-8383	74	11	,	,	PUNCT
bam-8383	74	12	administration	administration	NOUN
bam-8383	74	13	of	of	ADP
bam-8383	74	14	aminoguanidine	aminoguanidine	NOUN
bam-8383	74	15	(	(	PUNCT
bam-8383	74	16	50	50	NUM
bam-8383	74	17	and	and	CCONJ
bam-8383	74	18	100	100	NUM
bam-8383	74	19	mg	mg	NUM
bam-8383	74	20	/	/	SYM
bam-8383	74	21	kg	kg	NOUN
bam-8383	74	22	)	)	PUNCT
bam-8383	74	23	with	with	ADP
bam-8383	74	24	monobenzone	monobenzone	NOUN
bam-8383	74	25	40	40	NUM
bam-8383	74	26	%	%	NOUN
bam-8383	74	27	were	be	AUX
bam-8383	74	28	applied	apply	VERB
bam-8383	74	29	in	in	ADP
bam-8383	74	30	the	the	DET
bam-8383	74	31	current	current	ADJ
bam-8383	74	32	study	study	NOUN
bam-8383	74	33	(	(	PUNCT
bam-8383	74	34	f	f	X
bam-8383	75	1	[	[	X
bam-8383	75	2	5	5	NUM
bam-8383	75	3	,	,	PUNCT
bam-8383	75	4	30	30	NUM
bam-8383	75	5	]	]	PUNCT
bam-8383	75	6	=	=	SYM
bam-8383	75	7	273.0	273.0	NUM
bam-8383	75	8	;	;	PUNCT
bam-8383	75	9	p<0.001	p<0.001	X
bam-8383	75	10	;	;	PUNCT
bam-8383	75	11	fig	fig	NOUN
bam-8383	75	12	4	4	NUM
bam-8383	75	13	)	)	PUNCT
bam-8383	75	14	.	.	PUNCT
bam-8383	76	1	one	one	NUM
bam-8383	76	2	-	-	PUNCT
bam-8383	76	3	way	way	NOUN
bam-8383	76	4	anova	anova	PROPN
bam-8383	76	5	analysis	analysis	NOUN
bam-8383	76	6	suggested	suggest	VERB
bam-8383	76	7	that	that	SCONJ
bam-8383	76	8	administration	administration	NOUN
bam-8383	76	9	of	of	ADP
bam-8383	76	10	aminoguanidine	aminoguanidine	NOUN
bam-8383	76	11	(	(	PUNCT
bam-8383	76	12	100	100	NUM
bam-8383	76	13	mg	mg	NUM
bam-8383	76	14	/	/	SYM
bam-8383	76	15	kg	kg	PROPN
bam-8383	76	16	)	)	PUNCT
bam-8383	76	17	resulted	result	VERB
bam-8383	76	18	in	in	ADP
bam-8383	76	19	induction	induction	NOUN
bam-8383	76	20	of	of	ADP
bam-8383	76	21	depigmentation	depigmentation	NOUN
bam-8383	76	22	after	after	ADP
bam-8383	76	23	6	6	NUM
bam-8383	76	24	weeks	week	NOUN
bam-8383	76	25	as	as	SCONJ
bam-8383	76	26	compare	compare	VERB
bam-8383	76	27	to	to	ADP
bam-8383	76	28	aminoguanidine	aminoguanidine	NOUN
bam-8383	76	29	(	(	PUNCT
bam-8383	76	30	50	50	NUM
bam-8383	76	31	mg	mg	PROPN
bam-8383	76	32	/	/	SYM
bam-8383	76	33	kg	kg	PROPN
bam-8383	76	34	)	)	PUNCT
bam-8383	76	35	,	,	PUNCT
bam-8383	76	36	(	(	PUNCT
bam-8383	76	37	p<0.001	p<0.001	PROPN
bam-8383	76	38	)	)	PUNCT
bam-8383	76	39	.	.	PUNCT
bam-8383	77	1	this	this	DET
bam-8383	77	2	experiment	experiment	NOUN
bam-8383	77	3	showed	show	VERB
bam-8383	77	4	that	that	SCONJ
bam-8383	77	5	aminoguanidine	aminoguanidine	NOUN
bam-8383	77	6	dose	dose	NOUN
bam-8383	77	7	dependently	dependently	ADV
bam-8383	77	8	could	could	AUX
bam-8383	77	9	be	be	AUX
bam-8383	77	10	linked	link	VERB
bam-8383	77	11	to	to	ADP
bam-8383	77	12	decreased	decrease	VERB
bam-8383	77	13	depigmentation	depigmentation	NOUN
bam-8383	77	14	-	-	PUNCT
bam-8383	77	15	inducing	induce	VERB
bam-8383	77	16	effect	effect	NOUN
bam-8383	77	17	of	of	ADP
bam-8383	77	18	monobenzone	monobenzone	NOUN
bam-8383	77	19	following	follow	VERB
bam-8383	77	20	6	6	NUM
bam-8383	77	21	weeks	week	NOUN
bam-8383	77	22	treatment	treatment	NOUN
bam-8383	77	23	(	(	PUNCT
bam-8383	77	24	figure	figure	NOUN
bam-8383	77	25	4	4	NUM
bam-8383	77	26	)	)	PUNCT
bam-8383	77	27	.	.	PUNCT
bam-8383	78	1	effect	effect	NOUN
bam-8383	78	2	of	of	ADP
bam-8383	78	3	inos	ino	NOUN
bam-8383	78	4	inhibitor	inhibitor	NOUN
bam-8383	78	5	on	on	ADP
bam-8383	78	6	phototherapy	phototherapy	NOUN
bam-8383	78	7	finally	finally	ADV
bam-8383	78	8	,	,	PUNCT
bam-8383	78	9	we	we	PRON
bam-8383	78	10	evaluated	evaluate	VERB
bam-8383	78	11	the	the	DET
bam-8383	78	12	phototherapy	phototherapy	NOUN
bam-8383	78	13	by	by	ADP
bam-8383	78	14	using	use	VERB
bam-8383	78	15	nbuvb	nbuvb	NOUN
bam-8383	78	16	as	as	ADP
bam-8383	78	17	the	the	DET
bam-8383	78	18	common	common	ADJ
bam-8383	78	19	treatment	treatment	NOUN
bam-8383	78	20	of	of	ADP
bam-8383	78	21	vitiligo	vitiligo	NOUN
bam-8383	78	22	in	in	ADP
bam-8383	78	23	combination	combination	NOUN
bam-8383	78	24	with	with	ADP
bam-8383	78	25	l	l	NOUN
bam-8383	78	26	-	-	NOUN
bam-8383	78	27	arginine	arginine	NOUN
bam-8383	78	28	to	to	PART
bam-8383	78	29	clarify	clarify	VERB
bam-8383	78	30	the	the	DET
bam-8383	78	31	effect	effect	NOUN
bam-8383	78	32	of	of	ADP
bam-8383	78	33	no	no	DET
bam-8383	78	34	level	level	NOUN
bam-8383	78	35	on	on	ADP
bam-8383	78	36	nbuvb	nbuvb	ADJ
bam-8383	78	37	induced	induce	VERB
bam-8383	78	38	pigmentation	pigmentation	NOUN
bam-8383	78	39	(	(	PUNCT
bam-8383	78	40	f	f	X
bam-8383	79	1	[	[	X
bam-8383	79	2	2	2	NUM
bam-8383	79	3	,	,	PUNCT
bam-8383	79	4	15	15	NUM
bam-8383	79	5	]	]	PUNCT
bam-8383	79	6	=	=	SYM
bam-8383	79	7	10.12	10.12	NUM
bam-8383	79	8	;	;	PUNCT
bam-8383	79	9	p<0.001	p<0.001	X
bam-8383	79	10	;	;	PUNCT
bam-8383	79	11	fig	fig	NOUN
bam-8383	79	12	5	5	NUM
bam-8383	79	13	)	)	PUNCT
bam-8383	79	14	.	.	PUNCT
bam-8383	80	1	analysis	analysis	NOUN
bam-8383	80	2	revealed	reveal	VERB
bam-8383	80	3	that	that	SCONJ
bam-8383	80	4	a	a	DET
bam-8383	80	5	combination	combination	NOUN
bam-8383	80	6	therapy	therapy	NOUN
bam-8383	80	7	,	,	PUNCT
bam-8383	80	8	consisting	consist	VERB
bam-8383	80	9	l	l	NOUN
bam-8383	80	10	-	-	NOUN
bam-8383	80	11	arginine	arginine	NOUN
bam-8383	80	12	and	and	CCONJ
bam-8383	80	13	nbuvb	nbuvb	NOUN
bam-8383	80	14	was	be	AUX
bam-8383	80	15	significantly	significantly	ADV
bam-8383	80	16	capable	capable	ADJ
bam-8383	80	17	of	of	ADP
bam-8383	80	18	enhancing	enhance	VERB
bam-8383	80	19	the	the	DET
bam-8383	80	20	pigmentation	pigmentation	NOUN
bam-8383	80	21	of	of	ADP
bam-8383	80	22	the	the	DET
bam-8383	80	23	exposed	expose	VERB
bam-8383	80	24	area	area	NOUN
bam-8383	80	25	,	,	PUNCT
bam-8383	80	26	when	when	SCONJ
bam-8383	80	27	compared	compare	VERB
bam-8383	80	28	with	with	ADP
bam-8383	80	29	nbuvb	nbuvb	ADJ
bam-8383	80	30	treatment	treatment	NOUN
bam-8383	80	31	(	(	PUNCT
bam-8383	80	32	p<0.01	p<0.01	PROPN
bam-8383	80	33	)	)	PUNCT
bam-8383	80	34	.	.	PUNCT
bam-8383	81	1	duration	duration	NOUN
bam-8383	81	2	of	of	ADP
bam-8383	81	3	nbuvb	nbuvb	ADJ
bam-8383	81	4	radiation	radiation	NOUN
bam-8383	81	5	therapy	therapy	NOUN
bam-8383	81	6	is	be	AUX
bam-8383	81	7	about	about	ADV
bam-8383	81	8	4	4	NUM
bam-8383	81	9	weeks	week	NOUN
bam-8383	81	10	,	,	PUNCT
bam-8383	81	11	where	where	SCONJ
bam-8383	81	12	a	a	DET
bam-8383	81	13	fig	fig	NOUN
bam-8383	81	14	3	3	NUM
bam-8383	81	15	.	.	PUNCT
bam-8383	81	16	effect	effect	NOUN
bam-8383	81	17	of	of	ADP
bam-8383	81	18	l	l	NOUN
bam-8383	81	19	-	-	NOUN
bam-8383	81	20	arginine	arginine	NOUN
bam-8383	81	21	(	(	PUNCT
bam-8383	81	22	100	100	NUM
bam-8383	81	23	mg	mg	NUM
bam-8383	81	24	/	/	SYM
bam-8383	81	25	kg	kg	NOUN
bam-8383	81	26	)	)	PUNCT
bam-8383	81	27	plus	plus	CCONJ
bam-8383	81	28	monobenzone	monobenzone	NOUN
bam-8383	81	29	40	40	NUM
bam-8383	81	30	%	%	NOUN
bam-8383	81	31	on	on	ADP
bam-8383	81	32	depigmentation	depigmentation	NOUN
bam-8383	81	33	.	.	PUNCT
bam-8383	82	1	non	non	PROPN
bam-8383	82	2	co	co	PROPN
bam-8383	82	3	mmerc	mmerc	PROPN
bam-8383	82	4	ial	ial	PROPN
bam-8383	82	5	us	us	PROPN
bam-8383	83	1	e	e	NOUN
bam-8383	83	2	o	o	NOUN
bam-8383	83	3	nly	nly	ADV
bam-8383	83	4	inos	ino	NOUN
bam-8383	83	5	inhibition	inhibition	NOUN
bam-8383	83	6	for	for	ADP
bam-8383	83	7	vitiligo	vitiligo	PROPN
bam-8383	83	8	eur	eur	PROPN
bam-8383	83	9	j	j	PROPN
bam-8383	83	10	transl	transl	PROPN
bam-8383	83	11	myol	myol	ADV
bam-8383	83	12	29	29	NUM
bam-8383	83	13	(	(	PUNCT
bam-8383	83	14	3	3	NUM
bam-8383	83	15	):	):	PUNCT
bam-8383	83	16	251	251	NUM
bam-8383	83	17	-	-	SYM
bam-8383	83	18	260	260	NUM
bam-8383	83	19	,	,	PUNCT
bam-8383	83	20	2019	2019	NUM
bam-8383	83	21	255	255	NUM
bam-8383	83	22	combination	combination	NOUN
bam-8383	83	23	therapy	therapy	NOUN
bam-8383	83	24	of	of	ADP
bam-8383	83	25	l	l	NOUN
bam-8383	83	26	-	-	NOUN
bam-8383	83	27	arginine	arginine	NOUN
bam-8383	83	28	and	and	CCONJ
bam-8383	83	29	nbuvb	nbuvb	NOUN
bam-8383	83	30	increased	increase	VERB
bam-8383	83	31	the	the	DET
bam-8383	83	32	effect	effect	NOUN
bam-8383	83	33	of	of	ADP
bam-8383	83	34	nbuvb	nbuvb	NOUN
bam-8383	83	35	(	(	PUNCT
bam-8383	83	36	figure	figure	NOUN
bam-8383	83	37	5	5	NUM
bam-8383	83	38	)	)	PUNCT
bam-8383	83	39	.	.	PUNCT
bam-8383	84	1	discussion	discussion	NOUN
bam-8383	84	2	in	in	ADP
bam-8383	84	3	the	the	DET
bam-8383	84	4	current	current	ADJ
bam-8383	84	5	study	study	NOUN
bam-8383	84	6	,	,	PUNCT
bam-8383	84	7	we	we	PRON
bam-8383	84	8	demonstrated	demonstrate	VERB
bam-8383	84	9	that	that	SCONJ
bam-8383	84	10	aminoguanidine	aminoguanidine	NOUN
bam-8383	84	11	could	could	AUX
bam-8383	84	12	inhibit	inhibit	VERB
bam-8383	84	13	vitiligo	vitiligo	VERB
bam-8383	84	14	-	-	PUNCT
bam-8383	84	15	inducing	induce	VERB
bam-8383	84	16	effect	effect	NOUN
bam-8383	84	17	of	of	ADP
bam-8383	84	18	monobenzone	monobenzone	NOUN
bam-8383	84	19	after	after	ADP
bam-8383	84	20	about	about	ADV
bam-8383	84	21	4	4	NUM
bam-8383	84	22	weeks	week	NOUN
bam-8383	84	23	of	of	ADP
bam-8383	84	24	treatment	treatment	NOUN
bam-8383	84	25	.	.	PUNCT
bam-8383	85	1	in	in	ADP
bam-8383	85	2	addition	addition	NOUN
bam-8383	85	3	,	,	PUNCT
bam-8383	85	4	our	our	PRON
bam-8383	85	5	results	result	NOUN
bam-8383	85	6	verified	verify	VERB
bam-8383	85	7	that	that	SCONJ
bam-8383	85	8	l	l	NOUN
bam-8383	85	9	-	-	NOUN
bam-8383	85	10	arginine	arginine	NOUN
bam-8383	85	11	could	could	AUX
bam-8383	85	12	significantly	significantly	ADV
bam-8383	85	13	increase	increase	VERB
bam-8383	85	14	the	the	DET
bam-8383	85	15	effect	effect	NOUN
bam-8383	85	16	of	of	ADP
bam-8383	85	17	nbuvb	nbuvb	ADJ
bam-8383	85	18	treatment	treatment	NOUN
bam-8383	85	19	in	in	ADP
bam-8383	85	20	mice	mice	NOUN
bam-8383	85	21	model	model	NOUN
bam-8383	85	22	of	of	ADP
bam-8383	85	23	vitiligo	vitiligo	PROPN
bam-8383	85	24	.	.	PUNCT
bam-8383	86	1	nitric	nitric	ADJ
bam-8383	86	2	oxide	oxide	NOUN
bam-8383	86	3	has	have	AUX
bam-8383	86	4	been	be	AUX
bam-8383	86	5	defined	define	VERB
bam-8383	86	6	to	to	PART
bam-8383	86	7	be	be	AUX
bam-8383	86	8	a	a	DET
bam-8383	86	9	noteworthy	noteworthy	ADJ
bam-8383	86	10	mediator	mediator	NOUN
bam-8383	86	11	that	that	PRON
bam-8383	86	12	plays	play	VERB
bam-8383	86	13	a	a	DET
bam-8383	86	14	crucial	crucial	ADJ
bam-8383	86	15	role	role	NOUN
bam-8383	86	16	in	in	ADP
bam-8383	86	17	numerous	numerous	ADJ
bam-8383	86	18	biological	biological	ADJ
bam-8383	86	19	procedures	procedure	NOUN
bam-8383	86	20	including	include	VERB
bam-8383	86	21	melanogenesis	melanogenesis	NOUN
bam-8383	86	22	,	,	PUNCT
bam-8383	86	23	microcirculation	microcirculation	NOUN
bam-8383	86	24	,	,	PUNCT
bam-8383	86	25	and	and	CCONJ
bam-8383	86	26	keratinocyte	keratinocyte	NOUN
bam-8383	86	27	response	response	NOUN
bam-8383	86	28	to	to	ADP
bam-8383	86	29	ultraviolet	ultraviolet	ADJ
bam-8383	86	30	radiation	radiation	NOUN
bam-8383	86	31	,	,	PUNCT
bam-8383	86	32	cell	cell	NOUN
bam-8383	86	33	growth	growth	NOUN
bam-8383	86	34	and	and	CCONJ
bam-8383	86	35	differentiation	differentiation	NOUN
bam-8383	86	36	.	.	PUNCT
bam-8383	87	1	nitric	nitric	ADJ
bam-8383	87	2	oxide	oxide	NOUN
bam-8383	87	3	is	be	AUX
bam-8383	87	4	known	know	VERB
bam-8383	87	5	to	to	PART
bam-8383	87	6	be	be	AUX
bam-8383	87	7	a	a	DET
bam-8383	87	8	major	major	ADJ
bam-8383	87	9	neurotransmitter	neurotransmitter	NOUN
bam-8383	87	10	that	that	PRON
bam-8383	87	11	plays	play	VERB
bam-8383	87	12	a	a	DET
bam-8383	87	13	key	key	ADJ
bam-8383	87	14	role	role	NOUN
bam-8383	87	15	in	in	ADP
bam-8383	87	16	the	the	DET
bam-8383	87	17	pathophysiology	pathophysiology	NOUN
bam-8383	87	18	of	of	ADP
bam-8383	87	19	many	many	ADJ
bam-8383	87	20	diseases	disease	NOUN
bam-8383	87	21	of	of	ADP
bam-8383	87	22	the	the	DET
bam-8383	87	23	nervous	nervous	ADJ
bam-8383	87	24	system	system	NOUN
bam-8383	87	25	,	,	PUNCT
bam-8383	87	26	such	such	ADJ
bam-8383	87	27	as	as	ADP
bam-8383	87	28	epilepsy	epilepsy	NOUN
bam-8383	87	29	,	,	PUNCT
bam-8383	87	30	schizophrenia	schizophrenia	NOUN
bam-8383	87	31	,	,	PUNCT
bam-8383	87	32	anxiety	anxiety	NOUN
bam-8383	87	33	,	,	PUNCT
bam-8383	87	34	and	and	CCONJ
bam-8383	87	35	autoimmune	autoimmune	ADJ
bam-8383	87	36	disease	disease	NOUN
bam-8383	87	37	.	.	PUNCT
bam-8383	88	1	nitric	nitric	ADJ
bam-8383	88	2	oxide	oxide	NOUN
bam-8383	88	3	is	be	AUX
bam-8383	88	4	a	a	DET
bam-8383	88	5	chemical	chemical	ADJ
bam-8383	88	6	messenger	messenger	NOUN
bam-8383	88	7	that	that	PRON
bam-8383	88	8	can	can	AUX
bam-8383	88	9	easily	easily	ADV
bam-8383	88	10	pass	pass	VERB
bam-8383	88	11	through	through	ADP
bam-8383	88	12	cell	cell	NOUN
bam-8383	88	13	membranes	membrane	NOUN
bam-8383	88	14	,	,	PUNCT
bam-8383	88	15	and	and	CCONJ
bam-8383	88	16	unlike	unlike	ADP
bam-8383	88	17	other	other	ADJ
bam-8383	88	18	neurotransmitters	neurotransmitter	NOUN
bam-8383	88	19	,	,	PUNCT
bam-8383	88	20	it	it	PRON
bam-8383	88	21	does	do	AUX
bam-8383	88	22	not	not	PART
bam-8383	88	23	accumulate	accumulate	VERB
bam-8383	88	24	in	in	ADP
bam-8383	88	25	synaptic	synaptic	ADJ
bam-8383	88	26	vesicles	vesicle	NOUN
bam-8383	88	27	and	and	CCONJ
bam-8383	88	28	does	do	AUX
bam-8383	88	29	not	not	PART
bam-8383	88	30	release	release	VERB
bam-8383	88	31	through	through	ADP
bam-8383	88	32	exocytosis	exocytosis	NOUN
bam-8383	88	33	.	.	PUNCT
bam-8383	89	1	it	it	PRON
bam-8383	89	2	seems	seem	VERB
bam-8383	89	3	that	that	SCONJ
bam-8383	89	4	nitric	nitric	ADJ
bam-8383	89	5	oxide	oxide	NOUN
bam-8383	89	6	plays	play	VERB
bam-8383	89	7	a	a	DET
bam-8383	89	8	crucial	crucial	ADJ
bam-8383	89	9	role	role	NOUN
bam-8383	89	10	in	in	ADP
bam-8383	89	11	regulating	regulate	VERB
bam-8383	89	12	various	various	ADJ
bam-8383	89	13	body	body	NOUN
bam-8383	89	14	responses	response	NOUN
bam-8383	89	15	,	,	PUNCT
bam-8383	89	16	in	in	ADP
bam-8383	89	17	association	association	NOUN
bam-8383	89	18	with	with	ADP
bam-8383	89	19	other	other	ADJ
bam-8383	89	20	neurotransmitter	neurotransmitter	NOUN
bam-8383	89	21	systems	system	NOUN
bam-8383	89	22	,	,	PUNCT
bam-8383	89	23	such	such	ADJ
bam-8383	89	24	as	as	ADP
bam-8383	89	25	norepinephrine	norepinephrine	NOUN
bam-8383	89	26	,	,	PUNCT
bam-8383	89	27	serotonin	serotonin	NOUN
bam-8383	89	28	,	,	PUNCT
bam-8383	89	29	dopamine	dopamine	NOUN
bam-8383	89	30	,	,	PUNCT
bam-8383	89	31	and	and	CCONJ
bam-8383	89	32	glutamate	glutamate	VERB
bam-8383	89	33	.	.	PUNCT
bam-8383	90	1	an	an	DET
bam-8383	90	2	increasing	increase	VERB
bam-8383	90	3	body	body	NOUN
bam-8383	90	4	of	of	ADP
bam-8383	90	5	evidence	evidence	NOUN
bam-8383	90	6	indicates	indicate	VERB
bam-8383	90	7	a	a	DET
bam-8383	90	8	possible	possible	ADJ
bam-8383	90	9	role	role	NOUN
bam-8383	90	10	for	for	ADP
bam-8383	90	11	no	no	PRON
bam-8383	90	12	in	in	ADP
bam-8383	90	13	hair	hair	NOUN
bam-8383	90	14	follicle	follicle	NOUN
bam-8383	90	15	biology	biology	NOUN
bam-8383	90	16	,	,	PUNCT
bam-8383	90	17	where	where	SCONJ
bam-8383	90	18	is	be	AUX
bam-8383	90	19	not	not	PART
bam-8383	90	20	a	a	DET
bam-8383	90	21	well	well	ADV
bam-8383	90	22	-	-	PUNCT
bam-8383	90	23	known	know	VERB
bam-8383	90	24	regulator	regulator	NOUN
bam-8383	90	25	in	in	ADP
bam-8383	90	26	the	the	DET
bam-8383	90	27	human	human	ADJ
bam-8383	90	28	hair	hair	NOUN
bam-8383	90	29	follicle	follicle	VERB
bam-8383	90	30	and	and	CCONJ
bam-8383	90	31	the	the	DET
bam-8383	90	32	hair	hair	NOUN
bam-8383	90	33	-	-	PUNCT
bam-8383	90	34	growth	growth	NOUN
bam-8383	90	35	cycle.38,39	cycle.38,39	NOUN
bam-8383	90	36	no	no	INTJ
bam-8383	90	37	is	be	AUX
bam-8383	90	38	known	know	VERB
bam-8383	90	39	as	as	ADP
bam-8383	90	40	an	an	DET
bam-8383	90	41	important	important	ADJ
bam-8383	90	42	mediator	mediator	NOUN
bam-8383	90	43	of	of	ADP
bam-8383	90	44	inflammatory	inflammatory	ADJ
bam-8383	90	45	responses	response	NOUN
bam-8383	90	46	in	in	ADP
bam-8383	90	47	the	the	DET
bam-8383	90	48	body	body	NOUN
bam-8383	90	49	.	.	PUNCT
bam-8383	91	1	moreover	moreover	ADV
bam-8383	91	2	,	,	PUNCT
bam-8383	91	3	its	its	PRON
bam-8383	91	4	precarious	precarious	ADJ
bam-8383	91	5	role	role	NOUN
bam-8383	91	6	in	in	ADP
bam-8383	91	7	several	several	ADJ
bam-8383	91	8	hyperproliferative	hyperproliferative	ADJ
bam-8383	91	9	and	and	CCONJ
bam-8383	91	10	autoimmune	autoimmune	ADJ
bam-8383	91	11	disorders	disorder	NOUN
bam-8383	91	12	has	have	AUX
bam-8383	91	13	been	be	AUX
bam-8383	91	14	previously	previously	ADV
bam-8383	91	15	conformed.4043	conformed.4043	NUM
bam-8383	91	16	.	.	PUNCT
bam-8383	92	1	l	l	NOUN
bam-8383	92	2	-	-	NOUN
bam-8383	92	3	arginine	arginine	NOUN
bam-8383	92	4	is	be	AUX
bam-8383	92	5	defined	define	VERB
bam-8383	92	6	to	to	PART
bam-8383	92	7	be	be	AUX
bam-8383	92	8	a	a	DET
bam-8383	92	9	biological	biological	ADJ
bam-8383	92	10	precursor	precursor	NOUN
bam-8383	92	11	of	of	ADP
bam-8383	92	12	no	no	PRON
bam-8383	92	13	,	,	PUNCT
bam-8383	92	14	a	a	DET
bam-8383	92	15	nerve	nerve	NOUN
bam-8383	92	16	regulator	regulator	NOUN
bam-8383	92	17	in	in	ADP
bam-8383	92	18	the	the	DET
bam-8383	92	19	brain	brain	NOUN
bam-8383	92	20	,	,	PUNCT
bam-8383	92	21	by	by	ADP
bam-8383	92	22	the	the	DET
bam-8383	92	23	nitric	nitric	ADJ
bam-8383	92	24	oxide	oxide	NOUN
bam-8383	92	25	synthase	synthase	NOUN
bam-8383	92	26	(	(	PUNCT
bam-8383	92	27	nos	nos	NOUN
bam-8383	92	28	)	)	PUNCT
bam-8383	92	29	enzyme	enzyme	NOUN
bam-8383	92	30	.	.	PUNCT
bam-8383	93	1	the	the	DET
bam-8383	93	2	enzymatic	enzymatic	ADJ
bam-8383	93	3	family	family	NOUN
bam-8383	93	4	of	of	ADP
bam-8383	93	5	nos	nos	PROPN
bam-8383	93	6	consists	consist	VERB
bam-8383	93	7	of	of	ADP
bam-8383	93	8	three	three	NUM
bam-8383	93	9	isoforms	isoform	NOUN
bam-8383	93	10	that	that	PRON
bam-8383	93	11	include	include	VERB
bam-8383	93	12	inducible	inducible	ADJ
bam-8383	93	13	nos	no	NOUN
bam-8383	93	14	(	(	PUNCT
bam-8383	93	15	inos	ino	NOUN
bam-8383	93	16	)	)	PUNCT
bam-8383	93	17	,	,	PUNCT
bam-8383	93	18	neuronal	neuronal	ADJ
bam-8383	93	19	nos	no	NOUN
bam-8383	93	20	(	(	PUNCT
bam-8383	93	21	nnos	nno	NOUN
bam-8383	93	22	)	)	PUNCT
bam-8383	93	23	,	,	PUNCT
bam-8383	93	24	and	and	CCONJ
bam-8383	93	25	endothelial	endothelial	ADJ
bam-8383	93	26	nos	no	NOUN
bam-8383	93	27	(	(	PUNCT
bam-8383	93	28	enos	enos	PROPN
bam-8383	93	29	)	)	PUNCT
bam-8383	93	30	.	.	PUNCT
bam-8383	94	1	all	all	DET
bam-8383	94	2	three	three	NUM
bam-8383	94	3	nos	no	NOUN
bam-8383	94	4	isoforms	isoform	NOUN
bam-8383	94	5	play	play	VERB
bam-8383	94	6	their	their	PRON
bam-8383	94	7	crucial	crucial	ADJ
bam-8383	94	8	role	role	NOUN
bam-8383	94	9	in	in	ADP
bam-8383	94	10	different	different	ADJ
bam-8383	94	11	parts	part	NOUN
bam-8383	94	12	of	of	ADP
bam-8383	94	13	the	the	DET
bam-8383	94	14	brain	brain	NOUN
bam-8383	94	15	.	.	PUNCT
bam-8383	95	1	unlike	unlike	ADP
bam-8383	95	2	inos	ino	NOUN
bam-8383	95	3	,	,	PUNCT
bam-8383	95	4	nnos	nno	NOUN
bam-8383	95	5	and	and	CCONJ
bam-8383	95	6	enos	eno	NOUN
bam-8383	95	7	are	be	AUX
bam-8383	95	8	both	both	PRON
bam-8383	95	9	calcium	calcium	NOUN
bam-8383	95	10	/	/	SYM
bam-8383	95	11	calmodulin	calmodulin	NOUN
bam-8383	95	12	-	-	PUNCT
bam-8383	95	13	dependent	dependent	ADJ
bam-8383	95	14	,	,	PUNCT
bam-8383	95	15	where	where	SCONJ
bam-8383	95	16	preclinical	preclinical	ADJ
bam-8383	95	17	evidence	evidence	NOUN
bam-8383	95	18	supporting	support	VERB
bam-8383	95	19	important	important	ADJ
bam-8383	95	20	role	role	NOUN
bam-8383	95	21	for	for	ADP
bam-8383	95	22	this	this	DET
bam-8383	95	23	isoforms	isoform	NOUN
bam-8383	95	24	in	in	ADP
bam-8383	95	25	cell	cell	NOUN
bam-8383	95	26	homeostasis	homeostasis	NOUN
bam-8383	95	27	,	,	PUNCT
bam-8383	95	28	and	and	CCONJ
bam-8383	95	29	alteration	alteration	NOUN
bam-8383	95	30	of	of	ADP
bam-8383	95	31	immune	immune	ADJ
bam-8383	95	32	and	and	CCONJ
bam-8383	95	33	cytotoxic	cytotoxic	ADJ
bam-8383	95	34	response	response	NOUN
bam-8383	95	35	31	31	NUM
bam-8383	95	36	,	,	PUNCT
bam-8383	95	37	44	44	NUM
bam-8383	95	38	,	,	PUNCT
bam-8383	95	39	45	45	NUM
bam-8383	95	40	.	.	PUNCT
bam-8383	96	1	it	it	PRON
bam-8383	96	2	is	be	AUX
bam-8383	96	3	noteworthy	noteworthy	ADJ
bam-8383	96	4	,	,	PUNCT
bam-8383	96	5	that	that	PRON
bam-8383	96	6	enos	eno	NOUN
bam-8383	96	7	and	and	CCONJ
bam-8383	96	8	nnos	nno	NOUN
bam-8383	96	9	were	be	AUX
bam-8383	96	10	originated	originate	VERB
bam-8383	96	11	in	in	ADP
bam-8383	96	12	numerous	numerous	ADJ
bam-8383	96	13	tissues	tissue	NOUN
bam-8383	96	14	,	,	PUNCT
bam-8383	96	15	which	which	PRON
bam-8383	96	16	have	have	AUX
bam-8383	96	17	been	be	AUX
bam-8383	96	18	identified	identify	VERB
bam-8383	96	19	to	to	PART
bam-8383	96	20	synthesize	synthesize	VERB
bam-8383	96	21	by	by	ADP
bam-8383	96	22	different	different	ADJ
bam-8383	96	23	cell	cell	NOUN
bam-8383	96	24	including	include	VERB
bam-8383	96	25	keratinocytes	keratinocyte	NOUN
bam-8383	96	26	,	,	PUNCT
bam-8383	96	27	melanocytes	melanocyte	NOUN
bam-8383	96	28	,	,	PUNCT
bam-8383	96	29	and	and	CCONJ
bam-8383	96	30	fibroblasts	fibroblast	NOUN
bam-8383	96	31	in	in	ADP
bam-8383	96	32	skin	skin	NOUN
bam-8383	96	33	.	.	PUNCT
bam-8383	97	1	ample	ample	ADJ
bam-8383	97	2	evidence	evidence	NOUN
bam-8383	97	3	suggests	suggest	VERB
bam-8383	97	4	that	that	SCONJ
bam-8383	97	5	expression	expression	NOUN
bam-8383	97	6	of	of	ADP
bam-8383	97	7	inos	ino	NOUN
bam-8383	97	8	is	be	AUX
bam-8383	97	9	under	under	ADP
bam-8383	97	10	the	the	DET
bam-8383	97	11	regulation	regulation	NOUN
bam-8383	97	12	of	of	ADP
bam-8383	97	13	different	different	ADJ
bam-8383	97	14	cytokines	cytokine	NOUN
bam-8383	97	15	including	include	VERB
bam-8383	97	16	il-1	il-1	X
bam-8383	97	17	,	,	PUNCT
bam-8383	97	18	il-6	il-6	NOUN
bam-8383	97	19	,	,	PUNCT
bam-8383	97	20	il-23	il-23	NOUN
bam-8383	97	21	,	,	PUNCT
bam-8383	97	22	il-17	il-17	X
bam-8383	97	23	,	,	PUNCT
bam-8383	97	24	il-33	il-33	X
bam-8383	97	25	,	,	PUNCT
bam-8383	97	26	ifn	ifn	PROPN
bam-8383	97	27	-	-	PUNCT
bam-8383	97	28	γ	γ	X
bam-8383	97	29	and	and	CCONJ
bam-8383	97	30	tnf	tnf	PROPN
bam-8383	97	31	-	-	PUNCT
bam-8383	97	32	α,32,4649,50	α,32,4649,50	PROPN
bam-8383	97	33	-	-	NOUN
bam-8383	97	34	63	63	NUM
bam-8383	97	35	which	which	PRON
bam-8383	97	36	play	play	VERB
bam-8383	97	37	a	a	DET
bam-8383	97	38	key	key	ADJ
bam-8383	97	39	role	role	NOUN
bam-8383	97	40	in	in	ADP
bam-8383	97	41	inducing	induce	VERB
bam-8383	97	42	the	the	DET
bam-8383	97	43	depigmentation	depigmentation	NOUN
bam-8383	97	44	.	.	PUNCT
bam-8383	98	1	in	in	ADP
bam-8383	98	2	this	this	DET
bam-8383	98	3	regard	regard	NOUN
bam-8383	98	4	,	,	PUNCT
bam-8383	98	5	our	our	PRON
bam-8383	98	6	study	study	NOUN
bam-8383	98	7	should	should	AUX
bam-8383	98	8	be	be	AUX
bam-8383	98	9	considered	consider	VERB
bam-8383	98	10	in	in	ADP
bam-8383	98	11	light	light	NOUN
bam-8383	98	12	of	of	ADP
bam-8383	98	13	a	a	DET
bam-8383	98	14	limitation	limitation	NOUN
bam-8383	98	15	,	,	PUNCT
bam-8383	98	16	where	where	SCONJ
bam-8383	98	17	further	further	ADJ
bam-8383	98	18	studies	study	NOUN
bam-8383	98	19	are	be	AUX
bam-8383	98	20	needed	need	VERB
bam-8383	98	21	to	to	PART
bam-8383	98	22	clarify	clarify	VERB
bam-8383	98	23	the	the	DET
bam-8383	98	24	expression	expression	NOUN
bam-8383	98	25	of	of	ADP
bam-8383	98	26	cytokines	cytokine	NOUN
bam-8383	98	27	such	such	ADJ
bam-8383	98	28	as	as	ADP
bam-8383	98	29	tnf	tnf	PROPN
bam-8383	98	30	-	-	PUNCT
bam-8383	98	31	a	a	NOUN
bam-8383	98	32	in	in	ADP
bam-8383	98	33	the	the	DET
bam-8383	98	34	future	future	NOUN
bam-8383	98	35	.	.	PUNCT
bam-8383	99	1	ifn	ifn	PROPN
bam-8383	99	2	-	-	PUNCT
bam-8383	99	3	γ	γ	X
bam-8383	99	4	and	and	CCONJ
bam-8383	99	5	tnf	tnf	PROPN
bam-8383	99	6	-	-	PUNCT
bam-8383	99	7	α	α	PROPN
bam-8383	99	8	as	as	ADP
bam-8383	99	9	th1	th1	PROPN
bam-8383	99	10	cytokines	cytokine	NOUN
bam-8383	99	11	,	,	PUNCT
bam-8383	99	12	because	because	SCONJ
bam-8383	99	13	increasing	increase	VERB
bam-8383	99	14	evidence	evidence	NOUN
bam-8383	99	15	supports	support	VERB
bam-8383	99	16	a	a	DET
bam-8383	99	17	role	role	NOUN
bam-8383	99	18	for	for	ADP
bam-8383	99	19	th1	th1	NOUN
bam-8383	99	20	response	response	NOUN
bam-8383	99	21	in	in	ADP
bam-8383	99	22	mediating	mediate	VERB
bam-8383	99	23	vitiligo	vitiligo	NOUN
bam-8383	99	24	.	.	PUNCT
bam-8383	100	1	a	a	DET
bam-8383	100	2	study	study	NOUN
bam-8383	100	3	by	by	ADP
bam-8383	100	4	taïeb	taïeb	NOUN
bam-8383	100	5	described	describe	VERB
bam-8383	100	6	vitiligo	vitiligo	NOUN
bam-8383	100	7	as	as	ADP
bam-8383	100	8	an	an	DET
bam-8383	100	9	inflammatory	inflammatory	ADJ
bam-8383	100	10	disease	disease	NOUN
bam-8383	100	11	similar	similar	ADJ
bam-8383	100	12	to	to	ADP
bam-8383	100	13	other	other	ADJ
bam-8383	100	14	skin	skin	NOUN
bam-8383	100	15	inflammatory	inflammatory	ADJ
bam-8383	100	16	diseases	disease	NOUN
bam-8383	100	17	,	,	PUNCT
bam-8383	100	18	including	include	VERB
bam-8383	100	19	psoriasis	psoriasis	NOUN
bam-8383	100	20	and	and	CCONJ
bam-8383	100	21	atopic	atopic	NOUN
bam-8383	100	22	dermatitis	dermatitis	NOUN
bam-8383	100	23	.	.	PUNCT
bam-8383	101	1	this	this	DET
bam-8383	101	2	research	research	NOUN
bam-8383	101	3	reported	report	VERB
bam-8383	101	4	that	that	SCONJ
bam-8383	101	5	the	the	DET
bam-8383	101	6	elimination	elimination	NOUN
bam-8383	101	7	of	of	ADP
bam-8383	101	8	inflammation	inflammation	NOUN
bam-8383	101	9	can	can	AUX
bam-8383	101	10	be	be	AUX
bam-8383	101	11	considered	consider	VERB
bam-8383	101	12	as	as	ADP
bam-8383	101	13	a	a	DET
bam-8383	101	14	priority	priority	NOUN
bam-8383	101	15	in	in	ADP
bam-8383	101	16	the	the	DET
bam-8383	101	17	treatment	treatment	NOUN
bam-8383	101	18	of	of	ADP
bam-8383	101	19	this	this	DET
bam-8383	101	20	disease.64	disease.64	PROPN
bam-8383	101	21	fig	fig	NOUN
bam-8383	101	22	4	4	NUM
bam-8383	101	23	.	.	PUNCT
bam-8383	101	24	effect	effect	NOUN
bam-8383	101	25	of	of	ADP
bam-8383	101	26	dose	dose	NOUN
bam-8383	101	27	dependency	dependency	NOUN
bam-8383	101	28	of	of	ADP
bam-8383	101	29	aminoguanidine	aminoguanidine	NOUN
bam-8383	101	30	(	(	PUNCT
bam-8383	101	31	50	50	NUM
bam-8383	101	32	and	and	CCONJ
bam-8383	101	33	100	100	NUM
bam-8383	101	34	mg	mg	NUM
bam-8383	101	35	/	/	SYM
bam-8383	101	36	kg	kg	NOUN
bam-8383	101	37	)	)	PUNCT
bam-8383	101	38	in	in	ADP
bam-8383	101	39	comparison	comparison	NOUN
bam-8383	101	40	monobenzone	monobenzone	NOUN
bam-8383	101	41	40	40	NUM
bam-8383	101	42	%	%	NOUN
bam-8383	101	43	on	on	ADP
bam-8383	101	44	pigmentation	pigmentation	NOUN
bam-8383	101	45	incidence	incidence	NOUN
bam-8383	101	46	after	after	ADP
bam-8383	101	47	6	6	NUM
bam-8383	101	48	weeks	week	NOUN
bam-8383	101	49	.	.	PUNCT
bam-8383	102	1	non	non	PROPN
bam-8383	102	2	co	co	PROPN
bam-8383	102	3	mmerc	mmerc	PROPN
bam-8383	102	4	ial	ial	PROPN
bam-8383	102	5	us	us	PROPN
bam-8383	103	1	e	e	NOUN
bam-8383	103	2	o	o	NOUN
bam-8383	103	3	nly	nly	ADV
bam-8383	103	4	inos	ino	NOUN
bam-8383	103	5	inhibition	inhibition	NOUN
bam-8383	103	6	for	for	ADP
bam-8383	103	7	vitiligo	vitiligo	PROPN
bam-8383	103	8	eur	eur	PROPN
bam-8383	103	9	j	j	PROPN
bam-8383	103	10	transl	transl	PROPN
bam-8383	103	11	myol	myol	ADV
bam-8383	103	12	29	29	NUM
bam-8383	103	13	(	(	PUNCT
bam-8383	103	14	3	3	NUM
bam-8383	103	15	):	):	PUNCT
bam-8383	103	16	251	251	NUM
bam-8383	103	17	-	-	SYM
bam-8383	103	18	260	260	NUM
bam-8383	103	19	,	,	PUNCT
bam-8383	103	20	2019	2019	NUM
bam-8383	103	21	256	256	NUM
bam-8383	103	22	vaccaro	vaccaro	NOUN
bam-8383	103	23	et	et	PROPN
bam-8383	103	24	al	al	PROPN
bam-8383	103	25	.	.	PROPN
bam-8383	103	26	have	have	AUX
bam-8383	103	27	shown	show	VERB
bam-8383	103	28	that	that	SCONJ
bam-8383	103	29	uva	uva	PROPN
bam-8383	103	30	and	and	CCONJ
bam-8383	103	31	uvb	uvb	ADJ
bam-8383	103	32	radiation	radiation	NOUN
bam-8383	103	33	were	be	AUX
bam-8383	103	34	capable	capable	ADJ
bam-8383	103	35	of	of	ADP
bam-8383	103	36	triggering	trigger	VERB
bam-8383	103	37	the	the	DET
bam-8383	103	38	synthesis	synthesis	NOUN
bam-8383	103	39	of	of	ADP
bam-8383	103	40	no	no	DET
bam-8383	103	41	(	(	PUNCT
bam-8383	103	42	nos	nos	NOUN
bam-8383	103	43	)	)	PUNCT
bam-8383	103	44	enzymes	enzyme	NOUN
bam-8383	103	45	in	in	ADP
bam-8383	103	46	keratinocytes	keratinocyte	NOUN
bam-8383	103	47	and	and	CCONJ
bam-8383	103	48	melanocytes	melanocyte	NOUN
bam-8383	103	49	.	.	PUNCT
bam-8383	104	1	they	they	PRON
bam-8383	104	2	have	have	AUX
bam-8383	104	3	suggested	suggest	VERB
bam-8383	104	4	that	that	SCONJ
bam-8383	104	5	an	an	DET
bam-8383	104	6	increased	increase	VERB
bam-8383	104	7	level	level	NOUN
bam-8383	104	8	of	of	ADP
bam-8383	104	9	no	no	PRON
bam-8383	104	10	may	may	AUX
bam-8383	104	11	increase	increase	VERB
bam-8383	104	12	tyrosine	tyrosine	NOUN
bam-8383	104	13	kinase	kinase	NOUN
bam-8383	104	14	activity	activity	NOUN
bam-8383	104	15	and	and	CCONJ
bam-8383	104	16	then	then	ADV
bam-8383	104	17	triggered	trigger	VERB
bam-8383	104	18	melanin	melanin	NOUN
bam-8383	104	19	formation	formation	NOUN
bam-8383	104	20	,	,	PUNCT
bam-8383	104	21	but	but	CCONJ
bam-8383	104	22	excessive	excessive	ADJ
bam-8383	104	23	increased	increase	VERB
bam-8383	104	24	of	of	ADP
bam-8383	104	25	inos	ino	NOUN
bam-8383	104	26	could	could	AUX
bam-8383	104	27	lead	lead	VERB
bam-8383	104	28	to	to	ADP
bam-8383	104	29	processes	process	NOUN
bam-8383	104	30	that	that	PRON
bam-8383	104	31	result	result	VERB
bam-8383	104	32	in	in	ADP
bam-8383	104	33	depigmentation	depigmentation	NOUN
bam-8383	104	34	.	.	PUNCT
bam-8383	105	1	aforementioned	aforementioned	ADJ
bam-8383	105	2	study	study	NOUN
bam-8383	105	3	exhibited	exhibit	VERB
bam-8383	105	4	that	that	SCONJ
bam-8383	105	5	the	the	DET
bam-8383	105	6	no	no	DET
bam-8383	105	7	imbalance	imbalance	NOUN
bam-8383	105	8	play	play	VERB
bam-8383	105	9	a	a	DET
bam-8383	105	10	key	key	ADJ
bam-8383	105	11	role	role	NOUN
bam-8383	105	12	in	in	ADP
bam-8383	105	13	the	the	DET
bam-8383	105	14	development	development	NOUN
bam-8383	105	15	of	of	ADP
bam-8383	105	16	vitiligo	vitiligo	NOUN
bam-8383	105	17	,	,	PUNCT
bam-8383	105	18	where	where	SCONJ
bam-8383	105	19	inhibitors	inhibitor	NOUN
bam-8383	105	20	of	of	ADP
bam-8383	105	21	this	this	DET
bam-8383	105	22	factor	factor	NOUN
bam-8383	105	23	can	can	AUX
bam-8383	105	24	potentially	potentially	ADV
bam-8383	105	25	play	play	VERB
bam-8383	105	26	a	a	DET
bam-8383	105	27	role	role	NOUN
bam-8383	105	28	in	in	ADP
bam-8383	105	29	improving	improve	VERB
bam-8383	105	30	this	this	DET
bam-8383	105	31	complication	complication	NOUN
bam-8383	105	32	,	,	PUNCT
bam-8383	105	33	and	and	CCONJ
bam-8383	105	34	recommend	recommend	VERB
bam-8383	105	35	the	the	DET
bam-8383	105	36	assessment	assessment	NOUN
bam-8383	105	37	of	of	ADP
bam-8383	105	38	these	these	DET
bam-8383	105	39	inhibitors	inhibitor	NOUN
bam-8383	105	40	as	as	ADP
bam-8383	105	41	a	a	DET
bam-8383	105	42	priority.65	priority.65	NOUN
bam-8383	105	43	many	many	ADJ
bam-8383	105	44	studies	study	NOUN
bam-8383	105	45	suggested	suggest	VERB
bam-8383	105	46	the	the	DET
bam-8383	105	47	use	use	NOUN
bam-8383	105	48	of	of	ADP
bam-8383	105	49	topical	topical	ADJ
bam-8383	105	50	corticosteroids	corticosteroid	NOUN
bam-8383	105	51	as	as	ADP
bam-8383	105	52	the	the	DET
bam-8383	105	53	first	first	ADJ
bam-8383	105	54	line	line	NOUN
bam-8383	105	55	of	of	ADP
bam-8383	105	56	treatment	treatment	NOUN
bam-8383	105	57	for	for	ADP
bam-8383	105	58	vitiligo	vitiligo	NOUN
bam-8383	105	59	.	.	PUNCT
bam-8383	106	1	moreover	moreover	ADV
bam-8383	106	2	,	,	PUNCT
bam-8383	106	3	some	some	DET
bam-8383	106	4	studies	study	NOUN
bam-8383	106	5	emphasized	emphasize	VERB
bam-8383	106	6	on	on	ADP
bam-8383	106	7	the	the	DET
bam-8383	106	8	systemic	systemic	ADJ
bam-8383	106	9	effectiveness	effectiveness	NOUN
bam-8383	106	10	of	of	ADP
bam-8383	106	11	these	these	DET
bam-8383	106	12	drugs	drug	NOUN
bam-8383	106	13	for	for	ADP
bam-8383	106	14	reducing	reduce	VERB
bam-8383	106	15	inflammation	inflammation	NOUN
bam-8383	106	16	,	,	PUNCT
bam-8383	106	17	and	and	CCONJ
bam-8383	106	18	symptoms	symptom	NOUN
bam-8383	106	19	,	,	PUNCT
bam-8383	106	20	as	as	ADV
bam-8383	106	21	well	well	ADV
bam-8383	106	22	as	as	ADP
bam-8383	106	23	inducing	induce	VERB
bam-8383	106	24	repigmentation.65	repigmentation.65	NOUN
bam-8383	106	25	on	on	ADP
bam-8383	106	26	the	the	DET
bam-8383	106	27	other	other	ADJ
bam-8383	106	28	hand	hand	NOUN
bam-8383	106	29	,	,	PUNCT
bam-8383	106	30	immunomodulators	immunomodulator	NOUN
bam-8383	106	31	(	(	PUNCT
bam-8383	106	32	e.g.	e.g.	ADV
bam-8383	106	33	,	,	PUNCT
bam-8383	106	34	tacrolimus	tacrolimus	NOUN
bam-8383	106	35	and	and	CCONJ
bam-8383	106	36	calcineurin	calcineurin	ADJ
bam-8383	106	37	inhibitors	inhibitor	NOUN
bam-8383	106	38	)	)	PUNCT
bam-8383	106	39	and	and	CCONJ
bam-8383	106	40	reducing	reduce	VERB
bam-8383	106	41	the	the	DET
bam-8383	106	42	activity	activity	NOUN
bam-8383	106	43	of	of	ADP
bam-8383	106	44	t	t	NOUN
bam-8383	106	45	cells	cell	NOUN
bam-8383	106	46	by	by	ADP
bam-8383	106	47	decreasing	decrease	VERB
bam-8383	106	48	the	the	DET
bam-8383	106	49	expression	expression	NOUN
bam-8383	106	50	of	of	ADP
bam-8383	106	51	inflammatory	inflammatory	ADJ
bam-8383	106	52	cytokines	cytokine	NOUN
bam-8383	106	53	(	(	PUNCT
bam-8383	106	54	e.g.	e.g.	ADV
bam-8383	106	55	,	,	PUNCT
bam-8383	106	56	il-2	il-2	NUM
bam-8383	106	57	,	,	PUNCT
bam-8383	106	58	il-3	il-3	PRON
bam-8383	106	59	,	,	PUNCT
bam-8383	106	60	il-4	il-4	PRON
bam-8383	106	61	,	,	PUNCT
bam-8383	106	62	il-5	il-5	PROPN
bam-8383	106	63	,	,	PUNCT
bam-8383	106	64	interferon	interferon	NOUN
bam-8383	106	65	(	(	PUNCT
bam-8383	106	66	ifn	ifn	PROPN
bam-8383	106	67	)	)	PUNCT
bam-8383	106	68	,	,	PUNCT
bam-8383	106	69	and	and	CCONJ
bam-8383	106	70	tnf	tnf	PROPN
bam-8383	106	71	)	)	PUNCT
bam-8383	106	72	along	along	ADP
bam-8383	106	73	with	with	ADP
bam-8383	106	74	the	the	DET
bam-8383	106	75	granulocytemacrophage	granulocytemacrophage	NOUN
bam-8383	106	76	colony	colony	NOUN
bam-8383	106	77	-	-	PUNCT
bam-8383	106	78	stimulating	stimulate	VERB
bam-8383	106	79	factor	factor	NOUN
bam-8383	106	80	(	(	PUNCT
bam-8383	106	81	gm	gm	PROPN
bam-8383	106	82	-	-	PUNCT
bam-8383	106	83	csf	csf	NOUN
bam-8383	106	84	)	)	PUNCT
bam-8383	106	85	can	can	AUX
bam-8383	106	86	be	be	AUX
bam-8383	106	87	suggested	suggest	VERB
bam-8383	106	88	as	as	ADP
bam-8383	106	89	effective	effective	ADJ
bam-8383	106	90	therapeutic	therapeutic	ADJ
bam-8383	106	91	strategies	strategy	NOUN
bam-8383	106	92	for	for	ADP
bam-8383	106	93	vitiligo	vitiligo	NOUN
bam-8383	106	94	by	by	ADP
bam-8383	106	95	targeting	target	VERB
bam-8383	106	96	them	they	PRON
bam-8383	106	97	that	that	PRON
bam-8383	106	98	are	be	AUX
bam-8383	106	99	recently	recently	ADV
bam-8383	106	100	being	be	AUX
bam-8383	106	101	evaluated.66	evaluated.66	NOUN
bam-8383	106	102	-	-	PUNCT
bam-8383	106	103	67	67	NUM
bam-8383	106	104	previous	previous	ADJ
bam-8383	106	105	studies	study	NOUN
bam-8383	106	106	revealed	reveal	VERB
bam-8383	106	107	that	that	SCONJ
bam-8383	106	108	the	the	DET
bam-8383	106	109	production	production	NOUN
bam-8383	106	110	of	of	ADP
bam-8383	106	111	high	high	ADJ
bam-8383	106	112	no	no	DET
bam-8383	106	113	level	level	NOUN
bam-8383	106	114	could	could	AUX
bam-8383	106	115	be	be	AUX
bam-8383	106	116	associated	associate	VERB
bam-8383	106	117	with	with	ADP
bam-8383	106	118	the	the	DET
bam-8383	106	119	increased	increase	VERB
bam-8383	106	120	activity	activity	NOUN
bam-8383	106	121	of	of	ADP
bam-8383	106	122	inos	ino	NOUN
bam-8383	106	123	,	,	PUNCT
bam-8383	106	124	confer	confer	VERB
bam-8383	106	125	self	self	NOUN
bam-8383	106	126	-	-	PUNCT
bam-8383	106	127	destruction	destruction	NOUN
bam-8383	106	128	of	of	ADP
bam-8383	106	129	melanocytes	melanocyte	NOUN
bam-8383	106	130	,	,	PUNCT
bam-8383	106	131	leading	lead	VERB
bam-8383	106	132	to	to	ADP
bam-8383	106	133	a	a	DET
bam-8383	106	134	decrease	decrease	NOUN
bam-8383	106	135	in	in	ADP
bam-8383	106	136	de	de	X
bam-8383	106	137	novo	novo	NOUN
bam-8383	106	138	attachment	attachment	NOUN
bam-8383	106	139	of	of	ADP
bam-8383	106	140	melanocytes	melanocyte	NOUN
bam-8383	106	141	at	at	ADP
bam-8383	106	142	the	the	DET
bam-8383	106	143	extracellular	extracellular	ADJ
bam-8383	106	144	matrix,65	matrix,65	NOUN
bam-8383	106	145	,	,	PUNCT
bam-8383	106	146	68	68	NUM
bam-8383	106	147	-	-	SYM
bam-8383	106	148	70	70	NUM
bam-8383	106	149	where	where	SCONJ
bam-8383	106	150	such	such	ADJ
bam-8383	106	151	evidence	evidence	NOUN
bam-8383	106	152	can	can	AUX
bam-8383	106	153	follow	follow	VERB
bam-8383	106	154	skin	skin	NOUN
bam-8383	106	155	depigmentation.71	depigmentation.71	VERB
bam-8383	106	156	recent	recent	ADJ
bam-8383	106	157	mechanism	mechanism	NOUN
bam-8383	106	158	have	have	AUX
bam-8383	106	159	also	also	ADV
bam-8383	106	160	attributed	attribute	VERB
bam-8383	106	161	to	to	ADP
bam-8383	106	162	initial	initial	ADJ
bam-8383	106	163	imbalance	imbalance	NOUN
bam-8383	106	164	of	of	ADP
bam-8383	106	165	epidermal	epidermal	ADJ
bam-8383	106	166	cytokines	cytokine	NOUN
bam-8383	106	167	at	at	ADP
bam-8383	106	168	the	the	DET
bam-8383	106	169	affected	affect	VERB
bam-8383	106	170	areas	area	NOUN
bam-8383	106	171	in	in	ADP
bam-8383	106	172	promoting	promote	VERB
bam-8383	106	173	tetrahydrobiopterin	tetrahydrobiopterin	NOUN
bam-8383	106	174	,	,	PUNCT
bam-8383	106	175	inos	ino	NOUN
bam-8383	106	176	activation	activation	NOUN
bam-8383	106	177	,	,	PUNCT
bam-8383	106	178	and	and	CCONJ
bam-8383	106	179	no	no	DET
bam-8383	106	180	overproduction	overproduction	NOUN
bam-8383	106	181	,	,	PUNCT
bam-8383	106	182	resulting	result	VERB
bam-8383	106	183	in	in	ADP
bam-8383	106	184	an	an	DET
bam-8383	106	185	increase	increase	NOUN
bam-8383	106	186	of	of	ADP
bam-8383	106	187	self	self	NOUN
bam-8383	106	188	-	-	PUNCT
bam-8383	106	189	destruction	destruction	NOUN
bam-8383	106	190	of	of	ADP
bam-8383	106	191	melanocytes.65,72,73	melanocytes.65,72,73	NOUN
bam-8383	106	192	in	in	ADP
bam-8383	106	193	the	the	DET
bam-8383	106	194	present	present	ADJ
bam-8383	106	195	study	study	NOUN
bam-8383	106	196	,	,	PUNCT
bam-8383	106	197	vitiligo	vitiligo	NOUN
bam-8383	106	198	skin	skin	NOUN
bam-8383	106	199	was	be	AUX
bam-8383	106	200	induced	induce	VERB
bam-8383	106	201	by	by	ADP
bam-8383	106	202	monobenzone	monobenzone	NOUN
bam-8383	106	203	40	40	NUM
bam-8383	106	204	%	%	NOUN
bam-8383	106	205	,	,	PUNCT
bam-8383	106	206	where	where	SCONJ
bam-8383	106	207	early	early	ADJ
bam-8383	106	208	findings	finding	NOUN
bam-8383	106	209	demonstrated	demonstrate	VERB
bam-8383	106	210	a	a	DET
bam-8383	106	211	significant	significant	ADJ
bam-8383	106	212	degree	degree	NOUN
bam-8383	106	213	of	of	ADP
bam-8383	106	214	efficacy	efficacy	NOUN
bam-8383	106	215	with	with	ADP
bam-8383	106	216	appropriate	appropriate	ADJ
bam-8383	106	217	responses	response	NOUN
bam-8383	106	218	,	,	PUNCT
bam-8383	106	219	when	when	SCONJ
bam-8383	106	220	larginnine	larginnine	NOUN
bam-8383	106	221	was	be	AUX
bam-8383	106	222	applied	apply	VERB
bam-8383	106	223	,	,	PUNCT
bam-8383	106	224	leading	lead	VERB
bam-8383	106	225	to	to	ADP
bam-8383	106	226	a	a	DET
bam-8383	106	227	decrease	decrease	NOUN
bam-8383	106	228	in	in	ADP
bam-8383	106	229	the	the	DET
bam-8383	106	230	no	no	DET
bam-8383	106	231	level	level	NOUN
bam-8383	106	232	under	under	ADP
bam-8383	106	233	l	l	ADJ
bam-8383	106	234	-	-	ADJ
bam-8383	106	235	arginnine	arginnine	ADJ
bam-8383	106	236	treatment	treatment	NOUN
bam-8383	106	237	.	.	PUNCT
bam-8383	107	1	in	in	ADP
bam-8383	107	2	addition	addition	NOUN
bam-8383	107	3	,	,	PUNCT
bam-8383	107	4	using	use	VERB
bam-8383	107	5	inos	ino	NOUN
bam-8383	107	6	inhibitor	inhibitor	NOUN
bam-8383	107	7	could	could	AUX
bam-8383	107	8	decrease	decrease	VERB
bam-8383	107	9	the	the	DET
bam-8383	107	10	efficacy	efficacy	NOUN
bam-8383	107	11	of	of	ADP
bam-8383	107	12	monobenzone	monobenzone	NOUN
bam-8383	107	13	in	in	ADP
bam-8383	107	14	the	the	DET
bam-8383	107	15	present	present	ADJ
bam-8383	107	16	study	study	NOUN
bam-8383	107	17	.	.	PUNCT
bam-8383	108	1	therefore	therefore	ADV
bam-8383	108	2	,	,	PUNCT
bam-8383	108	3	emerging	emerge	VERB
bam-8383	108	4	evidence	evidence	NOUN
bam-8383	108	5	has	have	AUX
bam-8383	108	6	persuaded	persuade	VERB
bam-8383	108	7	us	we	PRON
bam-8383	108	8	to	to	PART
bam-8383	108	9	hypothesize	hypothesize	VERB
bam-8383	108	10	that	that	SCONJ
bam-8383	108	11	inos	ino	NOUN
bam-8383	108	12	and	and	CCONJ
bam-8383	108	13	no	no	DET
bam-8383	108	14	levels	level	NOUN
bam-8383	108	15	increased	increase	VERB
bam-8383	108	16	in	in	ADP
bam-8383	108	17	vitiligo	vitiligo	ADJ
bam-8383	108	18	lesions	lesion	NOUN
bam-8383	108	19	compared	compare	VERB
bam-8383	108	20	to	to	ADP
bam-8383	108	21	healthy	healthy	ADJ
bam-8383	108	22	controls	control	NOUN
bam-8383	108	23	.	.	PUNCT
bam-8383	109	1	in	in	ADP
bam-8383	109	2	particular	particular	ADJ
bam-8383	109	3	,	,	PUNCT
bam-8383	109	4	the	the	DET
bam-8383	109	5	increased	increase	VERB
bam-8383	109	6	activity	activity	NOUN
bam-8383	109	7	of	of	ADP
bam-8383	109	8	inos	ino	NOUN
bam-8383	109	9	might	might	AUX
bam-8383	109	10	be	be	AUX
bam-8383	109	11	responsible	responsible	ADJ
bam-8383	109	12	for	for	ADP
bam-8383	109	13	the	the	DET
bam-8383	109	14	overproduction	overproduction	NOUN
bam-8383	109	15	of	of	ADP
bam-8383	109	16	no	no	PRON
bam-8383	109	17	in	in	ADP
bam-8383	109	18	vitiligo	vitiligo	NOUN
bam-8383	109	19	model	model	NOUN
bam-8383	109	20	.	.	PUNCT
bam-8383	110	1	vitiligo	vitiligo	PROPN
bam-8383	110	2	is	be	AUX
bam-8383	110	3	linked	link	VERB
bam-8383	110	4	to	to	ADP
bam-8383	110	5	some	some	DET
bam-8383	110	6	factors	factor	NOUN
bam-8383	110	7	such	such	ADJ
bam-8383	110	8	as	as	ADP
bam-8383	110	9	increased	increase	VERB
bam-8383	110	10	cytokines	cytokine	NOUN
bam-8383	110	11	expression	expression	NOUN
bam-8383	110	12	and	and	CCONJ
bam-8383	110	13	inos	ino	NOUN
bam-8383	110	14	activation	activation	NOUN
bam-8383	110	15	that	that	PRON
bam-8383	110	16	play	play	VERB
bam-8383	110	17	pivotal	pivotal	ADJ
bam-8383	110	18	roles	role	NOUN
bam-8383	110	19	in	in	ADP
bam-8383	110	20	the	the	DET
bam-8383	110	21	depigmentation	depigmentation	NOUN
bam-8383	110	22	process	process	NOUN
bam-8383	110	23	even	even	ADV
bam-8383	110	24	,	,	PUNCT
bam-8383	110	25	if	if	SCONJ
bam-8383	110	26	nos	no	NOUN
bam-8383	110	27	overexpression	overexpression	NOUN
bam-8383	110	28	not	not	PART
bam-8383	110	29	being	be	AUX
bam-8383	110	30	considered	consider	VERB
bam-8383	110	31	as	as	ADP
bam-8383	110	32	the	the	DET
bam-8383	110	33	only	only	ADJ
bam-8383	110	34	important	important	ADJ
bam-8383	110	35	factor	factor	NOUN
bam-8383	110	36	involved	involve	VERB
bam-8383	110	37	in	in	ADP
bam-8383	110	38	vitiligo	vitiligo	NOUN
bam-8383	110	39	.	.	PUNCT
bam-8383	111	1	an	an	DET
bam-8383	111	2	increasing	increase	VERB
bam-8383	111	3	body	body	NOUN
bam-8383	111	4	of	of	ADP
bam-8383	111	5	evidence	evidence	NOUN
bam-8383	111	6	indicates	indicate	VERB
bam-8383	111	7	that	that	SCONJ
bam-8383	111	8	nos	nos	PROPN
bam-8383	111	9	has	have	AUX
bam-8383	111	10	been	be	AUX
bam-8383	111	11	overexpressed	overexpresse	VERB
bam-8383	111	12	in	in	ADP
bam-8383	111	13	vitiligo	vitiligo	ADJ
bam-8383	111	14	lesions	lesion	NOUN
bam-8383	111	15	in	in	ADP
bam-8383	111	16	comparison	comparison	NOUN
bam-8383	111	17	with	with	ADP
bam-8383	111	18	healthy	healthy	ADJ
bam-8383	111	19	subjects	subject	NOUN
bam-8383	111	20	,	,	PUNCT
bam-8383	111	21	as	as	ADV
bam-8383	111	22	well	well	ADV
bam-8383	111	23	as	as	ADP
bam-8383	111	24	no2−/no3−	no2−/no3−	NOUN
bam-8383	111	25	levels	level	NOUN
bam-8383	111	26	.	.	PUNCT
bam-8383	112	1	the	the	DET
bam-8383	112	2	increased	increase	VERB
bam-8383	112	3	activity	activity	NOUN
bam-8383	112	4	of	of	ADP
bam-8383	112	5	inos	ino	NOUN
bam-8383	112	6	has	have	AUX
bam-8383	112	7	been	be	AUX
bam-8383	112	8	also	also	ADV
bam-8383	112	9	suggested	suggest	VERB
bam-8383	112	10	to	to	PART
bam-8383	112	11	be	be	AUX
bam-8383	112	12	potentially	potentially	ADV
bam-8383	112	13	linked	link	VERB
bam-8383	112	14	to	to	ADP
bam-8383	112	15	the	the	DET
bam-8383	112	16	increased	increase	VERB
bam-8383	112	17	level	level	NOUN
bam-8383	112	18	of	of	ADP
bam-8383	112	19	no	no	PRON
bam-8383	112	20	in	in	ADP
bam-8383	112	21	vitiligo	vitiligo	NOUN
bam-8383	112	22	,	,	PUNCT
bam-8383	112	23	leading	lead	VERB
bam-8383	112	24	to	to	AUX
bam-8383	112	25	decrease	decrease	VERB
bam-8383	112	26	/	/	SYM
bam-8383	112	27	death	death	NOUN
bam-8383	112	28	of	of	ADP
bam-8383	112	29	melanocytes	melanocyte	NOUN
bam-8383	112	30	up	up	ADP
bam-8383	112	31	to	to	ADP
bam-8383	112	32	depigmentation.31	depigmentation.31	NOUN
bam-8383	112	33	therefore	therefore	ADV
bam-8383	112	34	,	,	PUNCT
bam-8383	112	35	in	in	ADP
bam-8383	112	36	the	the	DET
bam-8383	112	37	present	present	ADJ
bam-8383	112	38	study	study	NOUN
bam-8383	112	39	,	,	PUNCT
bam-8383	112	40	we	we	PRON
bam-8383	112	41	used	use	VERB
bam-8383	112	42	an	an	DET
bam-8383	112	43	inhibitor	inhibitor	NOUN
bam-8383	112	44	to	to	PART
bam-8383	112	45	demonstrate	demonstrate	VERB
bam-8383	112	46	whether	whether	SCONJ
bam-8383	112	47	inos	ino	NOUN
bam-8383	112	48	inhibition	inhibition	NOUN
bam-8383	112	49	,	,	PUNCT
bam-8383	112	50	which	which	PRON
bam-8383	112	51	is	be	AUX
bam-8383	112	52	associated	associate	VERB
bam-8383	112	53	with	with	ADP
bam-8383	112	54	a	a	DET
bam-8383	112	55	reduction	reduction	NOUN
bam-8383	112	56	in	in	ADP
bam-8383	112	57	no	no	DET
bam-8383	112	58	production	production	NOUN
bam-8383	112	59	,	,	PUNCT
bam-8383	112	60	can	can	AUX
bam-8383	112	61	lead	lead	VERB
bam-8383	112	62	to	to	ADP
bam-8383	112	63	lesion	lesion	NOUN
bam-8383	112	64	healing	healing	NOUN
bam-8383	112	65	.	.	PUNCT
bam-8383	113	1	it	it	PRON
bam-8383	113	2	is	be	AUX
bam-8383	113	3	noteworthy	noteworthy	ADJ
bam-8383	113	4	that	that	SCONJ
bam-8383	113	5	no	no	PRON
bam-8383	113	6	increased	increase	VERB
bam-8383	113	7	in	in	ADP
bam-8383	113	8	vitiligo	vitiligo	NOUN
bam-8383	113	9	,	,	PUNCT
bam-8383	113	10	as	as	SCONJ
bam-8383	113	11	shown	show	VERB
bam-8383	113	12	preciously	preciously	ADV
bam-8383	113	13	by	by	ADP
bam-8383	113	14	studies.31	studies.31	NOUN
bam-8383	113	15	but	but	CCONJ
bam-8383	113	16	its	its	PRON
bam-8383	113	17	types	type	NOUN
bam-8383	113	18	and	and	CCONJ
bam-8383	113	19	possible	possible	ADJ
bam-8383	113	20	interventions	intervention	NOUN
bam-8383	113	21	have	have	AUX
bam-8383	113	22	not	not	PART
bam-8383	113	23	been	be	AUX
bam-8383	113	24	thoroughly	thoroughly	ADV
bam-8383	113	25	investigated	investigate	VERB
bam-8383	113	26	as	as	ADP
bam-8383	113	27	compared	compare	VERB
bam-8383	113	28	to	to	ADP
bam-8383	113	29	presented	present	VERB
bam-8383	113	30	findings	finding	NOUN
bam-8383	113	31	herein	herein	NOUN
bam-8383	113	32	.	.	PUNCT
bam-8383	114	1	on	on	ADP
bam-8383	114	2	the	the	DET
bam-8383	114	3	other	other	ADJ
bam-8383	114	4	hand	hand	NOUN
bam-8383	114	5	,	,	PUNCT
bam-8383	114	6	evidence	evidence	NOUN
bam-8383	114	7	from	from	ADP
bam-8383	114	8	in	in	ADP
bam-8383	114	9	vivo	vivo	NOUN
bam-8383	114	10	and	and	CCONJ
bam-8383	114	11	in	in	ADP
bam-8383	114	12	vitro	vitro	X
bam-8383	114	13	studies	study	NOUN
bam-8383	114	14	supports	support	VERB
bam-8383	114	15	that	that	SCONJ
bam-8383	114	16	the	the	DET
bam-8383	114	17	melanocytes	melanocyte	NOUN
bam-8383	114	18	can	can	AUX
bam-8383	114	19	be	be	AUX
bam-8383	114	20	never	never	ADV
bam-8383	114	21	entirely	entirely	ADV
bam-8383	114	22	disappeared	disappear	VERB
bam-8383	114	23	in	in	ADP
bam-8383	114	24	the	the	DET
bam-8383	114	25	depigmented	depigmented	ADJ
bam-8383	114	26	epidermis	epidermis	NOUN
bam-8383	114	27	,	,	PUNCT
bam-8383	114	28	where	where	SCONJ
bam-8383	114	29	these	these	DET
bam-8383	114	30	melanocytes	melanocyte	NOUN
bam-8383	114	31	are	be	AUX
bam-8383	114	32	capable	capable	ADJ
bam-8383	114	33	of	of	ADP
bam-8383	114	34	recovering	recover	VERB
bam-8383	114	35	their	their	PRON
bam-8383	114	36	function	function	NOUN
bam-8383	114	37	in	in	ADP
bam-8383	114	38	vivo	vivo	NOUN
bam-8383	114	39	and	and	CCONJ
bam-8383	114	40	in	in	ADP
bam-8383	114	41	vitro	vitro	X
bam-8383	114	42	hydrogen	hydrogen	NOUN
bam-8383	114	43	peroxide	peroxide	NOUN
bam-8383	114	44	removal.74	removal.74	NOUN
bam-8383	114	45	moreover	moreover	ADV
bam-8383	114	46	,	,	PUNCT
bam-8383	114	47	melanocyte	melanocyte	NOUN
bam-8383	114	48	survival	survival	NOUN
bam-8383	114	49	after	after	ADP
bam-8383	114	50	some	some	DET
bam-8383	114	51	years	year	NOUN
bam-8383	114	52	has	have	AUX
bam-8383	114	53	been	be	AUX
bam-8383	114	54	previously	previously	ADV
bam-8383	114	55	demonstrated.75	demonstrated.75	VERB
bam-8383	114	56	although	although	SCONJ
bam-8383	114	57	measuring	measure	VERB
bam-8383	114	58	no	no	PRON
bam-8383	114	59	and	and	CCONJ
bam-8383	114	60	tnf	tnf	PROPN
bam-8383	114	61	levels	level	NOUN
bam-8383	114	62	and	and	CCONJ
bam-8383	114	63	viability	viability	NOUN
bam-8383	114	64	of	of	ADP
bam-8383	114	65	skin	skin	NOUN
bam-8383	114	66	melanocytes	melanocyte	NOUN
bam-8383	114	67	can	can	AUX
bam-8383	114	68	be	be	AUX
bam-8383	114	69	useful	useful	ADJ
bam-8383	114	70	in	in	ADP
bam-8383	114	71	confirming	confirm	VERB
bam-8383	114	72	the	the	DET
bam-8383	114	73	findings	finding	NOUN
bam-8383	114	74	,	,	PUNCT
bam-8383	114	75	their	their	PRON
bam-8383	114	76	assessments	assessment	NOUN
bam-8383	114	77	are	be	AUX
bam-8383	114	78	considered	consider	VERB
bam-8383	114	79	as	as	ADP
bam-8383	114	80	part	part	NOUN
bam-8383	114	81	of	of	ADP
bam-8383	114	82	our	our	PRON
bam-8383	114	83	limitations	limitation	NOUN
bam-8383	114	84	.	.	PUNCT
bam-8383	115	1	therefore	therefore	ADV
bam-8383	115	2	,	,	PUNCT
bam-8383	115	3	further	further	ADJ
bam-8383	115	4	evaluation	evaluation	NOUN
bam-8383	115	5	is	be	AUX
bam-8383	115	6	needed	need	VERB
bam-8383	115	7	as	as	ADP
bam-8383	115	8	a	a	DET
bam-8383	115	9	future	future	ADJ
bam-8383	115	10	study	study	NOUN
bam-8383	115	11	,	,	PUNCT
bam-8383	115	12	which	which	PRON
bam-8383	115	13	we	we	PRON
bam-8383	115	14	hope	hope	VERB
bam-8383	115	15	will	will	AUX
bam-8383	115	16	be	be	AUX
bam-8383	115	17	done	do	VERB
bam-8383	115	18	in	in	ADP
bam-8383	115	19	the	the	DET
bam-8383	115	20	near	near	ADJ
bam-8383	115	21	future	future	NOUN
bam-8383	115	22	.	.	PUNCT
bam-8383	116	1	anyhow	anyhow	ADV
bam-8383	116	2	,	,	PUNCT
bam-8383	116	3	our	our	PRON
bam-8383	116	4	findings	finding	NOUN
bam-8383	116	5	revealed	reveal	VERB
bam-8383	116	6	that	that	SCONJ
bam-8383	116	7	fig	fig	NOUN
bam-8383	116	8	5	5	NUM
bam-8383	116	9	.	.	PUNCT
bam-8383	116	10	effect	effect	NOUN
bam-8383	116	11	of	of	ADP
bam-8383	116	12	l	l	NOUN
bam-8383	116	13	-	-	NOUN
bam-8383	116	14	arginine	arginine	NOUN
bam-8383	116	15	(	(	PUNCT
bam-8383	116	16	100	100	NUM
bam-8383	116	17	mg	mg	NUM
bam-8383	116	18	/	/	SYM
bam-8383	116	19	kg	kg	NOUN
bam-8383	116	20	)	)	PUNCT
bam-8383	116	21	on	on	ADP
bam-8383	116	22	pigmentation	pigmentation	NOUN
bam-8383	116	23	by	by	ADP
bam-8383	116	24	using	use	VERB
bam-8383	116	25	nbuvb	nbuvb	ADJ
bam-8383	116	26	therapy	therapy	NOUN
bam-8383	116	27	.	.	PUNCT
bam-8383	117	1	non	non	PROPN
bam-8383	117	2	co	co	PROPN
bam-8383	117	3	mmerc	mmerc	PROPN
bam-8383	117	4	ial	ial	PROPN
bam-8383	117	5	us	us	PROPN
bam-8383	118	1	e	e	NOUN
bam-8383	118	2	o	o	NOUN
bam-8383	118	3	nly	nly	ADV
bam-8383	118	4	inos	ino	NOUN
bam-8383	118	5	inhibition	inhibition	NOUN
bam-8383	118	6	for	for	ADP
bam-8383	118	7	vitiligo	vitiligo	PROPN
bam-8383	118	8	eur	eur	PROPN
bam-8383	118	9	j	j	PROPN
bam-8383	118	10	transl	transl	PROPN
bam-8383	118	11	myol	myol	ADV
bam-8383	118	12	29	29	NUM
bam-8383	118	13	(	(	PUNCT
bam-8383	118	14	3	3	NUM
bam-8383	118	15	):	):	PUNCT
bam-8383	118	16	251	251	NUM
bam-8383	118	17	-	-	SYM
bam-8383	118	18	260	260	NUM
bam-8383	118	19	,	,	PUNCT
bam-8383	118	20	2019	2019	NUM
bam-8383	118	21	257	257	NUM
bam-8383	118	22	aminoguanidine	aminoguanidine	NOUN
bam-8383	118	23	in	in	ADP
bam-8383	118	24	combination	combination	NOUN
bam-8383	118	25	with	with	ADP
bam-8383	118	26	monobenzone	monobenzone	NOUN
bam-8383	118	27	was	be	AUX
bam-8383	118	28	able	able	ADJ
bam-8383	118	29	to	to	PART
bam-8383	118	30	decrease	decrease	VERB
bam-8383	118	31	the	the	DET
bam-8383	118	32	effect	effect	NOUN
bam-8383	118	33	of	of	ADP
bam-8383	118	34	monobenzone	monobenzone	NOUN
bam-8383	118	35	.	.	PUNCT
bam-8383	119	1	the	the	DET
bam-8383	119	2	findings	finding	NOUN
bam-8383	119	3	indicated	indicate	VERB
bam-8383	119	4	that	that	SCONJ
bam-8383	119	5	inos	ino	NOUN
bam-8383	119	6	inhibitor	inhibitor	NOUN
bam-8383	119	7	could	could	AUX
bam-8383	119	8	serve	serve	VERB
bam-8383	119	9	as	as	ADP
bam-8383	119	10	a	a	DET
bam-8383	119	11	novel	novel	ADJ
bam-8383	119	12	effective	effective	ADJ
bam-8383	119	13	therapy	therapy	NOUN
bam-8383	119	14	against	against	ADP
bam-8383	119	15	vitiligo	vitiligo	NOUN
bam-8383	119	16	by	by	ADP
bam-8383	119	17	combination	combination	NOUN
bam-8383	119	18	of	of	ADP
bam-8383	119	19	nbuvb	nbuvb	ADJ
bam-8383	119	20	therapy	therapy	NOUN
bam-8383	119	21	.	.	PUNCT
bam-8383	120	1	furthermore	furthermore	ADV
bam-8383	120	2	,	,	PUNCT
bam-8383	120	3	no	no	DET
bam-8383	120	4	agents	agent	NOUN
bam-8383	120	5	like	like	ADP
bam-8383	120	6	larginine	larginine	NOUN
bam-8383	120	7	could	could	AUX
bam-8383	120	8	markedly	markedly	ADV
bam-8383	120	9	increase	increase	VERB
bam-8383	120	10	the	the	DET
bam-8383	120	11	effectiveness	effectiveness	NOUN
bam-8383	120	12	of	of	ADP
bam-8383	120	13	phototherapy	phototherapy	NOUN
bam-8383	120	14	.	.	PUNCT
bam-8383	121	1	further	further	ADJ
bam-8383	121	2	studies	study	NOUN
bam-8383	121	3	are	be	AUX
bam-8383	121	4	needed	need	VERB
bam-8383	121	5	to	to	PART
bam-8383	121	6	illustrate	illustrate	VERB
bam-8383	121	7	expression	expression	NOUN
bam-8383	121	8	of	of	ADP
bam-8383	121	9	an	an	DET
bam-8383	121	10	inducible	inducible	ADJ
bam-8383	121	11	inos	ino	NOUN
bam-8383	121	12	,	,	PUNCT
bam-8383	121	13	no	no	PRON
bam-8383	121	14	and	and	CCONJ
bam-8383	121	15	tnf	tnf	PROPN
bam-8383	121	16	levels	level	NOUN
bam-8383	121	17	in	in	ADP
bam-8383	121	18	mice	mice	NOUN
bam-8383	121	19	model	model	NOUN
bam-8383	121	20	for	for	ADP
bam-8383	121	21	clarification	clarification	NOUN
bam-8383	121	22	of	of	ADP
bam-8383	121	23	their	their	PRON
bam-8383	121	24	role	role	NOUN
bam-8383	121	25	in	in	ADP
bam-8383	121	26	the	the	DET
bam-8383	121	27	pathogenesis	pathogenesis	NOUN
bam-8383	121	28	of	of	ADP
bam-8383	121	29	vitiligo	vitiligo	NOUN
bam-8383	121	30	.	.	PUNCT
bam-8383	122	1	another	another	DET
bam-8383	122	2	approach	approach	NOUN
bam-8383	122	3	is	be	AUX
bam-8383	122	4	necessary	necessary	ADJ
bam-8383	122	5	to	to	PART
bam-8383	122	6	confirm	confirm	VERB
bam-8383	122	7	the	the	DET
bam-8383	122	8	inos	ino	NOUN
bam-8383	122	9	implications	implication	NOUN
bam-8383	122	10	in	in	ADP
bam-8383	122	11	the	the	DET
bam-8383	122	12	near	near	ADJ
bam-8383	122	13	future	future	NOUN
bam-8383	122	14	:	:	PUNCT
bam-8383	122	15	the	the	DET
bam-8383	122	16	use	use	NOUN
bam-8383	122	17	of	of	ADP
bam-8383	122	18	1400w	1400w	NUM
bam-8383	122	19	.	.	PUNCT
bam-8383	123	1	these	these	DET
bam-8383	123	2	approaches	approach	NOUN
bam-8383	123	3	normalize	normalize	VERB
bam-8383	123	4	the	the	DET
bam-8383	123	5	"	"	PUNCT
bam-8383	123	6	nonspecific	nonspecific	ADJ
bam-8383	123	7	effects	effect	NOUN
bam-8383	123	8	"	"	PUNCT
bam-8383	123	9	of	of	ADP
bam-8383	123	10	aminoguanidine	aminoguanidine	NOUN
bam-8383	123	11	.	.	PUNCT
bam-8383	124	1	an	an	DET
bam-8383	124	2	in	in	ADP
bam-8383	124	3	-	-	PUNCT
bam-8383	124	4	vivo	vivo	NOUN
bam-8383	124	5	sirna	sirna	NOUN
bam-8383	124	6	targeting	target	VERB
bam-8383	124	7	inos	ino	NOUN
bam-8383	124	8	could	could	AUX
bam-8383	124	9	be	be	AUX
bam-8383	124	10	another	another	DET
bam-8383	124	11	way	way	NOUN
bam-8383	124	12	to	to	PART
bam-8383	124	13	link	link	VERB
bam-8383	124	14	the	the	DET
bam-8383	124	15	inos	ino	NOUN
bam-8383	124	16	to	to	ADP
bam-8383	124	17	vitilogous	vitilogous	ADJ
bam-8383	124	18	lesions	lesion	NOUN
bam-8383	124	19	.	.	PUNCT
bam-8383	125	1	systemic	systemic	ADJ
bam-8383	125	2	infusion	infusion	NOUN
bam-8383	125	3	of	of	ADP
bam-8383	125	4	the	the	DET
bam-8383	125	5	drugs	drug	NOUN
bam-8383	125	6	could	could	AUX
bam-8383	125	7	interfere	interfere	VERB
bam-8383	125	8	with	with	ADP
bam-8383	125	9	immune	immune	ADJ
bam-8383	125	10	profile	profile	NOUN
bam-8383	125	11	of	of	ADP
bam-8383	125	12	the	the	DET
bam-8383	125	13	animal	animal	NOUN
bam-8383	125	14	.	.	PUNCT
bam-8383	126	1	supporting	support	VERB
bam-8383	126	2	data	datum	NOUN
bam-8383	126	3	for	for	ADP
bam-8383	126	4	the	the	DET
bam-8383	126	5	immune	immune	ADJ
bam-8383	126	6	status	status	NOUN
bam-8383	126	7	would	would	AUX
bam-8383	126	8	strengthen	strengthen	VERB
bam-8383	126	9	our	our	PRON
bam-8383	126	10	results	result	NOUN
bam-8383	126	11	and	and	CCONJ
bam-8383	126	12	their	their	PRON
bam-8383	126	13	interpretations	interpretation	NOUN
bam-8383	126	14	.	.	PUNCT
bam-8383	127	1	list	list	NOUN
bam-8383	127	2	of	of	ADP
bam-8383	127	3	acronyms	acronym	NOUN
bam-8383	127	4	ifn	ifn	PROPN
bam-8383	127	5	–	–	PUNCT
bam-8383	127	6	interferon	interferon	ADJ
bam-8383	127	7	gm	gm	PROPN
bam-8383	127	8	-	-	PUNCT
bam-8383	127	9	csf	csf	ADJ
bam-8383	127	10	granulocyte	granulocyte	ADJ
bam-8383	127	11	-	-	PUNCT
bam-8383	127	12	macrophage	macrophage	ADJ
bam-8383	127	13	colony	colony	NOUN
bam-8383	127	14	-	-	PUNCT
bam-8383	127	15	stimulating	stimulate	VERB
bam-8383	127	16	factor	factor	NOUN
bam-8383	127	17	nbuvb	nbuvb	ADJ
bam-8383	127	18	narrow	narrow	ADJ
bam-8383	127	19	band	band	NOUN
bam-8383	127	20	narrowband	narrowband	PROPN
bam-8383	127	21	ultraviolet	ultraviolet	PROPN
bam-8383	127	22	b	b	PROPN
bam-8383	127	23	no	no	DET
bam-8383	127	24	nitric	nitric	ADJ
bam-8383	127	25	oxide	oxide	NOUN
bam-8383	127	26	nos	nos	X
bam-8383	127	27	nitric	nitric	ADJ
bam-8383	127	28	oxide	oxide	NOUN
bam-8383	127	29	synthase	synthase	NOUN
bam-8383	127	30	enos	eno	VERB
bam-8383	127	31	endothelial	endothelial	PROPN
bam-8383	127	32	nos	nos	PROPN
bam-8383	127	33	inos	inos	PROPN
bam-8383	127	34	inducible	inducible	ADJ
bam-8383	127	35	nos	nos	PROPN
bam-8383	127	36	nnos	nnos	ADJ
bam-8383	127	37	neuronal	neuronal	ADJ
bam-8383	127	38	nos	nos	PROPN
bam-8383	127	39	authors	author	NOUN
bam-8383	127	40	contributions	contribution	VERB
bam-8383	127	41	kz	kz	PROPN
bam-8383	127	42	,	,	PUNCT
bam-8383	127	43	hm	hm	INTJ
bam-8383	127	44	,	,	PUNCT
bam-8383	127	45	skm	skm	PROPN
bam-8383	127	46	,	,	PUNCT
bam-8383	127	47	and	and	CCONJ
bam-8383	127	48	ahp	ahp	PROPN
bam-8383	127	49	conceived	conceive	VERB
bam-8383	127	50	and	and	CCONJ
bam-8383	127	51	designed	design	VERB
bam-8383	127	52	the	the	DET
bam-8383	127	53	experiments	experiment	NOUN
bam-8383	127	54	,	,	PUNCT
bam-8383	127	55	analyzed	analyze	VERB
bam-8383	127	56	the	the	DET
bam-8383	127	57	data	datum	NOUN
bam-8383	127	58	and	and	CCONJ
bam-8383	127	59	wrote	write	VERB
bam-8383	127	60	the	the	DET
bam-8383	127	61	manuscript	manuscript	NOUN
bam-8383	127	62	and	and	CCONJ
bam-8383	127	63	supervised	supervise	VERB
bam-8383	127	64	the	the	DET
bam-8383	127	65	experiments	experiment	NOUN
bam-8383	127	66	.	.	PUNCT
bam-8383	128	1	all	all	DET
bam-8383	128	2	authors	author	NOUN
bam-8383	128	3	read	read	VERB
bam-8383	128	4	and	and	CCONJ
bam-8383	128	5	approved	approve	VERB
bam-8383	128	6	the	the	DET
bam-8383	128	7	final	final	ADJ
bam-8383	128	8	manuscript	manuscript	NOUN
bam-8383	128	9	.	.	PUNCT
bam-8383	129	1	acknowledgments	acknowledgment	NOUN
bam-8383	129	2	none	none	NOUN
bam-8383	129	3	.	.	PUNCT
bam-8383	130	1	funding	fund	VERB
bam-8383	130	2	none	none	NOUN
bam-8383	130	3	.	.	PUNCT
bam-8383	131	1	conflict	conflict	NOUN
bam-8383	131	2	of	of	ADP
bam-8383	131	3	interest	interest	NOUN
bam-8383	131	4	the	the	DET
bam-8383	131	5	authors	author	NOUN
bam-8383	131	6	declare	declare	VERB
bam-8383	131	7	they	they	PRON
bam-8383	131	8	have	have	VERB
bam-8383	131	9	no	no	DET
bam-8383	131	10	financial	financial	ADJ
bam-8383	131	11	,	,	PUNCT
bam-8383	131	12	personal	personal	ADJ
bam-8383	131	13	,	,	PUNCT
bam-8383	131	14	or	or	CCONJ
bam-8383	131	15	other	other	ADJ
bam-8383	131	16	conflicts	conflict	NOUN
bam-8383	131	17	of	of	ADP
bam-8383	131	18	interest	interest	NOUN
bam-8383	131	19	..	..	PUNCT
bam-8383	132	1	ethical	ethical	ADJ
bam-8383	132	2	publication	publication	NOUN
bam-8383	132	3	statement	statement	NOUN
bam-8383	132	4	we	we	PRON
bam-8383	132	5	confirm	confirm	VERB
bam-8383	132	6	that	that	SCONJ
bam-8383	132	7	we	we	PRON
bam-8383	132	8	have	have	AUX
bam-8383	132	9	read	read	VERB
bam-8383	132	10	the	the	DET
bam-8383	132	11	journal	journal	NOUN
bam-8383	132	12	’s	’s	PART
bam-8383	132	13	position	position	NOUN
bam-8383	132	14	on	on	ADP
bam-8383	132	15	issues	issue	NOUN
bam-8383	132	16	involved	involve	VERB
bam-8383	132	17	in	in	ADP
bam-8383	132	18	ethical	ethical	ADJ
bam-8383	132	19	publication	publication	NOUN
bam-8383	132	20	and	and	CCONJ
bam-8383	132	21	affirm	affirm	NOUN
bam-8383	132	22	that	that	SCONJ
bam-8383	132	23	this	this	DET
bam-8383	132	24	report	report	NOUN
bam-8383	132	25	is	be	AUX
bam-8383	132	26	consistent	consistent	ADJ
bam-8383	132	27	with	with	ADP
bam-8383	132	28	those	those	DET
bam-8383	132	29	guidelines	guideline	NOUN
bam-8383	132	30	.	.	PUNCT
bam-8383	133	1	corresponding	correspond	VERB
bam-8383	133	2	author	author	NOUN
bam-8383	133	3	katayoun	katayoun	NOUN
bam-8383	133	4	ziari	ziari	NOUN
bam-8383	133	5	,	,	PUNCT
bam-8383	133	6	departemnt	departemnt	NOUN
bam-8383	133	7	of	of	ADP
bam-8383	133	8	pathology	pathology	PROPN
bam-8383	133	9	,	,	PUNCT
bam-8383	133	10	aja	aja	PROPN
bam-8383	133	11	university	university	PROPN
bam-8383	133	12	of	of	ADP
bam-8383	133	13	medical	medical	ADJ
bam-8383	133	14	science	science	NOUN
bam-8383	133	15	,	,	PUNCT
bam-8383	133	16	tehran	tehran	PROPN
bam-8383	133	17	,	,	PUNCT
bam-8383	133	18	iran	iran	PROPN
bam-8383	133	19	.	.	PUNCT
bam-8383	134	1	tel	tel	ADP
bam-8383	134	2	:	:	PUNCT
bam-8383	134	3	00989122993226	00989122993226	NUM
bam-8383	134	4	email	email	NOUN
bam-8383	134	5	:	:	PUNCT
bam-8383	135	1	drk_ziari@yahoo.com	drk_ziari@yahoo.com	PROPN
bam-8383	135	2	e	e	X
bam-8383	135	3	-	-	NOUN
bam-8383	135	4	mails	mail	NOUN
bam-8383	135	5	of	of	ADP
bam-8383	135	6	co	co	NOUN
bam-8383	135	7	-	-	NOUN
bam-8383	135	8	authors	author	NOUN
bam-8383	135	9	hamid	hamid	PROPN
bam-8383	135	10	mansourpour	mansourpour	PROPN
bam-8383	135	11	:	:	PUNCT
bam-8383	135	12	mansourpourhamid@yahoo.com	mansourpourhamid@yahoo.com	PROPN
bam-8383	135	13	sahar	sahar	PROPN
bam-8383	135	14	kalantar	kalantar	PROPN
bam-8383	135	15	motamedi	motamedi	PROPN
bam-8383	135	16	:	:	PUNCT
bam-8383	135	17	skalantarmotamedi@yahoo.com	skalantarmotamedi@yahoo.com	X
bam-8383	136	1	amin	amin	PROPN
bam-8383	136	2	hassan	hassan	PROPN
bam-8383	136	3	poor	poor	ADJ
bam-8383	136	4	:	:	PUNCT
bam-8383	136	5	amin.hasanzadeh021@gmail.com	amin.hasanzadeh021@gmail.com	X
bam-8383	136	6	references	reference	NOUN
bam-8383	136	7	1	1	NUM
bam-8383	136	8	.	.	PUNCT
bam-8383	136	9	ala	ala	PROPN
bam-8383	136	10	y	y	PROPN
bam-8383	136	11	,	,	PUNCT
bam-8383	136	12	pasha	pasha	PROPN
bam-8383	136	13	mk	mk	PROPN
bam-8383	136	14	,	,	PUNCT
bam-8383	136	15	rao	rao	PROPN
bam-8383	136	16	rn	rn	PROPN
bam-8383	136	17	,	,	PUNCT
bam-8383	136	18	et	et	PROPN
bam-8383	136	19	al	al	PROPN
bam-8383	136	20	.	.	PROPN
bam-8383	136	21	association	association	PROPN
bam-8383	136	22	of	of	ADP
bam-8383	136	23	ifn	ifn	PROPN
bam-8383	136	24	-	-	PUNCT
bam-8383	136	25	gamma	gamma	NOUN
bam-8383	136	26	:	:	PUNCT
bam-8383	136	27	il-10	il-10	PRON
bam-8383	136	28	cytokine	cytokine	VERB
bam-8383	136	29	ratio	ratio	NOUN
bam-8383	136	30	with	with	ADP
bam-8383	136	31	nonsegmental	nonsegmental	NOUN
bam-8383	136	32	vitiligo	vitiligo	NOUN
bam-8383	136	33	pathogenesis	pathogenesis	NOUN
bam-8383	136	34	.	.	PUNCT
bam-8383	137	1	autoimmune	autoimmune	ADJ
bam-8383	137	2	diseases	disease	NOUN
bam-8383	137	3	2015;2015:423490	2015;2015:423490	NUM
bam-8383	137	4	.	.	NOUN
bam-8383	138	1	2	2	NUM
bam-8383	138	2	.	.	X
bam-8383	138	3	aroni	aroni	PROPN
bam-8383	138	4	k	k	PROPN
bam-8383	138	5	,	,	PUNCT
bam-8383	138	6	voudouris	voudouris	NOUN
bam-8383	138	7	s	s	PROPN
bam-8383	138	8	,	,	PUNCT
bam-8383	138	9	ioannidis	ioannidis	NOUN
bam-8383	138	10	e	e	NOUN
bam-8383	138	11	,	,	PUNCT
bam-8383	138	12	et	et	PROPN
bam-8383	138	13	al	al	PROPN
bam-8383	138	14	.	.	PROPN
bam-8383	138	15	increased	increase	VERB
bam-8383	138	16	angiogenesis	angiogenesis	NOUN
bam-8383	138	17	and	and	CCONJ
bam-8383	138	18	mast	mast	NOUN
bam-8383	138	19	cells	cell	NOUN
bam-8383	138	20	in	in	ADP
bam-8383	138	21	the	the	DET
bam-8383	138	22	centre	centre	NOUN
bam-8383	138	23	compared	compare	VERB
bam-8383	138	24	to	to	ADP
bam-8383	138	25	the	the	DET
bam-8383	138	26	periphery	periphery	NOUN
bam-8383	138	27	of	of	ADP
bam-8383	138	28	vitiligo	vitiligo	ADJ
bam-8383	138	29	lesions	lesion	NOUN
bam-8383	138	30	.	.	PUNCT
bam-8383	139	1	arch	arch	ADJ
bam-8383	139	2	dermatol	dermatol	NOUN
bam-8383	139	3	res	re	NOUN
bam-8383	139	4	2010;302:601	2010;302:601	NUM
bam-8383	139	5	-	-	SYM
bam-8383	139	6	7	7	NUM
bam-8383	139	7	.	.	NOUN
bam-8383	139	8	3	3	NUM
bam-8383	139	9	.	.	X
bam-8383	140	1	banerjee	banerjee	PROPN
bam-8383	140	2	p	p	NOUN
bam-8383	140	3	,	,	PUNCT
bam-8383	140	4	venkatachalam	venkatachalam	PROPN
bam-8383	140	5	s	s	PROPN
bam-8383	140	6	,	,	PUNCT
bam-8383	140	7	mamidi	mamidi	NOUN
bam-8383	140	8	mk	mk	PROPN
bam-8383	140	9	,	,	PUNCT
bam-8383	140	10	et	et	PROPN
bam-8383	140	11	al	al	PROPN
bam-8383	140	12	.	.	PROPN
bam-8383	140	13	vitiligo	vitiligo	VERB
bam-8383	140	14	patient	patient	NOUN
bam-8383	140	15	-	-	PUNCT
bam-8383	140	16	derived	derive	VERB
bam-8383	140	17	keratinocytes	keratinocyte	NOUN
bam-8383	140	18	exhibit	exhibit	VERB
bam-8383	140	19	characteristics	characteristic	NOUN
bam-8383	140	20	of	of	ADP
bam-8383	140	21	normal	normal	ADJ
bam-8383	140	22	wound	wound	NOUN
bam-8383	140	23	healing	healing	NOUN
bam-8383	140	24	via	via	ADP
bam-8383	140	25	epithelial	epithelial	ADJ
bam-8383	140	26	to	to	ADP
bam-8383	140	27	mesenchymal	mesenchymal	ADJ
bam-8383	140	28	transition	transition	NOUN
bam-8383	140	29	.	.	PUNCT
bam-8383	141	1	exp	exp	NOUN
bam-8383	141	2	dermatol	dermatol	NOUN
bam-8383	141	3	2015;24:391	2015;24:391	NOUN
bam-8383	141	4	-	-	SYM
bam-8383	141	5	3	3	NUM
bam-8383	141	6	.	.	NOUN
bam-8383	141	7	4	4	NUM
bam-8383	141	8	.	.	X
bam-8383	142	1	gupta	gupta	PROPN
bam-8383	142	2	sc	sc	PROPN
bam-8383	142	3	,	,	PUNCT
bam-8383	142	4	patchva	patchva	NOUN
bam-8383	142	5	s	s	PROPN
bam-8383	142	6	,	,	PUNCT
bam-8383	142	7	aggarwal	aggarwal	PROPN
bam-8383	142	8	bb	bb	NOUN
bam-8383	142	9	.	.	PUNCT
bam-8383	143	1	therapeutic	therapeutic	ADJ
bam-8383	143	2	roles	role	NOUN
bam-8383	143	3	of	of	ADP
bam-8383	143	4	curcumin	curcumin	NOUN
bam-8383	143	5	:	:	PUNCT
bam-8383	143	6	lessons	lesson	NOUN
bam-8383	143	7	learned	learn	VERB
bam-8383	143	8	from	from	ADP
bam-8383	143	9	clinical	clinical	ADJ
bam-8383	143	10	trials	trial	NOUN
bam-8383	143	11	.	.	PUNCT
bam-8383	144	1	aaps	aaps	PROPN
bam-8383	144	2	j	j	PROPN
bam-8383	144	3	2013;15:195	2013;15:195	NUM
bam-8383	144	4	-	-	SYM
bam-8383	144	5	218	218	NUM
bam-8383	144	6	.	.	PUNCT
bam-8383	145	1	5	5	X
bam-8383	145	2	.	.	X
bam-8383	145	3	camara	camara	ADJ
bam-8383	145	4	-	-	PUNCT
bam-8383	145	5	lemarroy	lemarroy	NOUN
bam-8383	145	6	cr	cr	PROPN
bam-8383	145	7	,	,	PUNCT
bam-8383	145	8	salas	salas	PROPN
bam-8383	145	9	-	-	PUNCT
bam-8383	145	10	alanis	alanis	PROPN
bam-8383	145	11	jc	jc	PROPN
bam-8383	145	12	.	.	PUNCT
bam-8383	146	1	the	the	DET
bam-8383	146	2	role	role	NOUN
bam-8383	146	3	of	of	ADP
bam-8383	146	4	tumor	tumor	NOUN
bam-8383	146	5	necrosis	necrosis	NOUN
bam-8383	146	6	factor	factor	NOUN
bam-8383	146	7	-	-	PUNCT
bam-8383	146	8	alpha	alpha	NOUN
bam-8383	146	9	in	in	ADP
bam-8383	146	10	the	the	DET
bam-8383	146	11	pathogenesis	pathogenesis	NOUN
bam-8383	146	12	of	of	ADP
bam-8383	146	13	vitiligo	vitiligo	PROPN
bam-8383	146	14	.	.	PUNCT
bam-8383	147	1	am	be	AUX
bam-8383	147	2	j	j	PROPN
bam-8383	147	3	clin	clin	PROPN
bam-8383	147	4	dermatol	dermatol	NOUN
bam-8383	147	5	2013;14:343	2013;14:343	PROPN
bam-8383	147	6	-	-	SYM
bam-8383	147	7	50	50	NUM
bam-8383	147	8	.	.	NOUN
bam-8383	148	1	6	6	NUM
bam-8383	148	2	.	.	PUNCT
bam-8383	148	3	campanati	campanati	PROPN
bam-8383	148	4	a	a	PROPN
bam-8383	148	5	,	,	PUNCT
bam-8383	148	6	giuliodori	giuliodori	ADJ
bam-8383	148	7	k	k	X
bam-8383	148	8	,	,	PUNCT
bam-8383	148	9	ganzetti	ganzetti	PROPN
bam-8383	148	10	g	g	PROPN
bam-8383	148	11	,	,	PUNCT
bam-8383	148	12	et	et	PROPN
bam-8383	148	13	al	al	PROPN
bam-8383	148	14	.	.	PUNCT
bam-8383	149	1	a	a	DET
bam-8383	149	2	patient	patient	NOUN
bam-8383	149	3	with	with	ADP
bam-8383	149	4	psoriasis	psoriasis	NOUN
bam-8383	149	5	and	and	CCONJ
bam-8383	149	6	vitiligo	vitiligo	NOUN
bam-8383	149	7	treated	treat	VERB
bam-8383	149	8	with	with	ADP
bam-8383	149	9	etanercept	etanercept	NOUN
bam-8383	149	10	.	.	PUNCT
bam-8383	150	1	am	be	AUX
bam-8383	150	2	j	j	PROPN
bam-8383	150	3	clin	clin	PROPN
bam-8383	150	4	dermatol	dermatol	NOUN
bam-8383	150	5	2010;11	2010;11	NUM
bam-8383	150	6	suppl	suppl	ADJ
bam-8383	150	7	1:46	1:46	NUM
bam-8383	150	8	-	-	SYM
bam-8383	150	9	8	8	NUM
bam-8383	150	10	.	.	X
bam-8383	151	1	7	7	NUM
bam-8383	151	2	.	.	PUNCT
bam-8383	151	3	barbaud	barbaud	PROPN
bam-8383	151	4	a.	a.	NOUN
bam-8383	152	1	what	what	PRON
bam-8383	152	2	's	be	AUX
bam-8383	152	3	new	new	ADJ
bam-8383	152	4	in	in	ADP
bam-8383	152	5	clinical	clinical	ADJ
bam-8383	152	6	dermatology	dermatology	NOUN
bam-8383	152	7	?	?	PUNCT
bam-8383	153	1	annales	annale	NOUN
bam-8383	153	2	de	de	ADP
bam-8383	153	3	dermatologie	dermatologie	X
bam-8383	153	4	et	et	PROPN
bam-8383	153	5	de	de	X
bam-8383	153	6	venereologie	venereologie	X
bam-8383	153	7	2014;141	2014;141	NUM
bam-8383	153	8	suppl	suppl	ADJ
bam-8383	153	9	4	4	NUM
bam-8383	153	10	:	:	PUNCT
bam-8383	153	11	s597	s597	PROPN
bam-8383	153	12	-	-	PUNCT
bam-8383	153	13	609	609	NUM
bam-8383	153	14	.	.	PUNCT
bam-8383	154	1	8	8	X
bam-8383	154	2	.	.	X
bam-8383	154	3	grandemange	grandemange	PROPN
bam-8383	154	4	s	s	PROPN
bam-8383	154	5	,	,	PUNCT
bam-8383	154	6	sanchez	sanchez	PROPN
bam-8383	154	7	e	e	PROPN
bam-8383	154	8	,	,	PUNCT
bam-8383	154	9	louis	louis	NOUN
bam-8383	154	10	-	-	PUNCT
bam-8383	154	11	plence	plence	NOUN
bam-8383	154	12	p	p	NOUN
bam-8383	154	13	,	,	PUNCT
bam-8383	154	14	et	et	PROPN
bam-8383	154	15	al	al	PROPN
bam-8383	154	16	.	.	PUNCT
bam-8383	155	1	a	a	DET
bam-8383	155	2	new	new	ADJ
bam-8383	155	3	autoinflammatory	autoinflammatory	NOUN
bam-8383	155	4	and	and	CCONJ
bam-8383	155	5	autoimmune	autoimmune	ADJ
bam-8383	155	6	syndrome	syndrome	NOUN
bam-8383	155	7	associated	associate	VERB
bam-8383	155	8	with	with	ADP
bam-8383	155	9	nlrp1	nlrp1	NOUN
bam-8383	155	10	mutations	mutation	NOUN
bam-8383	155	11	:	:	PUNCT
bam-8383	155	12	naiad	naiad	X
bam-8383	155	13	(	(	PUNCT
bam-8383	155	14	nlrp1	nlrp1	NOUN
bam-8383	155	15	-	-	PUNCT
bam-8383	155	16	associated	associate	VERB
bam-8383	155	17	autoinflammation	autoinflammation	NOUN
bam-8383	155	18	with	with	ADP
bam-8383	155	19	arthritis	arthritis	NOUN
bam-8383	155	20	and	and	CCONJ
bam-8383	155	21	dyskeratosis	dyskeratosis	NOUN
bam-8383	155	22	)	)	PUNCT
bam-8383	155	23	.	.	PUNCT
bam-8383	156	1	ann	ann	PROPN
bam-8383	156	2	rheum	rheum	PROPN
bam-8383	156	3	dis	dis	PROPN
bam-8383	156	4	2017;76:1191	2017;76:1191	NUM
bam-8383	156	5	-	-	SYM
bam-8383	156	6	8	8	NUM
bam-8383	156	7	.	.	NOUN
bam-8383	156	8	9	9	NUM
bam-8383	156	9	.	.	X
bam-8383	156	10	vaccaro	vaccaro	PROPN
bam-8383	156	11	m	m	PROPN
bam-8383	156	12	,	,	PUNCT
bam-8383	156	13	cicero	cicero	PROPN
bam-8383	156	14	f	f	PROPN
bam-8383	156	15	,	,	PUNCT
bam-8383	156	16	mannucci	mannucci	PROPN
bam-8383	156	17	c	c	AUX
bam-8383	156	18	,	,	PUNCT
bam-8383	156	19	et	et	PROPN
bam-8383	156	20	al	al	PROPN
bam-8383	156	21	.	.	PROPN
bam-8383	157	1	il-33	il-33	VERB
bam-8383	157	2	circulating	circulate	VERB
bam-8383	157	3	serum	serum	NOUN
bam-8383	157	4	levels	level	NOUN
bam-8383	157	5	are	be	AUX
bam-8383	157	6	increased	increase	VERB
bam-8383	157	7	in	in	ADP
bam-8383	157	8	patients	patient	NOUN
bam-8383	157	9	with	with	ADP
bam-8383	157	10	non	non	ADJ
bam-8383	157	11	-	-	ADJ
bam-8383	157	12	segmental	segmental	ADJ
bam-8383	157	13	generalized	generalized	ADJ
bam-8383	157	14	vitiligo	vitiligo	NOUN
bam-8383	157	15	.	.	PUNCT
bam-8383	158	1	arch	arch	ADJ
bam-8383	158	2	dermatol	dermatol	NOUN
bam-8383	158	3	res	re	NOUN
bam-8383	158	4	2016;308:527	2016;308:527	NUM
bam-8383	158	5	-	-	SYM
bam-8383	158	6	30	30	NUM
bam-8383	158	7	.	.	PUNCT
bam-8383	159	1	10	10	NUM
bam-8383	159	2	.	.	PUNCT
bam-8383	160	1	yao	yao	PROPN
bam-8383	160	2	l	l	PROPN
bam-8383	160	3	,	,	PUNCT
bam-8383	160	4	hu	hu	PROPN
bam-8383	160	5	dn	dn	PROPN
bam-8383	160	6	,	,	PUNCT
bam-8383	160	7	chen	chen	PROPN
bam-8383	160	8	m	m	PROPN
bam-8383	160	9	,	,	PUNCT
bam-8383	161	1	li	li	PROPN
bam-8383	161	2	ss	ss	PROPN
bam-8383	161	3	.	.	PUNCT
bam-8383	162	1	subtoxic	subtoxic	ADJ
bam-8383	162	2	levels	level	NOUN
bam-8383	162	3	hydrogen	hydrogen	NOUN
bam-8383	162	4	peroxide	peroxide	NOUN
bam-8383	162	5	-	-	PUNCT
bam-8383	162	6	induced	induce	VERB
bam-8383	162	7	expression	expression	NOUN
bam-8383	162	8	of	of	ADP
bam-8383	162	9	interleukin-6	interleukin-6	NUM
bam-8383	162	10	by	by	ADP
bam-8383	162	11	epidermal	epidermal	ADJ
bam-8383	162	12	melanocytes	melanocyte	NOUN
bam-8383	162	13	.	.	PUNCT
bam-8383	163	1	arch	arch	ADJ
bam-8383	163	2	dermatol	dermatol	NOUN
bam-8383	163	3	res	re	VERB
bam-8383	163	4	2012;304:831	2012;304:831	PROPN
bam-8383	163	5	-	-	SYM
bam-8383	163	6	8	8	NUM
bam-8383	163	7	.	.	PUNCT
bam-8383	163	8	11	11	NUM
bam-8383	163	9	.	.	X
bam-8383	164	1	yazici	yazici	PROPN
bam-8383	164	2	ac	ac	PROPN
bam-8383	164	3	,	,	PUNCT
bam-8383	164	4	erdal	erdal	PROPN
bam-8383	164	5	me	me	PROPN
bam-8383	164	6	,	,	PUNCT
bam-8383	164	7	et	et	PROPN
bam-8383	164	8	al	al	PROPN
bam-8383	164	9	.	.	PROPN
bam-8383	164	10	lack	lack	NOUN
bam-8383	164	11	of	of	ADP
bam-8383	164	12	association	association	NOUN
bam-8383	164	13	with	with	ADP
bam-8383	164	14	tnf	tnf	PROPN
bam-8383	164	15	-	-	PUNCT
bam-8383	164	16	alpha-308	alpha-308	NOUN
bam-8383	164	17	promoter	promoter	NOUN
bam-8383	164	18	polymorphism	polymorphism	NOUN
bam-8383	164	19	in	in	ADP
bam-8383	164	20	patients	patient	NOUN
bam-8383	164	21	with	with	ADP
bam-8383	164	22	vitiligo	vitiligo	PROPN
bam-8383	164	23	.	.	PUNCT
bam-8383	165	1	arch	arch	ADJ
bam-8383	165	2	dermatol	dermatol	NOUN
bam-8383	165	3	res	re	NOUN
bam-8383	165	4	2006;298:46	2006;298:46	NUM
bam-8383	165	5	-	-	SYM
bam-8383	165	6	9	9	NUM
bam-8383	165	7	.	.	NOUN
bam-8383	165	8	12	12	NUM
bam-8383	165	9	.	.	PUNCT
bam-8383	166	1	sandoval	sandoval	PROPN
bam-8383	166	2	-	-	PUNCT
bam-8383	166	3	cruz	cruz	PROPN
bam-8383	166	4	m	m	PROPN
bam-8383	166	5	,	,	PUNCT
bam-8383	166	6	garcia	garcia	PROPN
bam-8383	166	7	-	-	PUNCT
bam-8383	166	8	carrasco	carrasco	PROPN
bam-8383	166	9	m	m	PROPN
bam-8383	166	10	,	,	PUNCT
bam-8383	166	11	sanchezporras	sanchezporras	PROPN
bam-8383	166	12	r	r	PROPN
bam-8383	166	13	,	,	PUNCT
bam-8383	166	14	et	et	PROPN
bam-8383	166	15	al	al	PROPN
bam-8383	166	16	.	.	PROPN
bam-8383	166	17	immunopathogenesis	immunopathogenesis	NOUN
bam-8383	166	18	of	of	ADP
bam-8383	166	19	vitiligo	vitiligo	NOUN
bam-8383	166	20	.	.	PUNCT
bam-8383	167	1	autoimmun	autoimmun	PROPN
bam-8383	167	2	rev	rev	VERB
bam-8383	167	3	2011;10:762	2011;10:762	NUM
bam-8383	167	4	-	-	SYM
bam-8383	167	5	5	5	NUM
bam-8383	167	6	.	.	NOUN
bam-8383	167	7	13	13	NUM
bam-8383	167	8	.	.	PUNCT
bam-8383	168	1	karam	karam	PROPN
bam-8383	168	2	ra	ra	PROPN
bam-8383	168	3	,	,	PUNCT
bam-8383	168	4	zidan	zidan	PROPN
bam-8383	168	5	he	he	PRON
bam-8383	168	6	,	,	PUNCT
bam-8383	168	7	khater	khater	PROPN
bam-8383	168	8	mh	mh	PROPN
bam-8383	168	9	.	.	PUNCT
bam-8383	169	1	genetic	genetic	ADJ
bam-8383	169	2	variants	variant	NOUN
bam-8383	169	3	of	of	ADP
bam-8383	169	4	interferon	interferon	ADJ
bam-8383	169	5	-	-	PUNCT
bam-8383	169	6	gamma	gamma	NOUN
bam-8383	169	7	and	and	CCONJ
bam-8383	169	8	its	its	PRON
bam-8383	169	9	mrna	mrna	NOUN
bam-8383	169	10	expression	expression	NOUN
bam-8383	169	11	and	and	CCONJ
bam-8383	169	12	inflammatory	inflammatory	ADJ
bam-8383	169	13	parameters	parameter	NOUN
bam-8383	169	14	in	in	ADP
bam-8383	169	15	the	the	DET
bam-8383	169	16	pathogenesis	pathogenesis	NOUN
bam-8383	169	17	of	of	ADP
bam-8383	169	18	vitiligo	vitiligo	PROPN
bam-8383	169	19	.	.	PUNCT
bam-8383	170	1	biochem	biochem	PROPN
bam-8383	170	2	cell	cell	NOUN
bam-8383	170	3	biol	biol	PROPN
bam-8383	170	4	2017;95:474	2017;95:474	PROPN
bam-8383	170	5	-	-	PUNCT
bam-8383	170	6	81	81	NUM
bam-8383	170	7	.	.	PUNCT
bam-8383	170	8	14	14	NUM
bam-8383	170	9	.	.	PUNCT
bam-8383	171	1	ning	ning	PROPN
bam-8383	171	2	w	w	PROPN
bam-8383	171	3	,	,	PUNCT
bam-8383	171	4	wang	wang	PROPN
bam-8383	171	5	s	s	PROPN
bam-8383	171	6	,	,	PUNCT
bam-8383	171	7	dong	dong	PROPN
bam-8383	171	8	x	x	PROPN
bam-8383	171	9	,	,	PUNCT
bam-8383	171	10	et	et	PROPN
bam-8383	171	11	al	al	PROPN
bam-8383	171	12	.	.	PUNCT
bam-8383	172	1	epigallocatechin3	epigallocatechin3	PROPN
bam-8383	172	2	-	-	PUNCT
bam-8383	172	3	gallate	gallate	PROPN
bam-8383	172	4	(	(	PUNCT
bam-8383	172	5	egcg	egcg	NOUN
bam-8383	172	6	)	)	PUNCT
bam-8383	172	7	suppresses	suppress	VERB
bam-8383	172	8	the	the	DET
bam-8383	172	9	trafficking	trafficking	NOUN
bam-8383	172	10	of	of	ADP
bam-8383	172	11	lymphocytes	lymphocyte	NOUN
bam-8383	172	12	to	to	ADP
bam-8383	172	13	epidermal	epidermal	ADJ
bam-8383	172	14	melanocytes	melanocyte	NOUN
bam-8383	172	15	via	via	ADP
bam-8383	172	16	inhibition	inhibition	NOUN
bam-8383	172	17	of	of	ADP
bam-8383	172	18	jak2	jak2	NOUN
bam-8383	172	19	:	:	PUNCT
bam-8383	172	20	its	its	PRON
bam-8383	172	21	implication	implication	NOUN
bam-8383	172	22	for	for	ADP
bam-8383	172	23	vitiligo	vitiligo	ADJ
bam-8383	172	24	treatment	treatment	NOUN
bam-8383	172	25	.	.	PUNCT
bam-8383	173	1	biol	biol	PROPN
bam-8383	173	2	pharm	pharm	PROPN
bam-8383	173	3	bull	bull	PROPN
bam-8383	173	4	2015;38:1700	2015;38:1700	NUM
bam-8383	173	5	-	-	SYM
bam-8383	173	6	6	6	NUM
bam-8383	173	7	.	.	PUNCT
bam-8383	174	1	non	non	PROPN
bam-8383	174	2	co	co	PROPN
bam-8383	174	3	mmerc	mmerc	PROPN
bam-8383	174	4	ial	ial	PROPN
bam-8383	174	5	us	us	PROPN
bam-8383	174	6	e	e	NOUN
bam-8383	174	7	o	o	NOUN
bam-8383	174	8	nly	nly	ADV
bam-8383	174	9	mailto:drk_ziari@yahoo.com	mailto:drk_ziari@yahoo.com	X
bam-8383	174	10	inos	ino	NOUN
bam-8383	174	11	inhibition	inhibition	VERB
bam-8383	174	12	for	for	ADP
bam-8383	174	13	vitiligo	vitiligo	PROPN
bam-8383	174	14	eur	eur	PROPN
bam-8383	174	15	j	j	PROPN
bam-8383	174	16	transl	transl	PROPN
bam-8383	174	17	myol	myol	ADV
bam-8383	174	18	29	29	NUM
bam-8383	174	19	(	(	PUNCT
bam-8383	174	20	3	3	NUM
bam-8383	174	21	):	):	PUNCT
bam-8383	174	22	251	251	NUM
bam-8383	174	23	-	-	SYM
bam-8383	174	24	260	260	NUM
bam-8383	174	25	,	,	PUNCT
bam-8383	174	26	2019	2019	NUM
bam-8383	174	27	258	258	NUM
bam-8383	174	28	15	15	NUM
bam-8383	174	29	.	.	PUNCT
bam-8383	175	1	farhan	farhan	PROPN
bam-8383	175	2	j	j	PROPN
bam-8383	175	3	,	,	PUNCT
bam-8383	175	4	al	al	PROPN
bam-8383	175	5	-	-	PUNCT
bam-8383	175	6	shobaili	shobaili	NOUN
bam-8383	175	7	ha	ha	INTJ
bam-8383	175	8	,	,	PUNCT
bam-8383	175	9	zafar	zafar	PROPN
bam-8383	175	10	u	u	PROPN
bam-8383	175	11	,	,	PUNCT
bam-8383	175	12	et	et	PROPN
bam-8383	175	13	al	al	PROPN
bam-8383	175	14	.	.	PUNCT
bam-8383	176	1	interleukin-6	interleukin-6	PROPN
bam-8383	176	2	:	:	PUNCT
bam-8383	176	3	a	a	DET
bam-8383	176	4	possible	possible	ADJ
bam-8383	176	5	inflammatory	inflammatory	ADJ
bam-8383	176	6	link	link	NOUN
bam-8383	176	7	between	between	ADP
bam-8383	176	8	vitiligo	vitiligo	NOUN
bam-8383	176	9	and	and	CCONJ
bam-8383	176	10	type	type	NOUN
bam-8383	176	11	1	1	NUM
bam-8383	176	12	diabetes	diabetes	NOUN
bam-8383	176	13	.	.	PUNCT
bam-8383	177	1	brit	brit	PROPN
bam-8383	177	2	j	j	PROPN
bam-8383	177	3	biomed	biome	VERB
bam-8383	177	4	sci	sci	PROPN
bam-8383	177	5	2014;71:151	2014;71:151	PROPN
bam-8383	177	6	-	-	SYM
bam-8383	177	7	7	7	NUM
bam-8383	177	8	.	.	NOUN
bam-8383	177	9	16	16	NUM
bam-8383	177	10	.	.	PUNCT
bam-8383	178	1	dani	dani	PROPN
bam-8383	178	2	p	p	PROPN
bam-8383	178	3	,	,	PUNCT
bam-8383	178	4	patnaik	patnaik	PROPN
bam-8383	178	5	n	n	CCONJ
bam-8383	178	6	,	,	PUNCT
bam-8383	178	7	singh	singh	PROPN
bam-8383	178	8	a	a	NOUN
bam-8383	178	9	,	,	PUNCT
bam-8383	178	10	et	et	PROPN
bam-8383	178	11	al	al	PROPN
bam-8383	178	12	.	.	PROPN
bam-8383	178	13	association	association	NOUN
bam-8383	178	14	and	and	CCONJ
bam-8383	178	15	expression	expression	NOUN
bam-8383	178	16	of	of	ADP
bam-8383	178	17	the	the	DET
bam-8383	178	18	antigen	antigen	NOUN
bam-8383	178	19	-	-	PUNCT
bam-8383	178	20	processing	processing	NOUN
bam-8383	178	21	gene	gene	NOUN
bam-8383	178	22	psmb8	psmb8	NOUN
bam-8383	178	23	,	,	PUNCT
bam-8383	178	24	coding	code	VERB
bam-8383	178	25	for	for	ADP
bam-8383	178	26	low	low	ADJ
bam-8383	178	27	-	-	PUNCT
bam-8383	178	28	molecular	molecular	ADJ
bam-8383	178	29	-	-	PUNCT
bam-8383	178	30	mass	mass	NOUN
bam-8383	178	31	protease	protease	NOUN
bam-8383	178	32	7	7	NUM
bam-8383	178	33	,	,	PUNCT
bam-8383	178	34	with	with	ADP
bam-8383	178	35	vitiligo	vitiligo	NOUN
bam-8383	178	36	in	in	ADP
bam-8383	178	37	north	north	PROPN
bam-8383	178	38	india	india	PROPN
bam-8383	178	39	:	:	PUNCT
bam-8383	178	40	case	case	NOUN
bam-8383	178	41	-	-	PUNCT
bam-8383	178	42	control	control	NOUN
bam-8383	178	43	study	study	NOUN
bam-8383	178	44	.	.	PUNCT
bam-8383	179	1	brit	brit	PROPN
bam-8383	179	2	j	j	PROPN
bam-8383	179	3	dermatol	dermatol	NOUN
bam-8383	179	4	2018;178:482	2018;178:482	NUM
bam-8383	179	5	-	-	SYM
bam-8383	179	6	91	91	NUM
bam-8383	179	7	.	.	PUNCT
bam-8383	179	8	17	17	NUM
bam-8383	179	9	.	.	PUNCT
bam-8383	180	1	le	le	PROPN
bam-8383	180	2	poole	poole	PROPN
bam-8383	180	3	ic	ic	PROPN
bam-8383	180	4	,	,	PUNCT
bam-8383	180	5	stennett	stennett	PROPN
bam-8383	180	6	ls	ls	PROPN
bam-8383	180	7	,	,	PUNCT
bam-8383	180	8	bonish	bonish	ADJ
bam-8383	180	9	bk	bk	PROPN
bam-8383	180	10	,	,	PUNCT
bam-8383	180	11	et	et	PROPN
bam-8383	180	12	al	al	PROPN
bam-8383	180	13	.	.	PUNCT
bam-8383	181	1	expansion	expansion	NOUN
bam-8383	181	2	of	of	ADP
bam-8383	181	3	vitiligo	vitiligo	ADJ
bam-8383	181	4	lesions	lesion	NOUN
bam-8383	181	5	is	be	AUX
bam-8383	181	6	associated	associate	VERB
bam-8383	181	7	with	with	ADP
bam-8383	181	8	reduced	reduce	VERB
bam-8383	181	9	epidermal	epidermal	ADJ
bam-8383	181	10	cdw60	cdw60	ADJ
bam-8383	181	11	expression	expression	NOUN
bam-8383	181	12	and	and	CCONJ
bam-8383	181	13	increased	increase	VERB
bam-8383	181	14	expression	expression	NOUN
bam-8383	181	15	of	of	ADP
bam-8383	181	16	hla	hla	PROPN
bam-8383	181	17	-	-	PUNCT
bam-8383	181	18	dr	dr	PROPN
bam-8383	181	19	in	in	ADP
bam-8383	181	20	perilesional	perilesional	ADJ
bam-8383	181	21	skin	skin	NOUN
bam-8383	181	22	.	.	PUNCT
bam-8383	182	1	brit	brit	PROPN
bam-8383	182	2	j	j	PROPN
bam-8383	182	3	dermatol	dermatol	NOUN
bam-8383	182	4	2003;149:739	2003;149:739	PROPN
bam-8383	182	5	-	-	SYM
bam-8383	182	6	48	48	NUM
bam-8383	182	7	.	.	PUNCT
bam-8383	183	1	18	18	NUM
bam-8383	183	2	.	.	PUNCT
bam-8383	184	1	marie	marie	PROPN
bam-8383	184	2	j	j	PROPN
bam-8383	184	3	,	,	PUNCT
bam-8383	184	4	kovacs	kovacs	PROPN
bam-8383	184	5	d	d	PROPN
bam-8383	184	6	,	,	PUNCT
bam-8383	184	7	pain	pain	NOUN
bam-8383	184	8	c	c	NOUN
bam-8383	184	9	,	,	PUNCT
bam-8383	184	10	jouary	jouary	PROPN
bam-8383	184	11	t	t	PROPN
bam-8383	184	12	,	,	PUNCT
bam-8383	184	13	cota	cota	PROPN
bam-8383	184	14	c	c	PROPN
bam-8383	184	15	,	,	PUNCT
bam-8383	184	16	vergier	vergier	NOUN
bam-8383	184	17	b	b	NOUN
bam-8383	184	18	,	,	PUNCT
bam-8383	184	19	et	et	PROPN
bam-8383	184	20	al	al	PROPN
bam-8383	184	21	.	.	PROPN
bam-8383	184	22	inflammasome	inflammasome	PROPN
bam-8383	184	23	activation	activation	NOUN
bam-8383	184	24	and	and	CCONJ
bam-8383	184	25	vitiligo	vitiligo	VERB
bam-8383	184	26	/	/	SYM
bam-8383	184	27	nonsegmental	nonsegmental	NOUN
bam-8383	184	28	vitiligo	vitiligo	NOUN
bam-8383	184	29	progression	progression	NOUN
bam-8383	184	30	.	.	PUNCT
bam-8383	185	1	brit	brit	PROPN
bam-8383	185	2	j	j	PROPN
bam-8383	186	1	dermatol	dermatol	NOUN
bam-8383	186	2	2014;170:816	2014;170:816	NUM
bam-8383	186	3	-	-	SYM
bam-8383	186	4	23	23	NUM
bam-8383	186	5	.	.	PUNCT
bam-8383	186	6	19	19	NUM
bam-8383	186	7	.	.	PUNCT
bam-8383	187	1	speeckaert	speeckaert	PROPN
bam-8383	187	2	r	r	PROPN
bam-8383	187	3	,	,	PUNCT
bam-8383	187	4	lambert	lambert	PROPN
bam-8383	187	5	j	j	PROPN
bam-8383	187	6	,	,	PUNCT
bam-8383	187	7	grine	grine	PROPN
bam-8383	187	8	l	l	PROPN
bam-8383	187	9	,	,	PUNCT
bam-8383	187	10	et	et	PROPN
bam-8383	187	11	al	al	PROPN
bam-8383	187	12	.	.	PUNCT
bam-8383	188	1	the	the	DET
bam-8383	188	2	many	many	ADJ
bam-8383	188	3	faces	face	NOUN
bam-8383	188	4	of	of	ADP
bam-8383	188	5	interleukin-17	interleukin-17	PROPN
bam-8383	188	6	in	in	ADP
bam-8383	188	7	inflammatory	inflammatory	ADJ
bam-8383	188	8	skin	skin	NOUN
bam-8383	188	9	diseases	disease	NOUN
bam-8383	188	10	.	.	PUNCT
bam-8383	189	1	brit	brit	PROPN
bam-8383	189	2	j	j	PROPN
bam-8383	189	3	dermatol	dermatol	NOUN
bam-8383	189	4	2016;175:892	2016;175:892	NUM
bam-8383	189	5	-	-	PUNCT
bam-8383	189	6	901	901	NUM
bam-8383	189	7	.	.	PUNCT
bam-8383	190	1	20	20	NUM
bam-8383	190	2	.	.	PUNCT
bam-8383	190	3	webb	webb	PROPN
bam-8383	190	4	kc	kc	PROPN
bam-8383	190	5	,	,	PUNCT
bam-8383	190	6	tung	tung	PROPN
bam-8383	190	7	r	r	NOUN
bam-8383	190	8	,	,	PUNCT
bam-8383	190	9	winterfield	winterfield	NOUN
bam-8383	190	10	ls	ls	ADJ
bam-8383	190	11	,	,	PUNCT
bam-8383	190	12	et	et	PROPN
bam-8383	190	13	al	al	PROPN
bam-8383	190	14	.	.	PUNCT
bam-8383	191	1	tumour	tumour	NOUN
bam-8383	191	2	necrosis	necrosis	NOUN
bam-8383	191	3	factor	factor	NOUN
bam-8383	191	4	-	-	PUNCT
bam-8383	191	5	alpha	alpha	NOUN
bam-8383	191	6	inhibition	inhibition	NOUN
bam-8383	191	7	can	can	AUX
bam-8383	191	8	stabilize	stabilize	VERB
bam-8383	191	9	disease	disease	NOUN
bam-8383	191	10	in	in	ADP
bam-8383	191	11	progressive	progressive	ADJ
bam-8383	191	12	vitiligo	vitiligo	NOUN
bam-8383	191	13	.	.	PUNCT
bam-8383	192	1	brit	brit	PROPN
bam-8383	192	2	j	j	PROPN
bam-8383	192	3	dermatol	dermatol	NOUN
bam-8383	192	4	2015;173:641	2015;173:641	NUM
bam-8383	192	5	-	-	SYM
bam-8383	192	6	50	50	NUM
bam-8383	192	7	.	.	PUNCT
bam-8383	192	8	21	21	NUM
bam-8383	192	9	.	.	PUNCT
bam-8383	193	1	zayed	zayed	ADJ
bam-8383	193	2	aa	aa	PROPN
bam-8383	193	3	,	,	PUNCT
bam-8383	193	4	khorshied	khorshie	VERB
bam-8383	193	5	mm	mm	PROPN
bam-8383	193	6	,	,	PUNCT
bam-8383	193	7	hussein	hussein	PROPN
bam-8383	193	8	mf	mf	PROPN
bam-8383	193	9	.	.	PROPN
bam-8383	193	10	inducible	inducible	ADJ
bam-8383	193	11	nitric	nitric	ADJ
bam-8383	193	12	oxide	oxide	NOUN
bam-8383	193	13	synthase	synthase	NOUN
bam-8383	193	14	promoter	promoter	NOUN
bam-8383	193	15	polymorphism	polymorphism	NOUN
bam-8383	193	16	:	:	PUNCT
bam-8383	193	17	a	a	DET
bam-8383	193	18	molecular	molecular	ADJ
bam-8383	193	19	susceptibility	susceptibility	NOUN
bam-8383	193	20	marker	marker	NOUN
bam-8383	193	21	for	for	ADP
bam-8383	193	22	vitiligo	vitiligo	NOUN
bam-8383	193	23	in	in	ADP
bam-8383	193	24	egyptians	egyptians	PROPN
bam-8383	193	25	.	.	PUNCT
bam-8383	194	1	int	int	NOUN
bam-8383	194	2	j	j	PROPN
bam-8383	194	3	dermatol	dermatol	NOUN
bam-8383	194	4	2015;54:675	2015;54:675	PROPN
bam-8383	194	5	-	-	SYM
bam-8383	194	6	9	9	NUM
bam-8383	194	7	.	.	NOUN
bam-8383	194	8	22	22	NUM
bam-8383	194	9	.	.	PUNCT
bam-8383	195	1	yeh	yeh	PROPN
bam-8383	195	2	s	s	PROPN
bam-8383	195	3	,	,	PUNCT
bam-8383	195	4	li	li	PROPN
bam-8383	195	5	z	z	PROPN
bam-8383	195	6	,	,	PUNCT
bam-8383	195	7	sen	sen	PROPN
bam-8383	195	8	hn	hn	PROPN
bam-8383	195	9	,	,	PUNCT
bam-8383	195	10	et	et	PROPN
bam-8383	195	11	al	al	PROPN
bam-8383	195	12	.	.	PROPN
bam-8383	196	1	scleritis	scleritis	PROPN
bam-8383	196	2	and	and	CCONJ
bam-8383	196	3	multiple	multiple	ADJ
bam-8383	196	4	systemic	systemic	ADJ
bam-8383	196	5	autoimmune	autoimmune	ADJ
bam-8383	196	6	manifestations	manifestation	NOUN
bam-8383	196	7	in	in	ADP
bam-8383	196	8	chronic	chronic	ADJ
bam-8383	196	9	natural	natural	ADJ
bam-8383	196	10	killer	killer	NOUN
bam-8383	196	11	cell	cell	NOUN
bam-8383	196	12	lymphocytosis	lymphocytosis	NOUN
bam-8383	196	13	associated	associate	VERB
bam-8383	196	14	with	with	ADP
bam-8383	196	15	elevated	elevated	ADJ
bam-8383	196	16	tcralpha	tcralpha	NOUN
bam-8383	196	17	/	/	SYM
bam-8383	196	18	beta+cd3+cd4	beta+cd3+cd4	PROPN
bam-8383	196	19	-	-	ADJ
bam-8383	196	20	cd8doublenegative	cd8doublenegative	ADJ
bam-8383	196	21	t	t	NOUN
bam-8383	196	22	cells	cell	NOUN
bam-8383	196	23	.	.	PUNCT
bam-8383	197	1	brit	brit	PROPN
bam-8383	197	2	j	j	PROPN
bam-8383	197	3	ophthalmol	ophthalmol	PROPN
bam-8383	197	4	2010;94:74852	2010;94:74852	NUM
bam-8383	197	5	.	.	PUNCT
bam-8383	197	6	23	23	NUM
bam-8383	197	7	.	.	PUNCT
bam-8383	198	1	manni	manni	PROPN
bam-8383	198	2	m	m	PROPN
bam-8383	198	3	,	,	PUNCT
bam-8383	198	4	maestroni	maestroni	PROPN
bam-8383	198	5	gj	gj	PROPN
bam-8383	198	6	.	.	PUNCT
bam-8383	199	1	sympathetic	sympathetic	ADJ
bam-8383	199	2	nervous	nervous	ADJ
bam-8383	199	3	modulation	modulation	NOUN
bam-8383	199	4	of	of	ADP
bam-8383	199	5	the	the	DET
bam-8383	199	6	skin	skin	NOUN
bam-8383	199	7	innate	innate	ADJ
bam-8383	199	8	and	and	CCONJ
bam-8383	199	9	adaptive	adaptive	ADJ
bam-8383	199	10	immune	immune	ADJ
bam-8383	199	11	response	response	NOUN
bam-8383	199	12	to	to	ADP
bam-8383	199	13	peptidoglycan	peptidoglycan	NOUN
bam-8383	199	14	but	but	CCONJ
bam-8383	199	15	not	not	PART
bam-8383	199	16	lipopolysaccharide	lipopolysaccharide	ADJ
bam-8383	199	17	:	:	PUNCT
bam-8383	199	18	involvement	involvement	NOUN
bam-8383	199	19	of	of	ADP
bam-8383	199	20	betaadrenoceptors	betaadrenoceptor	NOUN
bam-8383	199	21	and	and	CCONJ
bam-8383	199	22	relevance	relevance	NOUN
bam-8383	199	23	in	in	ADP
bam-8383	199	24	inflammatory	inflammatory	ADJ
bam-8383	199	25	diseases	disease	NOUN
bam-8383	199	26	.	.	PUNCT
bam-8383	200	1	brain	brain	NOUN
bam-8383	200	2	behav	behav	PROPN
bam-8383	200	3	immun	immun	PROPN
bam-8383	200	4	2008;22:80	2008;22:80	PROPN
bam-8383	200	5	-	-	PUNCT
bam-8383	200	6	8	8	NUM
bam-8383	200	7	.	.	NUM
bam-8383	200	8	24	24	NUM
bam-8383	200	9	.	.	PUNCT
bam-8383	200	10	carvalho	carvalho	PROPN
bam-8383	200	11	cl	cl	PROPN
bam-8383	200	12	,	,	PUNCT
bam-8383	200	13	ortigosa	ortigosa	PROPN
bam-8383	200	14	lc	lc	PROPN
bam-8383	200	15	.	.	PUNCT
bam-8383	201	1	segmental	segmental	PROPN
bam-8383	201	2	vitiligo	vitiligo	PROPN
bam-8383	201	3	after	after	ADP
bam-8383	201	4	infliximab	infliximab	NOUN
bam-8383	201	5	use	use	NOUN
bam-8383	201	6	for	for	ADP
bam-8383	201	7	rheumatoid	rheumatoid	NOUN
bam-8383	201	8	arthritis	arthritis	NOUN
bam-8383	201	9	--	--	PUNCT
bam-8383	201	10	a	a	DET
bam-8383	201	11	case	case	NOUN
bam-8383	201	12	report	report	NOUN
bam-8383	201	13	.	.	PUNCT
bam-8383	202	1	anais	anais	PROPN
bam-8383	202	2	brasileiros	brasileiros	PROPN
bam-8383	202	3	de	de	PROPN
bam-8383	202	4	dermatologia	dermatologia	PROPN
bam-8383	202	5	2014;89:154	2014;89:154	PROPN
bam-8383	202	6	-	-	SYM
bam-8383	202	7	6	6	NUM
bam-8383	202	8	.	.	NOUN
bam-8383	202	9	25	25	NUM
bam-8383	202	10	.	.	PUNCT
bam-8383	202	11	miniati	miniati	PROPN
bam-8383	202	12	a	a	PROPN
bam-8383	202	13	,	,	PUNCT
bam-8383	202	14	weng	weng	PROPN
bam-8383	202	15	z	z	PROPN
bam-8383	202	16	,	,	PUNCT
bam-8383	202	17	zhang	zhang	PROPN
bam-8383	202	18	b	b	PROPN
bam-8383	202	19	,	,	PUNCT
bam-8383	202	20	et	et	PROPN
bam-8383	202	21	al	al	PROPN
bam-8383	202	22	.	.	PROPN
bam-8383	202	23	stimulated	stimulate	VERB
bam-8383	202	24	human	human	ADJ
bam-8383	202	25	melanocytes	melanocyte	NOUN
bam-8383	202	26	express	express	VERB
bam-8383	202	27	and	and	CCONJ
bam-8383	202	28	release	release	VERB
bam-8383	202	29	interleukin8	interleukin8	NOUN
bam-8383	202	30	,	,	PUNCT
bam-8383	202	31	which	which	PRON
bam-8383	202	32	is	be	AUX
bam-8383	202	33	inhibited	inhibit	VERB
bam-8383	202	34	by	by	ADP
bam-8383	202	35	luteolin	luteolin	PROPN
bam-8383	202	36	:	:	PUNCT
bam-8383	202	37	relevance	relevance	NOUN
bam-8383	202	38	to	to	ADP
bam-8383	202	39	early	early	ADJ
bam-8383	202	40	vitiligo	vitiligo	VERB
bam-8383	202	41	.	.	PUNCT
bam-8383	203	1	clin	clin	PROPN
bam-8383	203	2	exp	exp	NOUN
bam-8383	203	3	dermatol	dermatol	NOUN
bam-8383	203	4	2014;39:54	2014;39:54	NUM
bam-8383	203	5	-	-	SYM
bam-8383	203	6	7	7	NUM
bam-8383	203	7	.	.	NOUN
bam-8383	203	8	26	26	NUM
bam-8383	203	9	.	.	PUNCT
bam-8383	204	1	shin	shin	PROPN
bam-8383	204	2	j	j	PROPN
bam-8383	204	3	,	,	PUNCT
bam-8383	204	4	kang	kang	PROPN
bam-8383	204	5	hy	hy	PROPN
bam-8383	204	6	,	,	PUNCT
bam-8383	204	7	kim	kim	PROPN
bam-8383	204	8	kh	kh	PROPN
bam-8383	204	9	,	,	PUNCT
bam-8383	204	10	et	et	PROPN
bam-8383	204	11	al	al	PROPN
bam-8383	204	12	.	.	PUNCT
bam-8383	205	1	involvement	involvement	NOUN
bam-8383	205	2	of	of	ADP
bam-8383	205	3	t	t	NOUN
bam-8383	205	4	cells	cell	NOUN
bam-8383	205	5	in	in	ADP
bam-8383	205	6	early	early	ADJ
bam-8383	205	7	evolving	evolve	VERB
bam-8383	205	8	segmental	segmental	ADJ
bam-8383	205	9	vitiligo	vitiligo	NOUN
bam-8383	205	10	.	.	PUNCT
bam-8383	206	1	clin	clin	PROPN
bam-8383	206	2	exp	exp	PROPN
bam-8383	206	3	dermatol	dermatol	NOUN
bam-8383	206	4	2016;41:671	2016;41:671	PROPN
bam-8383	206	5	-	-	SYM
bam-8383	206	6	4	4	NUM
bam-8383	206	7	.	.	NOUN
bam-8383	206	8	27	27	NUM
bam-8383	206	9	.	.	PUNCT
bam-8383	206	10	birlea	birlea	PROPN
bam-8383	206	11	sa	sa	PROPN
bam-8383	206	12	,	,	PUNCT
bam-8383	206	13	costin	costin	PROPN
bam-8383	206	14	ge	ge	PROPN
bam-8383	206	15	,	,	PUNCT
bam-8383	206	16	norris	norris	PROPN
bam-8383	206	17	da	da	PROPN
bam-8383	206	18	.	.	PUNCT
bam-8383	207	1	cellular	cellular	ADJ
bam-8383	207	2	and	and	CCONJ
bam-8383	207	3	molecular	molecular	ADJ
bam-8383	207	4	mechanisms	mechanism	NOUN
bam-8383	207	5	involved	involve	VERB
bam-8383	207	6	in	in	ADP
bam-8383	207	7	the	the	DET
bam-8383	207	8	action	action	NOUN
bam-8383	207	9	of	of	ADP
bam-8383	207	10	vitamin	vitamin	NOUN
bam-8383	207	11	d	d	NOUN
bam-8383	207	12	analogs	analog	NOUN
bam-8383	207	13	targeting	target	VERB
bam-8383	207	14	vitiligo	vitiligo	ADJ
bam-8383	207	15	depigmentation	depigmentation	NOUN
bam-8383	207	16	.	.	PUNCT
bam-8383	208	1	curr	curr	PROPN
bam-8383	208	2	drug	drug	NOUN
bam-8383	208	3	targets	target	NOUN
bam-8383	208	4	2008;9:345	2008;9:345	NUM
bam-8383	208	5	-	-	SYM
bam-8383	208	6	59	59	NUM
bam-8383	208	7	.	.	PUNCT
bam-8383	208	8	28	28	NUM
bam-8383	208	9	.	.	PUNCT
bam-8383	209	1	bullon	bullon	PROPN
bam-8383	209	2	p	p	PROPN
bam-8383	209	3	,	,	PUNCT
bam-8383	209	4	navarro	navarro	PROPN
bam-8383	209	5	jm	jm	PROPN
bam-8383	209	6	.	.	PROPN
bam-8383	209	7	inflammasome	inflammasome	VERB
bam-8383	209	8	as	as	ADP
bam-8383	209	9	a	a	DET
bam-8383	209	10	key	key	ADJ
bam-8383	209	11	pathogenic	pathogenic	ADJ
bam-8383	209	12	mechanism	mechanism	NOUN
bam-8383	209	13	in	in	ADP
bam-8383	209	14	endometriosis	endometriosis	NOUN
bam-8383	209	15	.	.	PUNCT
bam-8383	210	1	curr	curr	PROPN
bam-8383	210	2	drug	drug	PROPN
bam-8383	210	3	targ	targ	PROPN
bam-8383	210	4	2017;18:997	2017;18:997	NOUN
bam-8383	210	5	-	-	PUNCT
bam-8383	210	6	1002	1002	NUM
bam-8383	210	7	.	.	PUNCT
bam-8383	211	1	29	29	NUM
bam-8383	211	2	.	.	PUNCT
bam-8383	211	3	strassner	strassner	PROPN
bam-8383	211	4	jp	jp	PROPN
bam-8383	211	5	,	,	PUNCT
bam-8383	211	6	harris	harris	PROPN
bam-8383	211	7	je	je	PROPN
bam-8383	211	8	.	.	PUNCT
bam-8383	212	1	understanding	understand	VERB
bam-8383	212	2	mechanisms	mechanism	NOUN
bam-8383	212	3	of	of	ADP
bam-8383	212	4	autoimmunity	autoimmunity	NOUN
bam-8383	212	5	through	through	ADP
bam-8383	212	6	translational	translational	ADJ
bam-8383	212	7	research	research	NOUN
bam-8383	212	8	in	in	ADP
bam-8383	212	9	vitiligo	vitiligo	NOUN
bam-8383	212	10	.	.	PUNCT
bam-8383	213	1	curr	curr	PROPN
bam-8383	213	2	opin	opin	NOUN
bam-8383	213	3	immunol	immunol	NOUN
bam-8383	213	4	2016;43:81	2016;43:81	NUM
bam-8383	213	5	-	-	SYM
bam-8383	213	6	8	8	NUM
bam-8383	213	7	.	.	NUM
bam-8383	213	8	30	30	NUM
bam-8383	213	9	.	.	PUNCT
bam-8383	214	1	trcka	trcka	PROPN
bam-8383	214	2	j	j	PROPN
bam-8383	214	3	,	,	PUNCT
bam-8383	214	4	kunz	kunz	PROPN
bam-8383	214	5	m.	m.	NOUN
bam-8383	214	6	functional	functional	ADJ
bam-8383	214	7	genome	genome	NOUN
bam-8383	214	8	and	and	CCONJ
bam-8383	214	9	proteome	proteome	ADJ
bam-8383	214	10	analyses	analysis	NOUN
bam-8383	214	11	of	of	ADP
bam-8383	214	12	cutaneous	cutaneous	ADJ
bam-8383	214	13	autoimmune	autoimmune	ADJ
bam-8383	214	14	diseases	disease	NOUN
bam-8383	214	15	.	.	PUNCT
bam-8383	215	1	curr	curr	PROPN
bam-8383	215	2	pharm	pharm	PROPN
bam-8383	215	3	des	des	PROPN
bam-8383	215	4	2006;12:3787	2006;12:3787	NUM
bam-8383	215	5	-	-	SYM
bam-8383	215	6	98	98	NUM
bam-8383	215	7	.	.	PUNCT
bam-8383	215	8	31	31	NUM
bam-8383	215	9	.	.	PUNCT
bam-8383	216	1	vaccaro	vaccaro	PROPN
bam-8383	216	2	m	m	PROPN
bam-8383	216	3	,	,	PUNCT
bam-8383	216	4	irrera	irrera	NOUN
bam-8383	216	5	n	n	CCONJ
bam-8383	216	6	,	,	PUNCT
bam-8383	216	7	cutroneo	cutroneo	VERB
bam-8383	216	8	g	g	PROPN
bam-8383	216	9	,	,	PUNCT
bam-8383	216	10	et	et	PROPN
bam-8383	216	11	al	al	PROPN
bam-8383	216	12	.	.	PROPN
bam-8383	216	13	differential	differential	ADJ
bam-8383	216	14	expression	expression	NOUN
bam-8383	216	15	of	of	ADP
bam-8383	216	16	nitric	nitric	ADJ
bam-8383	216	17	oxide	oxide	NOUN
bam-8383	216	18	synthase	synthase	NOUN
bam-8383	216	19	isoforms	isoform	VERB
bam-8383	216	20	nnos	nno	NOUN
bam-8383	216	21	and	and	CCONJ
bam-8383	216	22	inos	ino	NOUN
bam-8383	216	23	in	in	ADP
bam-8383	216	24	patients	patient	NOUN
bam-8383	216	25	with	with	ADP
bam-8383	216	26	non	non	ADJ
bam-8383	216	27	-	-	ADJ
bam-8383	216	28	segmental	segmental	ADJ
bam-8383	216	29	generalized	generalized	ADJ
bam-8383	216	30	vitiligo	vitiligo	NOUN
bam-8383	216	31	.	.	PUNCT
bam-8383	217	1	int	int	PROPN
bam-8383	217	2	j	j	PROPN
bam-8383	217	3	mol	mol	ADP
bam-8383	217	4	sci	sci	PROPN
bam-8383	217	5	2017;18(12	2017;18(12	NUM
bam-8383	217	6	)	)	PUNCT
bam-8383	217	7	.	.	PUNCT
bam-8383	218	1	32	32	NUM
bam-8383	218	2	.	.	PUNCT
bam-8383	218	3	ezzedine	ezzedine	PROPN
bam-8383	219	1	k	k	NOUN
bam-8383	219	2	,	,	PUNCT
bam-8383	219	3	eleftheriadou	eleftheriadou	NOUN
bam-8383	219	4	v	v	NOUN
bam-8383	219	5	,	,	PUNCT
bam-8383	219	6	whitton	whitton	PROPN
bam-8383	219	7	m	m	PROPN
bam-8383	219	8	,	,	PUNCT
bam-8383	219	9	van	van	PROPN
bam-8383	219	10	geel	geel	PROPN
bam-8383	219	11	n.	n.	PROPN
bam-8383	219	12	vitiligo	vitiligo	PROPN
bam-8383	219	13	.	.	PUNCT
bam-8383	220	1	lancet	lancet	PROPN
bam-8383	220	2	2015;386(9988):74	2015;386(9988):74	PROPN
bam-8383	220	3	-	-	PUNCT
bam-8383	220	4	84	84	NUM
bam-8383	220	5	.	.	PUNCT
bam-8383	221	1	33	33	NUM
bam-8383	221	2	.	.	PUNCT
bam-8383	222	1	esmat	esmat	PROPN
bam-8383	222	2	s	s	PROPN
bam-8383	222	3	,	,	PUNCT
bam-8383	222	4	mostafa	mostafa	PROPN
bam-8383	222	5	w	w	PROPN
bam-8383	222	6	,	,	PUNCT
bam-8383	222	7	hegazy	hegazy	PROPN
bam-8383	222	8	ra	ra	PROPN
bam-8383	222	9	,	,	PUNCT
bam-8383	222	10	et	et	PROPN
bam-8383	222	11	al	al	PROPN
bam-8383	222	12	.	.	PUNCT
bam-8383	222	13	phototherapy	phototherapy	PROPN
bam-8383	222	14	:	:	PUNCT
bam-8383	222	15	the	the	DET
bam-8383	222	16	vitiligo	vitiligo	PROPN
bam-8383	222	17	management	management	NOUN
bam-8383	222	18	pillar	pillar	NOUN
bam-8383	222	19	.	.	PUNCT
bam-8383	223	1	clin	clin	PROPN
bam-8383	223	2	in	in	ADP
bam-8383	223	3	dermatol	dermatol	NOUN
bam-8383	223	4	.	.	PUNCT
bam-8383	224	1	2016;34:594	2016;34:594	NUM
bam-8383	224	2	-	-	SYM
bam-8383	224	3	602	602	NUM
bam-8383	224	4	.	.	PUNCT
bam-8383	225	1	34	34	NUM
bam-8383	225	2	.	.	PUNCT
bam-8383	226	1	bhardwaj	bhardwaj	PROPN
bam-8383	226	2	s	s	PROPN
bam-8383	226	3	,	,	PUNCT
bam-8383	226	4	rani	rani	PROPN
bam-8383	226	5	s	s	PROPN
bam-8383	226	6	,	,	PUNCT
bam-8383	226	7	srivastava	srivastava	PROPN
bam-8383	226	8	n	n	PROPN
bam-8383	226	9	,	,	PUNCT
bam-8383	226	10	et	et	PROPN
bam-8383	226	11	al	al	PROPN
bam-8383	226	12	.	.	PROPN
bam-8383	226	13	increased	increase	VERB
bam-8383	226	14	systemic	systemic	ADJ
bam-8383	226	15	and	and	CCONJ
bam-8383	226	16	epidermal	epidermal	ADJ
bam-8383	226	17	levels	level	NOUN
bam-8383	226	18	of	of	ADP
bam-8383	226	19	il-17a	il-17a	PROPN
bam-8383	226	20	and	and	CCONJ
bam-8383	226	21	il1beta	il1beta	ADV
bam-8383	226	22	promotes	promote	VERB
bam-8383	226	23	progression	progression	NOUN
bam-8383	226	24	of	of	ADP
bam-8383	226	25	non	non	ADJ
bam-8383	226	26	-	-	ADJ
bam-8383	226	27	segmental	segmental	ADJ
bam-8383	226	28	vitiligo	vitiligo	NOUN
bam-8383	226	29	.	.	PUNCT
bam-8383	227	1	cytokine	cytokine	VERB
bam-8383	227	2	2017;91:153	2017;91:153	NOUN
bam-8383	227	3	-	-	SYM
bam-8383	227	4	61	61	NUM
bam-8383	227	5	.	.	PUNCT
bam-8383	227	6	35	35	NUM
bam-8383	227	7	.	.	PUNCT
bam-8383	228	1	wang	wang	PROPN
bam-8383	228	2	s	s	PROPN
bam-8383	228	3	,	,	PUNCT
bam-8383	228	4	liu	liu	PROPN
bam-8383	228	5	d	d	PROPN
bam-8383	228	6	,	,	PUNCT
bam-8383	228	7	ning	ning	PROPN
bam-8383	228	8	w	w	PROPN
bam-8383	228	9	,	,	PUNCT
bam-8383	228	10	xu	xu	PROPN
bam-8383	228	11	a.	a.	PROPN
bam-8383	228	12	cytosolic	cytosolic	PROPN
bam-8383	228	13	dsdna	dsdna	PROPN
bam-8383	228	14	triggers	trigger	VERB
bam-8383	228	15	apoptosis	apoptosis	NOUN
bam-8383	228	16	and	and	CCONJ
bam-8383	228	17	pro	pro	ADJ
bam-8383	228	18	-	-	ADJ
bam-8383	228	19	inflammatory	inflammatory	ADJ
bam-8383	228	20	cytokine	cytokine	ADJ
bam-8383	228	21	production	production	NOUN
bam-8383	228	22	in	in	ADP
bam-8383	228	23	normal	normal	ADJ
bam-8383	228	24	human	human	ADJ
bam-8383	228	25	melanocytes	melanocyte	NOUN
bam-8383	228	26	.	.	PUNCT
bam-8383	229	1	exp	exp	NOUN
bam-8383	229	2	dermatol	dermatol	NOUN
bam-8383	229	3	2015;24:298	2015;24:298	NOUN
bam-8383	229	4	-	-	SYM
bam-8383	229	5	300	300	NUM
bam-8383	229	6	.	.	PUNCT
bam-8383	230	1	36	36	NUM
bam-8383	230	2	.	.	PUNCT
bam-8383	231	1	vaccaro	vaccaro	PROPN
bam-8383	231	2	m	m	PROPN
bam-8383	231	3	,	,	PUNCT
bam-8383	231	4	irrera	irrera	NOUN
bam-8383	231	5	n	n	CCONJ
bam-8383	231	6	,	,	PUNCT
bam-8383	231	7	cutroneo	cutroneo	VERB
bam-8383	231	8	g	g	PROPN
bam-8383	231	9	,	,	PUNCT
bam-8383	231	10	et	et	PROPN
bam-8383	231	11	al	al	PROPN
bam-8383	231	12	.	.	PROPN
bam-8383	231	13	differential	differential	ADJ
bam-8383	231	14	expression	expression	NOUN
bam-8383	231	15	of	of	ADP
bam-8383	231	16	nitric	nitric	ADJ
bam-8383	231	17	oxide	oxide	NOUN
bam-8383	231	18	synthase	synthase	NOUN
bam-8383	231	19	isoforms	isoform	VERB
bam-8383	231	20	nnos	nno	NOUN
bam-8383	231	21	and	and	CCONJ
bam-8383	231	22	inos	ino	NOUN
bam-8383	231	23	in	in	ADP
bam-8383	231	24	patients	patient	NOUN
bam-8383	231	25	with	with	ADP
bam-8383	231	26	non	non	ADJ
bam-8383	231	27	-	-	ADJ
bam-8383	231	28	segmental	segmental	ADJ
bam-8383	231	29	generalized	generalized	ADJ
bam-8383	231	30	vitiligo	vitiligo	NOUN
bam-8383	231	31	.	.	PUNCT
bam-8383	232	1	int	int	PROPN
bam-8383	232	2	j	j	PROPN
bam-8383	232	3	mol	mol	ADP
bam-8383	232	4	sci	sci	PROPN
bam-8383	232	5	2017;18:2533	2017;18:2533	NUM
bam-8383	232	6	.	.	PUNCT
bam-8383	233	1	37	37	NUM
bam-8383	233	2	.	.	PUNCT
bam-8383	234	1	al	al	PROPN
bam-8383	234	2	-	-	PUNCT
bam-8383	234	3	shobaili	shobaili	NOUN
bam-8383	234	4	ha	ha	INTJ
bam-8383	234	5	,	,	PUNCT
bam-8383	234	6	rasheed	rasheed	PROPN
bam-8383	234	7	z.	z.	PROPN
bam-8383	234	8	mitochondrial	mitochondrial	PROPN
bam-8383	234	9	dna	dna	PROPN
bam-8383	234	10	acquires	acquire	VERB
bam-8383	234	11	immunogenicity	immunogenicity	NOUN
bam-8383	234	12	on	on	ADP
bam-8383	234	13	exposure	exposure	NOUN
bam-8383	234	14	to	to	ADP
bam-8383	234	15	nitrosative	nitrosative	ADJ
bam-8383	234	16	stress	stress	NOUN
bam-8383	234	17	in	in	ADP
bam-8383	234	18	patients	patient	NOUN
bam-8383	234	19	with	with	ADP
bam-8383	234	20	vitiligo	vitiligo	PROPN
bam-8383	234	21	.	.	PUNCT
bam-8383	235	1	hum	hum	PROPN
bam-8383	235	2	immunol	immunol	PROPN
bam-8383	235	3	2014;75:153	2014;75:153	NOUN
bam-8383	235	4	-	-	SYM
bam-8383	235	5	61	61	NUM
bam-8383	235	6	.	.	PUNCT
bam-8383	236	1	38	38	NUM
bam-8383	236	2	.	.	PUNCT
bam-8383	236	3	yu	yu	PROPN
bam-8383	236	4	n	n	CCONJ
bam-8383	236	5	,	,	PUNCT
bam-8383	236	6	zhang	zhang	PROPN
bam-8383	236	7	s	s	PROPN
bam-8383	236	8	,	,	PUNCT
bam-8383	236	9	sun	sun	PROPN
bam-8383	236	10	t	t	PROPN
bam-8383	236	11	,	,	PUNCT
bam-8383	236	12	et	et	PROPN
bam-8383	236	13	al	al	PROPN
bam-8383	236	14	.	.	PROPN
bam-8383	236	15	double	double	ADJ
bam-8383	236	16	-	-	PUNCT
bam-8383	236	17	stranded	strand	VERB
bam-8383	236	18	rna	rna	NOUN
bam-8383	236	19	induces	induce	VERB
bam-8383	236	20	melanocyte	melanocyte	NOUN
bam-8383	236	21	death	death	NOUN
bam-8383	236	22	via	via	ADP
bam-8383	236	23	activation	activation	NOUN
bam-8383	236	24	of	of	ADP
bam-8383	236	25	toll	toll	NOUN
bam-8383	236	26	-	-	PUNCT
bam-8383	236	27	like	like	ADJ
bam-8383	236	28	receptor	receptor	NOUN
bam-8383	236	29	3	3	NUM
bam-8383	236	30	.	.	PUNCT
bam-8383	236	31	exp	exp	NOUN
bam-8383	236	32	dermatol	dermatol	NOUN
bam-8383	236	33	2011;20:134	2011;20:134	NOUN
bam-8383	236	34	-	-	SYM
bam-8383	236	35	9	9	NUM
bam-8383	236	36	.	.	NOUN
bam-8383	236	37	39	39	NUM
bam-8383	236	38	.	.	PUNCT
bam-8383	237	1	zhu	zhu	PROPN
bam-8383	237	2	y	y	PROPN
bam-8383	237	3	,	,	PUNCT
bam-8383	237	4	wang	wang	PROPN
bam-8383	237	5	s	s	PROPN
bam-8383	237	6	,	,	PUNCT
bam-8383	237	7	lin	lin	PROPN
bam-8383	237	8	f	f	PROPN
bam-8383	237	9	,	,	PUNCT
bam-8383	237	10	li	li	PROPN
bam-8383	237	11	q	q	PROPN
bam-8383	237	12	,	,	PUNCT
bam-8383	237	13	xu	xu	PROPN
bam-8383	237	14	a.	a.	NOUN
bam-8383	238	1	the	the	DET
bam-8383	238	2	therapeutic	therapeutic	ADJ
bam-8383	238	3	effects	effect	NOUN
bam-8383	238	4	of	of	ADP
bam-8383	238	5	egcg	egcg	NOUN
bam-8383	238	6	on	on	ADP
bam-8383	238	7	vitiligo	vitiligo	PROPN
bam-8383	238	8	.	.	PUNCT
bam-8383	239	1	fitoterapia	fitoterapia	PROPN
bam-8383	239	2	2014;99:243	2014;99:243	PROPN
bam-8383	239	3	-	-	SYM
bam-8383	239	4	51	51	NUM
bam-8383	239	5	.	.	PUNCT
bam-8383	239	6	40	40	NUM
bam-8383	239	7	.	.	PUNCT
bam-8383	240	1	mitra	mitra	PROPN
bam-8383	240	2	s	s	PROPN
bam-8383	240	3	,	,	PUNCT
bam-8383	240	4	de	de	PROPN
bam-8383	240	5	sarkar	sarkar	PROPN
bam-8383	240	6	s	s	PROPN
bam-8383	240	7	,	,	PUNCT
bam-8383	240	8	pradhan	pradhan	PROPN
bam-8383	240	9	a	a	PROPN
bam-8383	240	10	,	,	PUNCT
bam-8383	240	11	et	et	PROPN
bam-8383	240	12	al	al	PROPN
bam-8383	240	13	.	.	PUNCT
bam-8383	240	14	levels	level	NOUN
bam-8383	240	15	of	of	ADP
bam-8383	240	16	oxidative	oxidative	ADJ
bam-8383	240	17	damage	damage	NOUN
bam-8383	240	18	and	and	CCONJ
bam-8383	240	19	proinflammatory	proinflammatory	ADJ
bam-8383	240	20	cytokines	cytokine	NOUN
bam-8383	240	21	are	be	AUX
bam-8383	240	22	enhanced	enhance	VERB
bam-8383	240	23	in	in	ADP
bam-8383	240	24	patients	patient	NOUN
bam-8383	240	25	with	with	ADP
bam-8383	240	26	active	active	ADJ
bam-8383	240	27	vitiligo	vitiligo	NOUN
bam-8383	240	28	.	.	PUNCT
bam-8383	241	1	free	free	PROPN
bam-8383	241	2	rad	rad	PROPN
bam-8383	241	3	res	re	NOUN
bam-8383	241	4	2017;51:986	2017;51:986	NUM
bam-8383	241	5	-	-	SYM
bam-8383	241	6	94	94	NUM
bam-8383	241	7	.	.	PUNCT
bam-8383	242	1	41	41	NUM
bam-8383	242	2	.	.	PUNCT
bam-8383	242	3	tsiskarishvili	tsiskarishvili	PROPN
bam-8383	242	4	nv	nv	PROPN
bam-8383	242	5	,	,	PUNCT
bam-8383	242	6	katsitadze	katsitadze	VERB
bam-8383	242	7	a	a	PRON
bam-8383	242	8	,	,	PUNCT
bam-8383	242	9	tsiskarishvili	tsiskarishvili	NOUN
bam-8383	242	10	ni	ni	PROPN
bam-8383	242	11	,	,	PUNCT
bam-8383	242	12	chitanava	chitanava	PROPN
bam-8383	242	13	l.	l.	PROPN
bam-8383	242	14	peculiarities	peculiarity	NOUN
bam-8383	242	15	of	of	ADP
bam-8383	242	16	cytokine	cytokine	ADJ
bam-8383	242	17	status	status	NOUN
bam-8383	242	18	in	in	ADP
bam-8383	242	19	patients	patient	NOUN
bam-8383	242	20	with	with	ADP
bam-8383	242	21	vitiligo	vitiligo	NOUN
bam-8383	242	22	and	and	CCONJ
bam-8383	242	23	stress	stress	NOUN
bam-8383	242	24	in	in	ADP
bam-8383	242	25	anamnesis	anamnesis	NOUN
bam-8383	242	26	.	.	PUNCT
bam-8383	243	1	georgian	georgian	PROPN
bam-8383	243	2	medical	medical	PROPN
bam-8383	243	3	news	news	PROPN
bam-8383	243	4	2014;235:45	2014;235:45	NUM
bam-8383	243	5	-	-	SYM
bam-8383	243	6	8	8	NUM
bam-8383	243	7	.	.	X
bam-8383	243	8	42	42	NUM
bam-8383	243	9	.	.	PUNCT
bam-8383	244	1	moretti	moretti	PROPN
bam-8383	244	2	s	s	PROPN
bam-8383	244	3	,	,	PUNCT
bam-8383	244	4	fabbri	fabbri	NOUN
bam-8383	244	5	p	p	NOUN
bam-8383	244	6	,	,	PUNCT
bam-8383	244	7	baroni	baroni	PROPN
bam-8383	244	8	g	g	PROPN
bam-8383	244	9	,	,	PUNCT
bam-8383	244	10	et	et	PROPN
bam-8383	244	11	al	al	PROPN
bam-8383	244	12	.	.	PROPN
bam-8383	244	13	keratinocyte	keratinocyte	PROPN
bam-8383	244	14	dysfunction	dysfunction	NOUN
bam-8383	244	15	in	in	ADP
bam-8383	244	16	vitiligo	vitiligo	ADJ
bam-8383	244	17	epidermis	epidermis	NOUN
bam-8383	244	18	:	:	PUNCT
bam-8383	244	19	cytokine	cytokine	ADJ
bam-8383	244	20	microenvironment	microenvironment	NOUN
bam-8383	244	21	and	and	CCONJ
bam-8383	244	22	correlation	correlation	NOUN
bam-8383	244	23	to	to	ADP
bam-8383	244	24	keratinocyte	keratinocyte	NOUN
bam-8383	244	25	apoptosis	apoptosis	NOUN
bam-8383	244	26	.	.	PUNCT
bam-8383	245	1	histol	histol	PROPN
bam-8383	245	2	histopathol	histopathol	NOUN
bam-8383	245	3	2009;24:849	2009;24:849	PROPN
bam-8383	245	4	-	-	SYM
bam-8383	245	5	57	57	NUM
bam-8383	245	6	.	.	PUNCT
bam-8383	246	1	43	43	NUM
bam-8383	246	2	.	.	PUNCT
bam-8383	247	1	osanto	osanto	PROPN
bam-8383	247	2	s	s	PROPN
bam-8383	247	3	,	,	PUNCT
bam-8383	247	4	schiphorst	schiphorst	ADV
bam-8383	247	5	pp	pp	PROPN
bam-8383	247	6	,	,	PUNCT
bam-8383	248	1	weijl	weijl	PROPN
bam-8383	248	2	ni	ni	PROPN
bam-8383	248	3	,	,	PUNCT
bam-8383	248	4	et	et	PROPN
bam-8383	248	5	al	al	PROPN
bam-8383	248	6	.	.	PROPN
bam-8383	248	7	vaccination	vaccination	NOUN
bam-8383	248	8	of	of	ADP
bam-8383	248	9	melanoma	melanoma	NOUN
bam-8383	248	10	patients	patient	NOUN
bam-8383	248	11	with	with	ADP
bam-8383	248	12	an	an	DET
bam-8383	248	13	allogeneic	allogeneic	ADJ
bam-8383	248	14	,	,	PUNCT
bam-8383	248	15	genetically	genetically	ADV
bam-8383	248	16	modified	modify	VERB
bam-8383	248	17	interleukin	interleukin	NOUN
bam-8383	248	18	2producing	2producing	NUM
bam-8383	248	19	melanoma	melanoma	NOUN
bam-8383	248	20	cell	cell	NOUN
bam-8383	248	21	line	line	NOUN
bam-8383	248	22	.	.	PUNCT
bam-8383	249	1	hum	hum	PROPN
bam-8383	249	2	gene	gene	NOUN
bam-8383	249	3	ther	ther	PROPN
bam-8383	249	4	2000;11:739	2000;11:739	NUM
bam-8383	249	5	-	-	SYM
bam-8383	249	6	50	50	NUM
bam-8383	249	7	.	.	PUNCT
bam-8383	250	1	non	non	PROPN
bam-8383	250	2	co	co	PROPN
bam-8383	250	3	mmerc	mmerc	PROPN
bam-8383	250	4	ial	ial	PROPN
bam-8383	250	5	us	us	PROPN
bam-8383	251	1	e	e	NOUN
bam-8383	251	2	o	o	NOUN
bam-8383	251	3	nly	nly	ADV
bam-8383	251	4	inos	ino	NOUN
bam-8383	251	5	inhibition	inhibition	NOUN
bam-8383	251	6	for	for	ADP
bam-8383	251	7	vitiligo	vitiligo	PROPN
bam-8383	251	8	eur	eur	PROPN
bam-8383	251	9	j	j	PROPN
bam-8383	251	10	transl	transl	PROPN
bam-8383	251	11	myol	myol	ADV
bam-8383	251	12	29	29	NUM
bam-8383	251	13	(	(	PUNCT
bam-8383	251	14	3	3	NUM
bam-8383	251	15	):	):	PUNCT
bam-8383	251	16	251	251	NUM
bam-8383	251	17	-	-	SYM
bam-8383	251	18	260	260	NUM
bam-8383	251	19	,	,	PUNCT
bam-8383	251	20	2019	2019	NUM
bam-8383	251	21	259	259	NUM
bam-8383	251	22	44	44	NUM
bam-8383	251	23	.	.	PUNCT
bam-8383	252	1	lamkanfi	lamkanfi	PROPN
bam-8383	252	2	m	m	PROPN
bam-8383	252	3	,	,	PUNCT
bam-8383	252	4	vande	vande	VERB
bam-8383	252	5	walle	walle	PROPN
bam-8383	252	6	l	l	PROPN
bam-8383	252	7	,	,	PUNCT
bam-8383	252	8	kanneganti	kanneganti	ADJ
bam-8383	252	9	td	td	NOUN
bam-8383	252	10	.	.	PUNCT
bam-8383	252	11	deregulated	deregulate	VERB
bam-8383	252	12	inflammasome	inflammasome	NOUN
bam-8383	252	13	signaling	signal	VERB
bam-8383	252	14	in	in	ADP
bam-8383	252	15	disease	disease	NOUN
bam-8383	252	16	.	.	PUNCT
bam-8383	253	1	immunol	immunol	NOUN
bam-8383	253	2	rev	rev	PROPN
bam-8383	253	3	2011;243:163	2011;243:163	NUM
bam-8383	253	4	-	-	SYM
bam-8383	253	5	73	73	NUM
bam-8383	253	6	.	.	PUNCT
bam-8383	254	1	45	45	NUM
bam-8383	254	2	.	.	PUNCT
bam-8383	254	3	vaccaro	vaccaro	PROPN
bam-8383	254	4	m	m	PROPN
bam-8383	254	5	,	,	PUNCT
bam-8383	254	6	cannavo	cannavo	PROPN
bam-8383	254	7	sp	sp	NOUN
bam-8383	254	8	,	,	PUNCT
bam-8383	254	9	imbesi	imbesi	NOUN
bam-8383	254	10	s	s	PROPN
bam-8383	254	11	,	,	PUNCT
bam-8383	254	12	et	et	PROPN
bam-8383	254	13	al	al	PROPN
bam-8383	254	14	.	.	PROPN
bam-8383	254	15	increased	increase	VERB
bam-8383	254	16	serum	serum	NOUN
bam-8383	254	17	levels	level	NOUN
bam-8383	254	18	of	of	ADP
bam-8383	254	19	interleukin-23	interleukin-23	PROPN
bam-8383	254	20	circulating	circulate	VERB
bam-8383	254	21	in	in	ADP
bam-8383	254	22	patients	patient	NOUN
bam-8383	254	23	with	with	ADP
bam-8383	254	24	non	non	ADJ
bam-8383	254	25	-	-	ADJ
bam-8383	254	26	segmental	segmental	ADJ
bam-8383	254	27	generalized	generalized	ADJ
bam-8383	254	28	vitiligo	vitiligo	NOUN
bam-8383	254	29	.	.	PUNCT
bam-8383	255	1	int	int	NOUN
bam-8383	255	2	j	j	PROPN
bam-8383	255	3	dermatol	dermatol	NOUN
bam-8383	255	4	2015;54:672	2015;54:672	NUM
bam-8383	255	5	-	-	SYM
bam-8383	255	6	4	4	NUM
bam-8383	255	7	.	.	NOUN
bam-8383	255	8	46	46	NUM
bam-8383	255	9	.	.	PUNCT
bam-8383	256	1	behfarjam	behfarjam	NOUN
bam-8383	256	2	f	f	X
bam-8383	256	3	,	,	PUNCT
bam-8383	256	4	mansouri	mansouri	PROPN
bam-8383	256	5	p	p	PROPN
bam-8383	256	6	,	,	PUNCT
bam-8383	256	7	jadali	jadali	PROPN
bam-8383	256	8	z.	z.	PROPN
bam-8383	256	9	imbalance	imbalance	NOUN
bam-8383	256	10	of	of	ADP
bam-8383	256	11	peripheral	peripheral	ADJ
bam-8383	256	12	blood	blood	NOUN
bam-8383	256	13	t	t	PROPN
bam-8383	256	14	helper	helper	NOUN
bam-8383	256	15	type	type	VERB
bam-8383	256	16	17	17	NUM
bam-8383	256	17	responses	response	NOUN
bam-8383	256	18	in	in	ADP
bam-8383	256	19	patients	patient	NOUN
bam-8383	256	20	with	with	ADP
bam-8383	256	21	vitiligo	vitiligo	PROPN
bam-8383	256	22	.	.	PUNCT
bam-8383	257	1	iranian	iranian	PROPN
bam-8383	257	2	journal	journal	PROPN
bam-8383	257	3	of	of	ADP
bam-8383	257	4	allergy	allergy	PROPN
bam-8383	257	5	,	,	PUNCT
bam-8383	257	6	asthma	asthma	NOUN
bam-8383	257	7	,	,	PUNCT
bam-8383	257	8	and	and	CCONJ
bam-8383	257	9	immunology	immunology	NOUN
bam-8383	257	10	2018;17:171	2018;17:171	NOUN
bam-8383	257	11	-	-	SYM
bam-8383	257	12	8	8	NUM
bam-8383	257	13	.	.	PUNCT
bam-8383	257	14	47	47	NUM
bam-8383	257	15	.	.	PUNCT
bam-8383	258	1	esmaeili	esmaeili	PROPN
bam-8383	258	2	b	b	PROPN
bam-8383	258	3	,	,	PUNCT
bam-8383	258	4	rezaee	rezaee	PROPN
bam-8383	258	5	sa	sa	PROPN
bam-8383	258	6	,	,	PUNCT
bam-8383	258	7	layegh	layegh	VERB
bam-8383	258	8	p	p	X
bam-8383	258	9	,	,	PUNCT
bam-8383	258	10	et	et	PROPN
bam-8383	258	11	al	al	PROPN
bam-8383	258	12	.	.	PUNCT
bam-8383	258	13	expression	expression	NOUN
bam-8383	258	14	of	of	ADP
bam-8383	258	15	il-17	il-17	NUM
bam-8383	258	16	and	and	CCONJ
bam-8383	258	17	cox2	cox2	NOUN
bam-8383	258	18	gene	gene	NOUN
bam-8383	258	19	in	in	ADP
bam-8383	258	20	peripheral	peripheral	ADJ
bam-8383	258	21	blood	blood	NOUN
bam-8383	258	22	leukocytes	leukocyte	NOUN
bam-8383	258	23	of	of	ADP
bam-8383	258	24	vitiligo	vitiligo	ADJ
bam-8383	258	25	patients	patient	NOUN
bam-8383	258	26	.	.	PUNCT
bam-8383	259	1	iranian	iranian	ADJ
bam-8383	259	2	journal	journal	PROPN
bam-8383	259	3	of	of	ADP
bam-8383	259	4	allergy	allergy	PROPN
bam-8383	259	5	,	,	PUNCT
bam-8383	259	6	asthma	asthma	NOUN
bam-8383	259	7	,	,	PUNCT
bam-8383	259	8	and	and	CCONJ
bam-8383	259	9	immunology	immunology	NOUN
bam-8383	259	10	.	.	PUNCT
bam-8383	260	1	2011;10:81	2011;10:81	NUM
bam-8383	260	2	-	-	SYM
bam-8383	260	3	9	9	NUM
bam-8383	260	4	.	.	NUM
bam-8383	260	5	48	48	NUM
bam-8383	260	6	.	.	PUNCT
bam-8383	261	1	strassner	strassner	PROPN
bam-8383	261	2	jp	jp	PROPN
bam-8383	261	3	,	,	PUNCT
bam-8383	261	4	rashighi	rashighi	PROPN
bam-8383	261	5	m	m	PROPN
bam-8383	261	6	,	,	PUNCT
bam-8383	261	7	ahmed	ahmed	PROPN
bam-8383	261	8	refat	refat	PROPN
bam-8383	261	9	m	m	PROPN
bam-8383	261	10	,	,	PUNCT
bam-8383	261	11	et	et	PROPN
bam-8383	261	12	al	al	PROPN
bam-8383	261	13	.	.	PUNCT
bam-8383	261	14	suction	suction	NOUN
bam-8383	261	15	blistering	blister	VERB
bam-8383	261	16	the	the	DET
bam-8383	261	17	lesional	lesional	ADJ
bam-8383	261	18	skin	skin	NOUN
bam-8383	261	19	of	of	ADP
bam-8383	261	20	vitiligo	vitiligo	ADJ
bam-8383	261	21	patients	patient	NOUN
bam-8383	261	22	reveals	reveal	VERB
bam-8383	261	23	useful	useful	ADJ
bam-8383	261	24	biomarkers	biomarker	NOUN
bam-8383	261	25	of	of	ADP
bam-8383	261	26	disease	disease	NOUN
bam-8383	261	27	activity	activity	NOUN
bam-8383	261	28	.	.	PUNCT
bam-8383	262	1	j	j	PROPN
bam-8383	262	2	am	be	AUX
bam-8383	262	3	acad	acad	ADJ
bam-8383	262	4	dermatol	dermatol	NOUN
bam-8383	262	5	2017;76:847	2017;76:847	PROPN
bam-8383	262	6	-	-	SYM
bam-8383	262	7	55	55	NUM
bam-8383	262	8	.	.	PUNCT
bam-8383	263	1	49	49	NUM
bam-8383	263	2	.	.	PUNCT
bam-8383	264	1	pimparkar	pimparkar	PROPN
bam-8383	264	2	bd	bd	PROPN
bam-8383	264	3	,	,	PUNCT
bam-8383	264	4	bhave	bhave	PROPN
bam-8383	264	5	a.	a.	NOUN
bam-8383	264	6	arsenicosis	arsenicosis	PROPN
bam-8383	264	7	:	:	PUNCT
bam-8383	264	8	review	review	NOUN
bam-8383	264	9	of	of	ADP
bam-8383	264	10	recent	recent	ADJ
bam-8383	264	11	advances	advance	NOUN
bam-8383	264	12	.	.	PUNCT
bam-8383	265	1	the	the	DET
bam-8383	265	2	journal	journal	NOUN
bam-8383	265	3	of	of	ADP
bam-8383	265	4	the	the	DET
bam-8383	265	5	association	association	NOUN
bam-8383	265	6	of	of	ADP
bam-8383	265	7	physicians	physician	NOUN
bam-8383	265	8	of	of	ADP
bam-8383	265	9	india	india	PROPN
bam-8383	265	10	2010;58:617	2010;58:617	PROPN
bam-8383	265	11	-	-	PROPN
bam-8383	265	12	24	24	NUM
bam-8383	265	13	.	.	PUNCT
bam-8383	265	14	50	50	NUM
bam-8383	265	15	.	.	PUNCT
bam-8383	266	1	paulos	paulos	PROPN
bam-8383	266	2	cm	cm	PROPN
bam-8383	266	3	,	,	PUNCT
bam-8383	266	4	wrzesinski	wrzesinski	PROPN
bam-8383	266	5	c	c	NOUN
bam-8383	266	6	,	,	PUNCT
bam-8383	266	7	kaiser	kaiser	PROPN
bam-8383	266	8	a	a	PROPN
bam-8383	266	9	,	,	PUNCT
bam-8383	266	10	et	et	PROPN
bam-8383	266	11	al	al	PROPN
bam-8383	266	12	.	.	PUNCT
bam-8383	266	13	microbial	microbial	ADJ
bam-8383	266	14	translocation	translocation	NOUN
bam-8383	266	15	augments	augment	VERB
bam-8383	266	16	the	the	DET
bam-8383	266	17	function	function	NOUN
bam-8383	266	18	of	of	ADP
bam-8383	266	19	adoptively	adoptively	ADV
bam-8383	266	20	transferred	transfer	VERB
bam-8383	266	21	self	self	NOUN
bam-8383	266	22	/	/	SYM
bam-8383	266	23	tumor	tumor	NOUN
bam-8383	266	24	-	-	PUNCT
bam-8383	266	25	specific	specific	ADJ
bam-8383	266	26	cd8	cd8	PROPN
bam-8383	266	27	+	+	PROPN
bam-8383	266	28	t	t	NOUN
bam-8383	266	29	cells	cell	NOUN
bam-8383	266	30	via	via	ADP
bam-8383	266	31	tlr4	tlr4	NOUN
bam-8383	266	32	signaling	signal	VERB
bam-8383	266	33	.	.	PUNCT
bam-8383	267	1	j	j	PROPN
bam-8383	267	2	clin	clin	PROPN
bam-8383	267	3	invest	invest	VERB
bam-8383	267	4	2007;117:2197	2007;117:2197	NUM
bam-8383	267	5	-	-	SYM
bam-8383	267	6	204	204	NUM
bam-8383	267	7	.	.	PUNCT
bam-8383	268	1	51	51	NUM
bam-8383	268	2	.	.	PUNCT
bam-8383	269	1	barygina	barygina	PROPN
bam-8383	269	2	v	v	NOUN
bam-8383	269	3	,	,	PUNCT
bam-8383	269	4	becatti	becatti	PROPN
bam-8383	269	5	m	m	PROPN
bam-8383	269	6	,	,	PUNCT
bam-8383	269	7	lotti	lotti	PROPN
bam-8383	269	8	t	t	PROPN
bam-8383	269	9	,	,	PUNCT
bam-8383	270	1	et	et	PROPN
bam-8383	270	2	al	al	PROPN
bam-8383	270	3	.	.	PUNCT
bam-8383	270	4	treatment	treatment	NOUN
bam-8383	270	5	with	with	ADP
bam-8383	270	6	low	low	ADJ
bam-8383	270	7	-	-	PUNCT
bam-8383	270	8	dose	dose	NOUN
bam-8383	270	9	cytokines	cytokine	NOUN
bam-8383	270	10	reduces	reduce	VERB
bam-8383	270	11	oxidativemediated	oxidativemediate	VERB
bam-8383	270	12	injury	injury	NOUN
bam-8383	270	13	in	in	ADP
bam-8383	270	14	perilesional	perilesional	ADJ
bam-8383	270	15	keratinocytes	keratinocyte	NOUN
bam-8383	270	16	from	from	ADP
bam-8383	270	17	vitiligo	vitiligo	ADJ
bam-8383	270	18	skin	skin	NOUN
bam-8383	270	19	.	.	PUNCT
bam-8383	271	1	j	j	PROPN
bam-8383	271	2	dermatol	dermatol	NOUN
bam-8383	271	3	sci	sci	PROPN
bam-8383	271	4	2015;79:163	2015;79:163	PROPN
bam-8383	271	5	-	-	NOUN
bam-8383	271	6	70	70	NUM
bam-8383	271	7	.	.	PUNCT
bam-8383	271	8	52	52	NUM
bam-8383	271	9	.	.	PUNCT
bam-8383	272	1	yang	yang	PROPN
bam-8383	272	2	y	y	PROPN
bam-8383	272	3	,	,	PUNCT
bam-8383	272	4	li	li	PROPN
bam-8383	272	5	s	s	PROPN
bam-8383	272	6	,	,	PUNCT
bam-8383	272	7	zhu	zhu	PROPN
bam-8383	272	8	g	g	PROPN
bam-8383	272	9	,	,	PUNCT
bam-8383	272	10	et	et	PROPN
bam-8383	272	11	al	al	PROPN
bam-8383	272	12	.	.	PUNCT
bam-8383	273	1	a	a	DET
bam-8383	273	2	similar	similar	ADJ
bam-8383	273	3	local	local	ADJ
bam-8383	273	4	immune	immune	ADJ
bam-8383	273	5	and	and	CCONJ
bam-8383	273	6	oxidative	oxidative	ADJ
bam-8383	273	7	stress	stress	NOUN
bam-8383	273	8	phenotype	phenotype	NOUN
bam-8383	273	9	in	in	ADP
bam-8383	273	10	vitiligo	vitiligo	NOUN
bam-8383	273	11	and	and	CCONJ
bam-8383	273	12	halo	halo	NOUN
bam-8383	273	13	nevus	nevus	NOUN
bam-8383	273	14	.	.	PUNCT
bam-8383	274	1	j	j	PROPN
bam-8383	274	2	dermatol	dermatol	NOUN
bam-8383	274	3	sci	sci	PROPN
bam-8383	274	4	2017;87:50	2017;87:50	NUM
bam-8383	274	5	-	-	SYM
bam-8383	274	6	9	9	NUM
bam-8383	274	7	.	.	X
bam-8383	274	8	53	53	NUM
bam-8383	274	9	.	.	PUNCT
bam-8383	274	10	moreira	moreira	PROPN
bam-8383	274	11	cg	cg	PROPN
bam-8383	274	12	,	,	PUNCT
bam-8383	274	13	carrenho	carrenho	NOUN
bam-8383	274	14	lz	lz	PROPN
bam-8383	274	15	,	,	PUNCT
bam-8383	274	16	pawloski	pawloski	PROPN
bam-8383	274	17	pl	pl	PROPN
bam-8383	274	18	,	,	PUNCT
bam-8383	274	19	et	et	PROPN
bam-8383	274	20	al	al	PROPN
bam-8383	274	21	.	.	PUNCT
bam-8383	275	1	preclinical	preclinical	ADJ
bam-8383	275	2	evidences	evidence	NOUN
bam-8383	275	3	of	of	ADP
bam-8383	275	4	pyrostegia	pyrostegia	ADJ
bam-8383	275	5	venusta	venusta	NOUN
bam-8383	275	6	in	in	ADP
bam-8383	275	7	the	the	DET
bam-8383	275	8	treatment	treatment	NOUN
bam-8383	275	9	of	of	ADP
bam-8383	275	10	vitiligo	vitiligo	NOUN
bam-8383	275	11	.	.	PUNCT
bam-8383	276	1	j	j	PROPN
bam-8383	276	2	ethnopharm	ethnopharm	PROPN
bam-8383	276	3	2015;168:31525	2015;168:31525	NUM
bam-8383	276	4	.	.	PUNCT
bam-8383	277	1	54	54	NUM
bam-8383	277	2	.	.	PUNCT
bam-8383	278	1	roy	roy	PROPN
bam-8383	278	2	p	p	PROPN
bam-8383	278	3	,	,	PUNCT
bam-8383	278	4	amdekar	amdekar	PROPN
bam-8383	278	5	s	s	PROPN
bam-8383	278	6	,	,	PUNCT
bam-8383	278	7	kumar	kumar	PROPN
bam-8383	278	8	a	a	PROPN
bam-8383	278	9	,	,	PUNCT
bam-8383	278	10	et	et	PROPN
bam-8383	278	11	al	al	PROPN
bam-8383	278	12	.	.	PROPN
bam-8383	279	1	in	in	ADP
bam-8383	279	2	vivo	vivo	NOUN
bam-8383	279	3	antioxidative	antioxidative	ADJ
bam-8383	279	4	property	property	NOUN
bam-8383	279	5	,	,	PUNCT
bam-8383	279	6	antimicrobial	antimicrobial	ADJ
bam-8383	279	7	and	and	CCONJ
bam-8383	279	8	wound	wound	ADJ
bam-8383	279	9	healing	healing	NOUN
bam-8383	279	10	activity	activity	NOUN
bam-8383	279	11	of	of	ADP
bam-8383	279	12	flower	flower	NOUN
bam-8383	279	13	extracts	extract	NOUN
bam-8383	279	14	of	of	ADP
bam-8383	279	15	pyrostegia	pyrostegia	ADJ
bam-8383	279	16	venusta	venusta	NOUN
bam-8383	279	17	(	(	PUNCT
bam-8383	279	18	ker	ker	PROPN
bam-8383	279	19	gawl	gawl	PROPN
bam-8383	279	20	)	)	PUNCT
bam-8383	279	21	miers	miers	PROPN
bam-8383	279	22	.	.	PUNCT
bam-8383	280	1	j	j	PROPN
bam-8383	280	2	ethnopharma	ethnopharma	PROPN
bam-8383	280	3	2012;140:186	2012;140:186	NUM
bam-8383	280	4	-	-	SYM
bam-8383	280	5	92	92	NUM
bam-8383	280	6	.	.	PUNCT
bam-8383	281	1	55	55	NUM
bam-8383	281	2	.	.	PUNCT
bam-8383	282	1	garzorz	garzorz	NOUN
bam-8383	282	2	n	n	CCONJ
bam-8383	282	3	,	,	PUNCT
bam-8383	282	4	alsisi	alsisi	PROPN
bam-8383	282	5	m	m	PROPN
bam-8383	282	6	,	,	PUNCT
bam-8383	282	7	todorova	todorova	PRON
bam-8383	282	8	a	a	X
bam-8383	282	9	,	,	PUNCT
bam-8383	282	10	et	et	PROPN
bam-8383	282	11	al	al	PROPN
bam-8383	282	12	.	.	PUNCT
bam-8383	283	1	dissecting	dissect	VERB
bam-8383	283	2	susceptibility	susceptibility	NOUN
bam-8383	283	3	from	from	ADP
bam-8383	283	4	exogenous	exogenous	ADJ
bam-8383	283	5	triggers	trigger	NOUN
bam-8383	283	6	:	:	PUNCT
bam-8383	283	7	the	the	DET
bam-8383	283	8	model	model	NOUN
bam-8383	283	9	of	of	ADP
bam-8383	283	10	alopecia	alopecia	NOUN
bam-8383	283	11	areata	areata	ADJ
bam-8383	283	12	and	and	CCONJ
bam-8383	283	13	associated	associate	VERB
bam-8383	283	14	inflammatory	inflammatory	ADJ
bam-8383	283	15	skin	skin	NOUN
bam-8383	283	16	diseases	disease	NOUN
bam-8383	283	17	.	.	PUNCT
bam-8383	284	1	j	j	PROPN
bam-8383	284	2	eur	eur	PROPN
bam-8383	284	3	acad	acad	PROPN
bam-8383	284	4	dermatol	dermatol	NOUN
bam-8383	284	5	venereol	venereol	NOUN
bam-8383	284	6	2015;29:2429	2015;29:2429	PROPN
bam-8383	284	7	-	-	SYM
bam-8383	284	8	35	35	NUM
bam-8383	284	9	.	.	PUNCT
bam-8383	285	1	56	56	NUM
bam-8383	285	2	.	.	PUNCT
bam-8383	286	1	kim	kim	PROPN
bam-8383	286	2	eh	eh	PROPN
bam-8383	286	3	,	,	PUNCT
bam-8383	286	4	gasper	gasper	PROPN
bam-8383	286	5	dj	dj	PROPN
bam-8383	286	6	,	,	PUNCT
bam-8383	286	7	lee	lee	PROPN
bam-8383	286	8	sh	sh	PROPN
bam-8383	286	9	,	,	PUNCT
bam-8383	286	10	plisch	plisch	INTJ
bam-8383	286	11	eh	eh	INTJ
bam-8383	286	12	,	,	PUNCT
bam-8383	286	13	svaren	svaren	PROPN
bam-8383	286	14	j	j	PROPN
bam-8383	286	15	,	,	PUNCT
bam-8383	286	16	suresh	suresh	PROPN
bam-8383	286	17	m.	m.	PROPN
bam-8383	286	18	bach2	bach2	PROPN
bam-8383	286	19	regulates	regulate	VERB
bam-8383	286	20	homeostasis	homeostasis	NOUN
bam-8383	286	21	of	of	ADP
bam-8383	286	22	foxp3	foxp3	NOUN
bam-8383	286	23	+	+	X
bam-8383	286	24	regulatory	regulatory	ADJ
bam-8383	286	25	t	t	NOUN
bam-8383	286	26	cells	cell	NOUN
bam-8383	286	27	and	and	CCONJ
bam-8383	286	28	protects	protect	VERB
bam-8383	286	29	against	against	ADP
bam-8383	286	30	fatal	fatal	ADJ
bam-8383	286	31	lung	lung	NOUN
bam-8383	286	32	disease	disease	NOUN
bam-8383	286	33	in	in	ADP
bam-8383	286	34	mice	mouse	NOUN
bam-8383	286	35	.	.	PUNCT
bam-8383	287	1	j	j	PROPN
bam-8383	287	2	immunol	immunol	PROPN
bam-8383	287	3	(	(	PUNCT
bam-8383	287	4	baltimore	baltimore	PROPN
bam-8383	287	5	,	,	PUNCT
bam-8383	287	6	md	md	PROPN
bam-8383	287	7	:	:	PUNCT
bam-8383	287	8	1950	1950	NUM
bam-8383	287	9	)	)	PUNCT
bam-8383	287	10	.	.	PUNCT
bam-8383	288	1	2014;192:985	2014;192:985	NUM
bam-8383	288	2	-	-	SYM
bam-8383	288	3	95	95	NUM
bam-8383	288	4	.	.	PUNCT
bam-8383	289	1	57	57	NUM
bam-8383	289	2	.	.	PUNCT
bam-8383	290	1	li	li	PROPN
bam-8383	290	2	yl	yl	PROPN
bam-8383	290	3	,	,	PUNCT
bam-8383	290	4	yu	yu	PROPN
bam-8383	290	5	cl	cl	PROPN
bam-8383	290	6	,	,	PUNCT
bam-8383	290	7	yu	yu	PROPN
bam-8383	290	8	hs	hs	PROPN
bam-8383	290	9	.	.	PROPN
bam-8383	291	1	igg	igg	PROPN
bam-8383	291	2	anti	anti	ADJ
bam-8383	291	3	-	-	ADJ
bam-8383	291	4	melanocyte	melanocyte	ADJ
bam-8383	291	5	antibodies	antibody	NOUN
bam-8383	291	6	purified	purify	VERB
bam-8383	291	7	from	from	ADP
bam-8383	291	8	patients	patient	NOUN
bam-8383	291	9	with	with	ADP
bam-8383	291	10	active	active	ADJ
bam-8383	291	11	vitiligo	vitiligo	NOUN
bam-8383	291	12	induce	induce	VERB
bam-8383	291	13	hla	hla	PROPN
bam-8383	291	14	-	-	PUNCT
bam-8383	291	15	dr	dr	PROPN
bam-8383	291	16	and	and	CCONJ
bam-8383	291	17	intercellular	intercellular	ADJ
bam-8383	291	18	adhesion	adhesion	NOUN
bam-8383	291	19	molecule-1	molecule-1	NOUN
bam-8383	291	20	expression	expression	NOUN
bam-8383	291	21	and	and	CCONJ
bam-8383	291	22	an	an	DET
bam-8383	291	23	increase	increase	NOUN
bam-8383	291	24	in	in	ADP
bam-8383	291	25	interleukin-8	interleukin-8	NUM
bam-8383	291	26	release	release	NOUN
bam-8383	291	27	by	by	ADP
bam-8383	291	28	melanocytes	melanocyte	NOUN
bam-8383	291	29	.	.	PUNCT
bam-8383	292	1	j	j	PROPN
bam-8383	292	2	inv	inv	VERB
bam-8383	292	3	dermatol	dermatol	NOUN
bam-8383	292	4	2000;115:969	2000;115:969	NOUN
bam-8383	292	5	-	-	SYM
bam-8383	292	6	73	73	NUM
bam-8383	292	7	.	.	PUNCT
bam-8383	293	1	58	58	NUM
bam-8383	293	2	.	.	PUNCT
bam-8383	294	1	morelli	morelli	PROPN
bam-8383	294	2	jg	jg	PROPN
bam-8383	294	3	,	,	PUNCT
bam-8383	294	4	kincannon	kincannon	PROPN
bam-8383	294	5	j	j	PROPN
bam-8383	294	6	,	,	PUNCT
bam-8383	294	7	yohn	yohn	PROPN
bam-8383	294	8	jj	jj	PROPN
bam-8383	294	9	,	,	PUNCT
bam-8383	294	10	et	et	PROPN
bam-8383	294	11	al	al	PROPN
bam-8383	294	12	.	.	PUNCT
bam-8383	295	1	leukotriene	leukotriene	PROPN
bam-8383	295	2	c4	c4	PROPN
bam-8383	295	3	and	and	CCONJ
bam-8383	295	4	tgf	tgf	PROPN
bam-8383	295	5	-	-	PUNCT
bam-8383	295	6	alpha	alpha	NOUN
bam-8383	295	7	are	be	AUX
bam-8383	295	8	stimulators	stimulator	NOUN
bam-8383	295	9	of	of	ADP
bam-8383	295	10	human	human	ADJ
bam-8383	295	11	melanocyte	melanocyte	NOUN
bam-8383	295	12	migration	migration	NOUN
bam-8383	295	13	in	in	ADP
bam-8383	295	14	vitro	vitro	X
bam-8383	295	15	.	.	PUNCT
bam-8383	296	1	j	j	PROPN
bam-8383	296	2	inv	inv	VERB
bam-8383	296	3	dermatol	dermatol	NOUN
bam-8383	296	4	1992;98:290	1992;98:290	NUM
bam-8383	296	5	-	-	SYM
bam-8383	296	6	5	5	NUM
bam-8383	296	7	.	.	X
bam-8383	296	8	59	59	NUM
bam-8383	296	9	.	.	PUNCT
bam-8383	297	1	redondo	redondo	PROPN
bam-8383	297	2	p	p	PROPN
bam-8383	297	3	,	,	PUNCT
bam-8383	297	4	del	del	PROPN
bam-8383	297	5	olmo	olmo	PROPN
bam-8383	297	6	j	j	PROPN
bam-8383	297	7	,	,	PUNCT
bam-8383	297	8	lopez	lopez	PROPN
bam-8383	297	9	-	-	PUNCT
bam-8383	297	10	diaz	diaz	PROPN
bam-8383	297	11	de	de	PROPN
bam-8383	297	12	cerio	cerio	PROPN
bam-8383	297	13	a	a	PROPN
bam-8383	297	14	,	,	PUNCT
bam-8383	297	15	et	et	PROPN
bam-8383	297	16	al	al	PROPN
bam-8383	297	17	.	.	PUNCT
bam-8383	298	1	imiquimod	imiquimod	PROPN
bam-8383	298	2	enhances	enhance	VERB
bam-8383	298	3	the	the	DET
bam-8383	298	4	systemic	systemic	ADJ
bam-8383	298	5	immunity	immunity	NOUN
bam-8383	298	6	attained	attain	VERB
bam-8383	298	7	by	by	ADP
bam-8383	298	8	local	local	ADJ
bam-8383	298	9	cryosurgery	cryosurgery	NOUN
bam-8383	298	10	destruction	destruction	NOUN
bam-8383	298	11	of	of	ADP
bam-8383	298	12	melanoma	melanoma	NOUN
bam-8383	298	13	lesions	lesion	NOUN
bam-8383	298	14	.	.	PUNCT
bam-8383	299	1	j	j	PROPN
bam-8383	299	2	inv	inv	VERB
bam-8383	299	3	dermatol	dermatol	NOUN
bam-8383	299	4	2007;127:167380	2007;127:167380	X
bam-8383	299	5	.	.	PUNCT
bam-8383	300	1	60	60	NUM
bam-8383	300	2	.	.	X
bam-8383	301	1	yu	yu	PROPN
bam-8383	301	2	hs	hs	PROPN
bam-8383	301	3	,	,	PUNCT
bam-8383	301	4	chang	chang	PROPN
bam-8383	301	5	kl	kl	PROPN
bam-8383	301	6	,	,	PUNCT
bam-8383	301	7	yu	yu	PROPN
bam-8383	301	8	cl	cl	PROPN
bam-8383	301	9	,	,	PUNCT
bam-8383	301	10	et	et	PROPN
bam-8383	301	11	al	al	PROPN
bam-8383	301	12	.	.	PUNCT
bam-8383	301	13	alterations	alteration	NOUN
bam-8383	301	14	in	in	ADP
bam-8383	301	15	il6	il6	NOUN
bam-8383	301	16	,	,	PUNCT
bam-8383	301	17	il-8	il-8	VERB
bam-8383	301	18	,	,	PUNCT
bam-8383	301	19	gm	gm	PROPN
bam-8383	301	20	-	-	PUNCT
bam-8383	301	21	csf	csf	PROPN
bam-8383	301	22	,	,	PUNCT
bam-8383	301	23	tnf	tnf	PROPN
bam-8383	301	24	-	-	PUNCT
bam-8383	301	25	alpha	alpha	NOUN
bam-8383	301	26	,	,	PUNCT
bam-8383	301	27	and	and	CCONJ
bam-8383	301	28	ifn	ifn	PROPN
bam-8383	301	29	-	-	PUNCT
bam-8383	301	30	gamma	gamma	NOUN
bam-8383	301	31	release	release	NOUN
bam-8383	301	32	by	by	ADP
bam-8383	301	33	peripheral	peripheral	ADJ
bam-8383	301	34	mononuclear	mononuclear	ADJ
bam-8383	301	35	cells	cell	NOUN
bam-8383	301	36	in	in	ADP
bam-8383	301	37	patients	patient	NOUN
bam-8383	301	38	with	with	ADP
bam-8383	301	39	active	active	ADJ
bam-8383	301	40	vitiligo	vitiligo	NOUN
bam-8383	301	41	.	.	PUNCT
bam-8383	302	1	j	j	PROPN
bam-8383	302	2	inv	inv	VERB
bam-8383	302	3	dermatol	dermatol	NOUN
bam-8383	302	4	1997;108:5279	1997;108:5279	NUM
bam-8383	302	5	.	.	PUNCT
bam-8383	302	6	61	61	NUM
bam-8383	302	7	.	.	PUNCT
bam-8383	303	1	richmond	richmond	PROPN
bam-8383	303	2	jm	jm	PROPN
bam-8383	303	3	,	,	PUNCT
bam-8383	303	4	bangari	bangari	ADJ
bam-8383	303	5	ds	ds	X
bam-8383	303	6	,	,	PUNCT
bam-8383	303	7	essien	essien	PROPN
bam-8383	303	8	ki	ki	PROPN
bam-8383	303	9	,	,	PUNCT
bam-8383	303	10	et	et	PROPN
bam-8383	303	11	al	al	PROPN
bam-8383	303	12	.	.	PUNCT
bam-8383	303	13	keratinocyte	keratinocyte	NOUN
bam-8383	303	14	-	-	PUNCT
bam-8383	303	15	derived	derive	VERB
bam-8383	303	16	chemokines	chemokine	NOUN
bam-8383	303	17	orchestrate	orchestrate	VERB
bam-8383	303	18	tcell	tcell	NOUN
bam-8383	303	19	positioning	positioning	NOUN
bam-8383	303	20	in	in	ADP
bam-8383	303	21	the	the	DET
bam-8383	303	22	epidermis	epidermis	NOUN
bam-8383	303	23	during	during	ADP
bam-8383	303	24	vitiligo	vitiligo	NOUN
bam-8383	303	25	and	and	CCONJ
bam-8383	303	26	may	may	AUX
bam-8383	303	27	serve	serve	VERB
bam-8383	303	28	as	as	ADP
bam-8383	303	29	biomarkers	biomarker	NOUN
bam-8383	303	30	of	of	ADP
bam-8383	303	31	disease	disease	NOUN
bam-8383	303	32	.	.	PUNCT
bam-8383	304	1	the	the	DET
bam-8383	304	2	j	j	PROPN
bam-8383	304	3	inv	inv	VERB
bam-8383	304	4	dermatol	dermatol	NOUN
bam-8383	304	5	2017;137:350	2017;137:350	NUM
bam-8383	304	6	-	-	SYM
bam-8383	304	7	8	8	NUM
bam-8383	304	8	.	.	NUM
bam-8383	304	9	62	62	NUM
bam-8383	304	10	.	.	PUNCT
bam-8383	305	1	lipson	lipson	PROPN
bam-8383	305	2	ej	ej	PROPN
bam-8383	305	3	,	,	PUNCT
bam-8383	305	4	sharfman	sharfman	PROPN
bam-8383	305	5	wh	wh	PROPN
bam-8383	305	6	,	,	PUNCT
bam-8383	305	7	chen	chen	PROPN
bam-8383	305	8	s	s	PROPN
bam-8383	305	9	,	,	PUNCT
bam-8383	305	10	et	et	PROPN
bam-8383	305	11	al	al	PROPN
bam-8383	305	12	.	.	PROPN
bam-8383	305	13	safety	safety	PROPN
bam-8383	305	14	and	and	CCONJ
bam-8383	305	15	immunologic	immunologic	PROPN
bam-8383	305	16	correlates	correlate	VERB
bam-8383	305	17	of	of	ADP
bam-8383	305	18	melanoma	melanoma	NOUN
bam-8383	305	19	gvax	gvax	NOUN
bam-8383	305	20	,	,	PUNCT
bam-8383	305	21	a	a	DET
bam-8383	305	22	gm	gm	NOUN
bam-8383	305	23	-	-	PUNCT
bam-8383	305	24	csf	csf	ADJ
bam-8383	305	25	secreting	secrete	VERB
bam-8383	305	26	allogeneic	allogeneic	ADJ
bam-8383	305	27	melanoma	melanoma	NOUN
bam-8383	305	28	cell	cell	NOUN
bam-8383	305	29	vaccine	vaccine	NOUN
bam-8383	305	30	administered	administer	VERB
bam-8383	305	31	in	in	ADP
bam-8383	305	32	the	the	DET
bam-8383	305	33	adjuvant	adjuvant	ADJ
bam-8383	305	34	setting	setting	NOUN
bam-8383	305	35	.	.	PUNCT
bam-8383	306	1	j	j	PROPN
bam-8383	306	2	transl	transl	PROPN
bam-8383	306	3	med	me	VERB
bam-8383	306	4	2015;13:214	2015;13:214	NUM
bam-8383	306	5	.	.	PUNCT
bam-8383	307	1	63	63	NUM
bam-8383	307	2	.	.	PUNCT
bam-8383	308	1	speeckaert	speeckaert	PROPN
bam-8383	308	2	r	r	PROPN
bam-8383	308	3	,	,	PUNCT
bam-8383	308	4	lambert	lambert	PROPN
bam-8383	308	5	j	j	PROPN
bam-8383	308	6	,	,	PUNCT
bam-8383	308	7	van	van	PROPN
bam-8383	308	8	geel	geel	PROPN
bam-8383	308	9	n.	n.	PROPN
bam-8383	308	10	clinical	clinical	ADJ
bam-8383	308	11	significance	significance	NOUN
bam-8383	308	12	of	of	ADP
bam-8383	308	13	serum	serum	NOUN
bam-8383	308	14	soluble	soluble	ADJ
bam-8383	308	15	cd	cd	NOUN
bam-8383	308	16	molecules	molecule	NOUN
bam-8383	308	17	to	to	PART
bam-8383	308	18	assess	assess	VERB
bam-8383	308	19	disease	disease	NOUN
bam-8383	308	20	activity	activity	NOUN
bam-8383	308	21	in	in	ADP
bam-8383	308	22	vitiligo	vitiligo	NOUN
bam-8383	308	23	.	.	PUNCT
bam-8383	309	1	jama	jama	PROPN
bam-8383	309	2	dermatol	dermatol	NOUN
bam-8383	309	3	2016;152:1194	2016;152:1194	NUM
bam-8383	309	4	-	-	SYM
bam-8383	309	5	200	200	NUM
bam-8383	309	6	.	.	NOUN
bam-8383	309	7	64	64	NUM
bam-8383	309	8	.	.	PUNCT
bam-8383	309	9	taïeb	taïeb	NOUN
bam-8383	309	10	a.	a.	NOUN
bam-8383	309	11	vitiligo	vitiligo	PROPN
bam-8383	309	12	as	as	ADP
bam-8383	309	13	an	an	DET
bam-8383	309	14	inflammatory	inflammatory	ADJ
bam-8383	309	15	skin	skin	NOUN
bam-8383	309	16	disorder	disorder	NOUN
bam-8383	309	17	:	:	PUNCT
bam-8383	309	18	a	a	DET
bam-8383	309	19	therapeutic	therapeutic	ADJ
bam-8383	309	20	perspective	perspective	NOUN
bam-8383	309	21	.	.	PUNCT
bam-8383	310	1	pigment	pigment	ADJ
bam-8383	310	2	cell	cell	PROPN
bam-8383	310	3	&	&	CCONJ
bam-8383	310	4	melanoma	melanoma	PROPN
bam-8383	310	5	res	re	NOUN
bam-8383	310	6	2012;25:9	2012;25:9	NOUN
bam-8383	310	7	-	-	SYM
bam-8383	310	8	13	13	NUM
bam-8383	310	9	.	.	PUNCT
bam-8383	310	10	65	65	NUM
bam-8383	310	11	.	.	PUNCT
bam-8383	311	1	vaccaro	vaccaro	PROPN
bam-8383	311	2	m	m	PROPN
bam-8383	311	3	,	,	PUNCT
bam-8383	311	4	irrera	irrera	NOUN
bam-8383	311	5	n	n	CCONJ
bam-8383	311	6	,	,	PUNCT
bam-8383	311	7	cutroneo	cutroneo	VERB
bam-8383	311	8	g	g	PROPN
bam-8383	311	9	,	,	PUNCT
bam-8383	311	10	et	et	PROPN
bam-8383	311	11	al	al	PROPN
bam-8383	311	12	.	.	PROPN
bam-8383	311	13	differential	differential	ADJ
bam-8383	311	14	expression	expression	NOUN
bam-8383	311	15	of	of	ADP
bam-8383	311	16	nitric	nitric	ADJ
bam-8383	311	17	oxide	oxide	NOUN
bam-8383	311	18	synthase	synthase	NOUN
bam-8383	311	19	isoforms	isoform	VERB
bam-8383	311	20	nnos	nno	NOUN
bam-8383	311	21	and	and	CCONJ
bam-8383	311	22	inos	ino	NOUN
bam-8383	311	23	in	in	ADP
bam-8383	311	24	patients	patient	NOUN
bam-8383	311	25	with	with	ADP
bam-8383	311	26	non	non	ADJ
bam-8383	311	27	-	-	ADJ
bam-8383	311	28	segmental	segmental	ADJ
bam-8383	311	29	generalized	generalized	ADJ
bam-8383	311	30	vitiligo	vitiligo	NOUN
bam-8383	311	31	.	.	PUNCT
bam-8383	312	1	int	int	PROPN
bam-8383	312	2	j	j	PROPN
bam-8383	312	3	mol	mol	ADP
bam-8383	312	4	sci	sci	PROPN
bam-8383	312	5	2017;18:2533	2017;18:2533	NUM
bam-8383	312	6	.	.	PROPN
bam-8383	313	1	66	66	NUM
bam-8383	313	2	.	.	PUNCT
bam-8383	313	3	falabella	falabella	PROPN
bam-8383	313	4	r	r	PROPN
bam-8383	313	5	,	,	PUNCT
bam-8383	313	6	barona	barona	PROPN
bam-8383	313	7	mi	mi	PROPN
bam-8383	313	8	.	.	PROPN
bam-8383	313	9	update	update	NOUN
bam-8383	313	10	on	on	ADP
bam-8383	313	11	skin	skin	NOUN
bam-8383	313	12	repigmentation	repigmentation	NOUN
bam-8383	313	13	therapies	therapy	NOUN
bam-8383	313	14	in	in	ADP
bam-8383	313	15	vitiligo	vitiligo	NOUN
bam-8383	313	16	.	.	PUNCT
bam-8383	314	1	pigment	pigment	ADJ
bam-8383	314	2	cell	cell	PROPN
bam-8383	314	3	&	&	CCONJ
bam-8383	314	4	melanoma	melanoma	PROPN
bam-8383	314	5	res	re	VERB
bam-8383	314	6	2009;22(1):42	2009;22(1):42	PROPN
bam-8383	314	7	-	-	SYM
bam-8383	314	8	65	65	NUM
bam-8383	314	9	.	.	PROPN
bam-8383	315	1	67	67	NUM
bam-8383	315	2	.	.	PUNCT
bam-8383	316	1	grines	grine	NOUN
bam-8383	316	2	p.	p.	PROPN
bam-8383	316	3	white	white	PROPN
bam-8383	316	4	patches	patch	NOUN
bam-8383	316	5	and	and	CCONJ
bam-8383	316	6	bruised	bruise	VERB
bam-8383	316	7	souls	soul	NOUN
bam-8383	316	8	:	:	PUNCT
bam-8383	316	9	advances	advance	NOUN
bam-8383	316	10	in	in	ADP
bam-8383	316	11	the	the	DET
bam-8383	316	12	pathogenesis	pathogenesis	NOUN
bam-8383	316	13	and	and	CCONJ
bam-8383	316	14	treatment	treatment	NOUN
bam-8383	316	15	of	of	ADP
bam-8383	316	16	vitiligo	vitiligo	NOUN
bam-8383	316	17	.	.	PUNCT
bam-8383	317	1	j	j	PROPN
bam-8383	317	2	am	be	AUX
bam-8383	317	3	acad	acad	ADJ
bam-8383	317	4	dermatol	dermatol	NOUN
bam-8383	317	5	2004;51:85	2004;51:85	NUM
bam-8383	317	6	-	-	SYM
bam-8383	317	7	7	7	NUM
bam-8383	317	8	.	.	NUM
bam-8383	317	9	68	68	NUM
bam-8383	317	10	.	.	PUNCT
bam-8383	318	1	rashed	rashe	VERB
bam-8383	318	2	l	l	PROPN
bam-8383	318	3	,	,	PUNCT
bam-8383	318	4	abdel	abdel	PROPN
bam-8383	318	5	hay	hay	PROPN
bam-8383	318	6	r	r	PROPN
bam-8383	318	7	,	,	PUNCT
bam-8383	318	8	mahmoud	mahmoud	PROPN
bam-8383	318	9	r	r	PROPN
bam-8383	318	10	,	,	PUNCT
bam-8383	318	11	et	et	PROPN
bam-8383	318	12	al	al	PROPN
bam-8383	318	13	.	.	PROPN
bam-8383	318	14	association	association	PROPN
bam-8383	318	15	of	of	ADP
bam-8383	318	16	angiotensin	angiotensin	NOUN
bam-8383	318	17	-	-	PUNCT
bam-8383	318	18	converting	convert	VERB
bam-8383	318	19	enzyme	enzyme	NOUN
bam-8383	318	20	(	(	PUNCT
bam-8383	318	21	ace	ace	NOUN
bam-8383	318	22	)	)	PUNCT
bam-8383	318	23	gene	gene	NOUN
bam-8383	318	24	polymorphism	polymorphism	NOUN
bam-8383	318	25	with	with	ADP
bam-8383	318	26	inflammation	inflammation	NOUN
bam-8383	318	27	and	and	CCONJ
bam-8383	318	28	cellular	cellular	ADJ
bam-8383	318	29	cytotoxicity	cytotoxicity	NOUN
bam-8383	318	30	in	in	ADP
bam-8383	318	31	vitiligo	vitiligo	ADJ
bam-8383	318	32	patients	patient	NOUN
bam-8383	318	33	.	.	PUNCT
bam-8383	319	1	plos	plos	PROPN
bam-8383	319	2	one	one	NUM
bam-8383	319	3	2015;10	2015;10	NUM
bam-8383	319	4	:	:	PUNCT
bam-8383	319	5	e0132915	e0132915	PROPN
bam-8383	319	6	.	.	PROPN
bam-8383	319	7	69	69	NUM
bam-8383	319	8	.	.	PUNCT
bam-8383	320	1	wang	wang	PROPN
bam-8383	320	2	cq	cq	PROPN
bam-8383	320	3	,	,	PUNCT
bam-8383	320	4	cruz	cruz	PROPN
bam-8383	320	5	-	-	PUNCT
bam-8383	320	6	inigo	inigo	PROPN
bam-8383	320	7	ae	ae	PROPN
bam-8383	320	8	,	,	PUNCT
bam-8383	320	9	fuentes	fuentes	PROPN
bam-8383	320	10	-	-	PUNCT
bam-8383	320	11	duculan	duculan	PROPN
bam-8383	320	12	j	j	PROPN
bam-8383	320	13	,	,	PUNCT
bam-8383	320	14	et	et	PROPN
bam-8383	320	15	al	al	PROPN
bam-8383	320	16	.	.	PUNCT
bam-8383	321	1	th17	th17	NOUN
bam-8383	321	2	cells	cell	NOUN
bam-8383	321	3	and	and	CCONJ
bam-8383	321	4	activated	activate	VERB
bam-8383	321	5	dendritic	dendritic	ADJ
bam-8383	321	6	cells	cell	NOUN
bam-8383	321	7	are	be	AUX
bam-8383	321	8	increased	increase	VERB
bam-8383	321	9	in	in	ADP
bam-8383	321	10	vitiligo	vitiligo	ADJ
bam-8383	321	11	lesions	lesion	NOUN
bam-8383	321	12	.	.	PUNCT
bam-8383	322	1	plos	plos	PROPN
bam-8383	322	2	one	one	NUM
bam-8383	322	3	2011;6	2011;6	NUM
bam-8383	322	4	:	:	PUNCT
bam-8383	322	5	e18907	e18907	PROPN
bam-8383	322	6	.	.	PUNCT
bam-8383	323	1	70	70	NUM
bam-8383	323	2	.	.	PUNCT
bam-8383	324	1	pastor	pastor	PROPN
bam-8383	324	2	f	f	PROPN
bam-8383	324	3	,	,	PUNCT
bam-8383	324	4	dumas	dumas	PROPN
bam-8383	324	5	k	k	PROPN
bam-8383	324	6	,	,	PUNCT
bam-8383	324	7	barthelemy	barthelemy	PROPN
bam-8383	324	8	ma	ma	PROPN
bam-8383	324	9	,	,	PUNCT
bam-8383	324	10	et	et	PROPN
bam-8383	324	11	al	al	PROPN
bam-8383	324	12	.	.	PROPN
bam-8383	324	13	implication	implication	NOUN
bam-8383	324	14	of	of	ADP
bam-8383	324	15	redd1	redd1	NOUN
bam-8383	324	16	in	in	ADP
bam-8383	324	17	the	the	DET
bam-8383	324	18	activation	activation	NOUN
bam-8383	324	19	of	of	ADP
bam-8383	324	20	inflammatory	inflammatory	ADJ
bam-8383	324	21	pathways	pathway	NOUN
bam-8383	324	22	.	.	PUNCT
bam-8383	325	1	sci	sci	PROPN
bam-8383	325	2	rep	rep	PROPN
bam-8383	325	3	2017;7:7023	2017;7:7023	PROPN
bam-8383	325	4	.	.	PUNCT
bam-8383	326	1	71	71	NUM
bam-8383	326	2	.	.	PUNCT
bam-8383	326	3	levandowski	levandowski	PROPN
bam-8383	326	4	cb	cb	PROPN
bam-8383	326	5	,	,	PUNCT
bam-8383	326	6	mailloux	mailloux	VERB
bam-8383	326	7	cm	cm	PROPN
bam-8383	326	8	,	,	PUNCT
bam-8383	326	9	et	et	PROPN
bam-8383	326	10	al	al	PROPN
bam-8383	326	11	.	.	PUNCT
bam-8383	326	12	nlrp1	nlrp1	NOUN
bam-8383	326	13	haplotypes	haplotype	NOUN
bam-8383	326	14	associated	associate	VERB
bam-8383	326	15	with	with	ADP
bam-8383	326	16	vitiligo	vitiligo	NOUN
bam-8383	326	17	and	and	CCONJ
bam-8383	326	18	autoimmunity	autoimmunity	NOUN
bam-8383	326	19	increase	increase	NOUN
bam-8383	326	20	interleukin-1beta	interleukin-1beta	PUNCT
bam-8383	326	21	non	non	X
bam-8383	326	22	co	co	X
bam-8383	326	23	mmerc	mmerc	PROPN
bam-8383	326	24	ial	ial	PROPN
bam-8383	326	25	us	us	PROPN
bam-8383	327	1	e	e	NOUN
bam-8383	327	2	o	o	NOUN
bam-8383	327	3	nly	nly	ADV
bam-8383	327	4	inos	ino	NOUN
bam-8383	327	5	inhibition	inhibition	NOUN
bam-8383	327	6	for	for	ADP
bam-8383	327	7	vitiligo	vitiligo	PROPN
bam-8383	327	8	eur	eur	PROPN
bam-8383	327	9	j	j	PROPN
bam-8383	327	10	transl	transl	PROPN
bam-8383	327	11	myol	myol	ADV
bam-8383	327	12	29	29	NUM
bam-8383	327	13	(	(	PUNCT
bam-8383	327	14	3	3	NUM
bam-8383	327	15	):	):	PUNCT
bam-8383	327	16	251	251	NUM
bam-8383	327	17	-	-	SYM
bam-8383	327	18	260	260	NUM
bam-8383	327	19	,	,	PUNCT
bam-8383	327	20	2019	2019	NUM
bam-8383	327	21	260	260	NUM
bam-8383	327	22	processing	processing	NOUN
bam-8383	327	23	via	via	ADP
bam-8383	327	24	the	the	DET
bam-8383	327	25	nlrp1	nlrp1	NOUN
bam-8383	327	26	inflammasome	inflammasome	NOUN
bam-8383	327	27	.	.	PUNCT
bam-8383	328	1	proc	proc	PROPN
bam-8383	328	2	natl	natl	PROPN
bam-8383	328	3	acad	acad	PROPN
bam-8383	328	4	sci	sci	PROPN
bam-8383	328	5	usa	usa	PROPN
bam-8383	328	6	2013;110:2952	2013;110:2952	NUM
bam-8383	328	7	-	-	SYM
bam-8383	328	8	6	6	NUM
bam-8383	328	9	.	.	NUM
bam-8383	328	10	72	72	NUM
bam-8383	328	11	.	.	PUNCT
bam-8383	329	1	wilson	wilson	PROPN
bam-8383	329	2	sp	sp	PROPN
bam-8383	329	3	,	,	PUNCT
bam-8383	329	4	cassel	cassel	PROPN
bam-8383	329	5	sl	sl	PROPN
bam-8383	329	6	.	.	PUNCT
bam-8383	329	7	inflammasome	inflammasome	NOUN
bam-8383	329	8	-	-	PUNCT
bam-8383	329	9	mediated	mediate	VERB
bam-8383	329	10	autoinflammatory	autoinflammatory	NOUN
bam-8383	329	11	disorders	disorder	NOUN
bam-8383	329	12	.	.	PUNCT
bam-8383	330	1	postgrad	postgrad	PROPN
bam-8383	330	2	med	med	PROPN
bam-8383	330	3	2010;122:125	2010;122:125	NUM
bam-8383	330	4	-	-	SYM
bam-8383	330	5	33	33	NUM
bam-8383	330	6	.	.	PUNCT
bam-8383	331	1	73	73	NUM
bam-8383	331	2	.	.	PUNCT
bam-8383	332	1	pichler	pichler	NOUN
bam-8383	332	2	r	r	NOUN
bam-8383	332	3	,	,	PUNCT
bam-8383	332	4	sfetsos	sfetsos	PROPN
bam-8383	332	5	k	k	NOUN
bam-8383	332	6	,	,	PUNCT
bam-8383	332	7	badics	badics	PROPN
bam-8383	332	8	b	b	PROPN
bam-8383	332	9	,	,	PUNCT
bam-8383	332	10	et	et	PROPN
bam-8383	332	11	al	al	PROPN
bam-8383	332	12	.	.	PROPN
bam-8383	332	13	lymphocyte	lymphocyte	ADJ
bam-8383	332	14	imbalance	imbalance	NOUN
bam-8383	332	15	in	in	ADP
bam-8383	332	16	vitiligo	vitiligo	NOUN
bam-8383	332	17	patients	patient	NOUN
bam-8383	332	18	indicated	indicate	VERB
bam-8383	332	19	by	by	ADP
bam-8383	332	20	elevated	elevated	ADJ
bam-8383	332	21	cd4+/cd8	cd4+/cd8	NOUN
bam-8383	332	22	+	+	CCONJ
bam-8383	332	23	t	t	NOUN
bam-8383	332	24	-	-	PUNCT
bam-8383	332	25	cell	cell	NOUN
bam-8383	332	26	ratio	ratio	NOUN
bam-8383	332	27	.	.	PUNCT
bam-8383	333	1	wiener	wiener	NOUN
bam-8383	333	2	medizinische	medizinische	PROPN
bam-8383	333	3	wochenschrift	wochenschrift	NOUN
bam-8383	333	4	(	(	PUNCT
bam-8383	333	5	1946	1946	NUM
bam-8383	333	6	)	)	PUNCT
bam-8383	333	7	.	.	PUNCT
bam-8383	334	1	2009;159:337	2009;159:337	NUM
bam-8383	334	2	-	-	SYM
bam-8383	334	3	41	41	NUM
bam-8383	334	4	.	.	PUNCT
bam-8383	335	1	74	74	NUM
bam-8383	335	2	.	.	PUNCT
bam-8383	336	1	tobin	tobin	PROPN
bam-8383	336	2	dj	dj	PROPN
bam-8383	336	3	,	,	PUNCT
bam-8383	336	4	swanson	swanson	PROPN
bam-8383	336	5	nn	nn	PROPN
bam-8383	336	6	,	,	PUNCT
bam-8383	336	7	pittelkow	pittelkow	PROPN
bam-8383	336	8	mr	mr	PROPN
bam-8383	336	9	,	,	PUNCT
bam-8383	336	10	et	et	PROPN
bam-8383	336	11	al	al	PROPN
bam-8383	336	12	.	.	PROPN
bam-8383	336	13	melanocytes	melanocyte	NOUN
bam-8383	336	14	are	be	AUX
bam-8383	336	15	not	not	PART
bam-8383	336	16	absent	absent	ADJ
bam-8383	336	17	in	in	ADP
bam-8383	336	18	lesional	lesional	ADJ
bam-8383	336	19	skin	skin	NOUN
bam-8383	336	20	of	of	ADP
bam-8383	336	21	long	long	ADJ
bam-8383	336	22	duration	duration	NOUN
bam-8383	336	23	vitiligo	vitiligo	NOUN
bam-8383	336	24	.	.	PUNCT
bam-8383	337	1	j	j	PROPN
bam-8383	337	2	pathol	pathol	PROPN
bam-8383	337	3	2000;191:407	2000;191:407	PROPN
bam-8383	337	4	-	-	SYM
bam-8383	337	5	16	16	NUM
bam-8383	337	6	.	.	PUNCT
bam-8383	338	1	75	75	NUM
bam-8383	338	2	.	.	PUNCT
bam-8383	339	1	gottschalk	gottschalk	PROPN
bam-8383	339	2	gm	gm	PROPN
bam-8383	339	3	,	,	PUNCT
bam-8383	339	4	kidson	kidson	PROPN
bam-8383	339	5	sh	sh	PROPN
bam-8383	339	6	.	.	PROPN
bam-8383	339	7	molecular	molecular	ADJ
bam-8383	339	8	analysis	analysis	NOUN
bam-8383	339	9	of	of	ADP
bam-8383	339	10	vitiligo	vitiligo	ADJ
bam-8383	339	11	lesions	lesion	NOUN
bam-8383	339	12	reveals	reveal	VERB
bam-8383	339	13	sporadic	sporadic	ADJ
bam-8383	339	14	melanocyte	melanocyte	NOUN
bam-8383	339	15	survival	survival	NOUN
bam-8383	339	16	.	.	PUNCT
bam-8383	340	1	int	int	NOUN
bam-8383	340	2	j	j	PROPN
bam-8383	340	3	dermatol	dermatol	NOUN
bam-8383	340	4	2007;46:268	2007;46:268	NUM
bam-8383	340	5	-	-	SYM
bam-8383	340	6	72	72	NUM
bam-8383	340	7	.	.	PUNCT
bam-8383	341	1	submission	submission	NOUN
bam-8383	341	2	:	:	PUNCT
bam-8383	341	3	july	july	PROPN
bam-8383	341	4	9	9	NUM
bam-8383	341	5	,	,	PUNCT
bam-8383	341	6	2019	2019	NUM
bam-8383	341	7	acceptance	acceptance	NOUN
bam-8383	341	8	:	:	PUNCT
bam-8383	341	9	july	july	PROPN
bam-8383	341	10	24	24	NUM
bam-8383	341	11	,	,	PUNCT
bam-8383	341	12	2019	2019	NUM
bam-8383	341	13	non	non	X
bam-8383	341	14	co	co	X
bam-8383	341	15	mmerc	mmerc	PROPN
bam-8383	341	16	ial	ial	PROPN
bam-8383	341	17	us	us	PROPN
bam-8383	342	1	e	e	NOUN
bam-8383	342	2	o	o	NOUN
bam-8383	342	3	nly	nly	ADV